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ii 
ABSTRACT 
 
The purpose of this project was to investigate whether methodology developed in 
these laboratories for preparing 5/6 and 6/6 azabicyclic systems with bridged 
head nitrogen can be extended to 7/6, 8/6, 9/6 and 13/6 azabicyclic systems. The 
methodology entails the use of enaminones as central to the formation of the 
azabicyclic systems.  
 
The synthetic route adopted began with the Beckmann rearrangement reaction 
and/or the Schmidt reaction of cyclic ketones to make lactams, which were then 
thionated by Curphy or Brillon procedures. The Michael reaction of NH 
thiolactams with tert-butyl acrylate was followed by Eschenmoser sulfide 
contraction to afford the enaminones 132 which were utilised in the ring-closing 
step. This involved hydrolysis of the tert-butyl ester and cyclisation via a mixed 
anhydride. Ethyl 7-oxo-1,2,3,5,6,7-hexahydroindolizine-8-carboxylate 170b, 1-(4-
nitrobenzoyl)-3,4,6,7,8,9-hexahydroquinolizin-2-one 172a, 1-benzoyl-
3,4,7,8,9,10-hexahydropyrido[1,2-a]azepin-2(6H)-one 173d, 1-(4-nitrobenzoyl)-
3,4,6,7,8,9,10,11-octahydropyrido[1,2-a]azocin-2-one 174a, and 1-(4-
nitrobenzoyl)-3,4,7,8,9,10,11,12,13,14,17,16-dodecahydropyrido[1,2-a]azacyclo- 
tridecin-2(6H)-one 176a were synthesised in good yields, but yields of 8-(4-
nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one 171a and 1-(4-nitrobenzoyl)-
3,4,7,8,9,10,11,12-octahydropyrido[1,2-a]azonin-2(6H)-one 175a were not 
satisfactory.  
 
In a much shorter synthetic route that involves enaminone chemistry as well, NH 
vinylogous amides were synthesised by the Eschenmoser sulfide contraction and 
used in the aza-annulation reaction with acryloyl chloride. Structural isomers (to 
compounds mentioned above) 8-(4-nitrobenzoyl)-2,3,6,7-tetrahydroindolizin-
5(1H)-one 178a, 1-(4-nitrobenzoyl)-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-
4(6H)-one 180a, 1-benzoyl-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-4(6H)-one 
180b, 1-(4-nitrobenzoyl)-2,3,6,7,8,9,10,11-octahydropyrido[1,2-a]azocin-4-one 
iii 
181a, 1-(4-nitrobenzoyl)-2,3,7,8,9,10,11,12-octahydropyrido[1,2-a]azonin-4(6H)-
one 182a and 1-(4-nitrobenzoyl)-2,6,7,8,9,10,11,12,13,14,15,16-
dodecahydropyrido[1,2-a]azacyclo-tridecin-4(3H)-one 183a were synthesised in 
good yields. 1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one 179a was 
obtained in low yield, and apparently as two conformational isomers.  
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CHAPTER 1: BACKGROUND TO THE PROJECT 
 
1.1 Introduction  
 
The organic group at the University of the Witwatersrand (Wits) has devoted 
considerable effort to making azabicyclic alkaloids containing the indolizidine 1 
and quinolizidine 2 ring systems, which are very common in natural products. 
Other azabicyclic systems such as 3 and 4 are much less common in nature, and 
the Wits research group has paid almost no attention to them up to now (Figure 
1). The purpose of this project is to investigate whether methodology developed 
in these laboratories for smaller azabicyclic systems can be extended to 
analogues in which at least one of the rings is seven-membered or larger. 
         
N N N N
1 2 3 4
Figure 1. Azabicyclic systems with small and medium rings
 
This discussion will begin with a short survey of some natural products containing 
azabicyclic systems with seven-membered and larger rings. The second part will 
be a short survey on how other groups make these azabicyclic systems. The 
Wits approach to alkaloid synthesis via enaminone intermediates will then be 
introduced. The specific aims of this project and strategies to be followed will 
then be presented. 
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1.2 Alkaloids with seven and larger-membered rings 
1.2.1 Lehmizidines 
                                                   
N
R2 R1
X
3
5
 
Lehmizidines R1 R2 X 
5 (CH2)7C≡CH CH3 H 
6 (CH2)5CH=CHCH=CH2 CH3 H 
7 (CH2)7CH=CH2 CH3 H 
8 C9H13O (=O, C≡CH) CH3 H 
9 (CH2)5CH=CHC≡CH CH3 OH 
10 C9H15O CH3 H 
11 (CH2)7C≡CH CH3 OH 
12 C9H17O (=O) CH3 H 
13 (CH2)7CH=CH2 CH3 OH 
14 (CH2)3CH3 H – 
                      Table 1. Lehmizidines1,2 
Lehmizidine alkaloids originate from a group of Colombian dendrobatid frogs, 
known as Dendrobates lehmanni.1 Ten alkaloids, 5 – 14, belonging to this group 
have been reported. Their structures were elucidated by mass spectral analysis. 
The mass spectrum of lehmizidines revealed the presence of a substituent at C-
3, indicated by a base peak; and a methyl substituent at C-5, indicated by a small 
fragment. The relative structural configuration of all lehmizidines is unknown, 
3 
except for compound 5, which is shown with the relative configuration. Positions 
of the OH groups are also unknown. No toxicity or biological activity data have 
been reported.1 Unlike the frog lehmizidines with a methyl group, (3R)-3-butyl-
octahydro-1H-pyrrolo[1,2-a]azepine 14, isolated together with some indolizidine 
alkaloids from an ant Myrmicaria melanogaster from Brunei Darussalam, has a 
butyl side as the only substituent at C-3.2  
 
1.2.2 Stemona alkaloids 
 
Stemona alkaloids are another group of alkaloids that contain the azabicyclic 
nucleus 3 of interest. They are found in the family Stemonaceae, which occurs 
from southern Asia and Malaysia to northern Australia.3 The pyrrolo[1,2-
a]azepine nucleus, also known as perhydroazaazulene and 4-azaazulene, is at 
the heart of most Stemona alkaloids (A, Figure 2). The Stemona alkaloids have 
been classified by Pilli and de Oliveira into five groups according to their 
structural features, namely stenine I, stemoamide II, tuberostemonine III, 
stemonamine IV and tuberostemoamide V (Figure 2).3 
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Figure 2. Main classes of Stemona alkaloids.3
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Some specific examples of classes (I) – (V) are shown in Figure 3. They include 
stenine 15, tuberostemonine 16 and tuberostemonine A 17, which can be 
structurally represented by the tetracyclic furo[2,3-h]pyrrolo[3,2,1-
jk][1]benzazepin-10(2H)-one nucleus (I); stemoamide 18 and neostemodiol 19, 
which display the tricyclic 2H-furo[3,2-c]pyrrolo[1,2-a]azepine nucleus (II); 
tuberostemospironine 20 and didehydrocroomine 21, which are structurally 
characterized by a 2H-spiro[furan-2,9’[9H]pyrrolo[1,2-a]azepin-5-one nucleus 
(III); stemonamine 22, which is structurally characterized by a 2’H,11H-spiro[1H-
cyclopenta[b]pyrrolo[1,2-a]azepine-1,2’furan]-5’,10-dione nucleus (IV) and 
didehydroparvistemonine 23, which is characterized by the lack of the B-C ring 
fusion and a hexahydro-2,6-dimethyl-5-oxofuro[3,2,-b]furan-3-yl]moiety attached 
to C-9 in the pyrrolo[1,2-a]azepine nucleus (V). 3 
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Figure 3. Examples of Stemona alkaloids.3
3
 
 
5 
Of interest to this project are alkaloids in which the azabicyclic system is not 
fused to other carbocyclic rings. These include most members of the 
stemoamide, tuberostemospironine and parvistemoline families. The 
representative examples in these groups are neostemodiol 19, 
didehydrocroomine 21 and didehydroparvistemonine 23 respectively.  
 
The crude extracts of Stemonaceae species have been used by the Chinese and 
Japanese as insecticides, vermifuges and in the treatment of respiratory 
diseases. They have also shown antitubercular and antitussive activities. 
Tuberostemonine 16 has shown activity when tested against Angiostrongylus 
cantonensis, Dipylidium caninum and Fasciola hepatica, with an effect of motility 
of these helminthic worms. Tuberostemonine has also been shown by Shinozaki 
and Ishida to depress glutamate-induced responses at similar concentrations to 
those of established glutamate inhibitors. This has been shown on the 
neuromuscular transmission in crayfish, which is considered a model for studying 
the mechanism of drug action in the mammalian central nervous system. A few 
other Stemona alkaloids have also been reported to show insect anti-feeding 
activity, but it seems that no other biological activity has been reported.3 
 
The stemocurtisine group of the Stemona alkaloids containing the pyrido[1,2-
a]azepine nucleus (B, Figure 4) has been isolated mainly from the roots S. kerrii, 
collected in North and Northwest Thailand.4 The specific alkaloids are 
stemokerrin 24, methoxystemokerrin-N-oxide 25, oxystemokerrin 26, 
oxystemokerrin-N-oxide 27 and pyridostemin 28 (Figure 4). Oxystemokerrin 26 
has an oxygen bridge between C-1 and C-9, while stemokerrin 24 is unsaturated 
between C-8 and C-9. Pyridostemin 28 lacks the substituent at C-4 of 
oxystemokerrin 26.4 
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A common biogenetic origin may be suggested by the occurrence of both the 
pyrrolo- and pyridoazepine alkaloids in the same plant species. For example, 
protostemonine 29 (Figure 5) is a likely biosynthetic precursor of the 
pyridoazepine alkaloids. The butyl side chain at C-3 of compound 30 might be 
interpreted as a result of hydrolysis of the lactone ring of compound 29 followed 
by decarboxylation. The propyl side chain at C-4 of compound 31 might also be 
interpreted as the cleavage of the C-3–N bond, followed by the formation of C-
18–N (Figure 5) [also labeled as C-4–N bond on (B, Figure 4)].4  
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The strongest insecticidal activity was found for oxystemokerrin 26, which had a 
LC50 value of 5.9 ppm. N-Oxidation in oxystemokerrin-N-oxide 27 or insertion of 
double bond in stemokerrin 24 resulted in decreased activities to LC50 values of 
12.5 ppm and 58 ppm, respectively. The biggest drop in activity was due to loss 
of the side chain in 28 (LC50 = 149) or O-methylation in 25 (LC50 > 100 ppm). In 
general compounds 24, 26, 27, 28 and 29 were characterized by the paralysis 
and softening of the larval bodies.4 
 
1.2.3 Securinega alkaloids 
 
The Securinega alkaloids include four well-known natural occurring alkaloids, 
which occur in plants of the family Euphorbiaceae. They are securinine 32, 
virosecurinine 33, allosecurinine 34 and viroallosecurinine 45 (Figure 6).5 
Securinine 32 and allosecurinine 34 occur in Securinega suffruticosa, whilst 
virosecurinine 33 and viroallosecurinine 35 occur in S. virosa.5 In addition to 
these alkaloids (–)-norsecurinine 36 and (–)-allonorsecurinine 37 are naturally 
occurring, and the rare alkaloids phyllanthidine 38 and ent-phyllanthidine 39 were 
isolated from Phyllanthus discoides and Securinega suffruticosa.6,7 
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Securinine 32 was the first to have its structure elucidated in 1962 by 
degradation and spectroscopic studies. The structure was confirmed in 1965 by 
X-ray crystallography.5 The Securinega alkaloids present a tetracyclic structure 
formed by an α,ß-butenolide (ring D), a 6-azabicyclo[3.2.1]octane system (rings 
9 
B and C), and a piperidine or pyrrolidine (ring A) (32, Figure 6).5 Rings A and C 
together constitute the pyridoazepine skeleton that is of interest for this project. 
 
The biological activity of securinine 32 is of interest as the compound has been 
used in Russia as a CNS stimulating drug, acting as a stereospecific antagonist 
at the GABA binding site of the GABAA–receptor complex. Its rigidity might aid in 
understanding the shape of the GABAA receptor site.5 
 
Recently, new Securinega alkaloids have been discovered from the wood of 
Securinega suffruticasa var. amamiensis which occurs in the Ryukyu Islands in 
the subtropical area of Japan.8 They have been found with the relatively known 
Securinega alkaloids securinine 32 and phyllanthidine 38. The new alkaloids are 
secu’amamine A 43, 4-epiphyllanthine 44, securitinine 45, 15α-methoxy-14,15-
dihydrophyllochrysine 46 and they are secu’ amamines B 40, C 41, D 42.8  
 
Their structures as shown in Figure 6 contain methoxy groups compared to 
securinine 32 with no methoxy group. The Securinega alkaloids are of interest to 
this project because they contain the 5,7, 6,7 and 5,8 ring systems.  
 
1.2.4 Manzamine alkaloids 
 
The manzamine alkaloids, which include ircinal A 47, manzamine A 48, 8-
hydroxymanzamine A 49, 6-hydroxymanzamine A 50, 6-deoxymanzamine X 51, 
manzamine E 52 and manzamine F 53, were isolated from the Indonesian 
marine sponge Acanthostrongylophora (Figure 7).9,10 Their structure is 
characterized by the decahydropyrrolo[1,2-a]azocine nucleus C fused to a 
octahydroisoquinoline at C-25 and C-26 and a 13-membered ring fused with 
octahydroisoquinoline nucleus between C-12 and N-21.  
10 
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Biological activities such as insecticidal, antiparasitic, anti-inflammatory, cytotoxic 
and antibacterial activities have been previously reported for manzamine 
alkaloids. In addition to this, the manzamine alkaloids have recently shown 
biological activities against M. tuberculosis (H37Rv), chloroquine sensitive D6 
clone and chloroquine resistant W2 clone of P. falciparum and Leishmania 
donovani, AIDS opportunistic pathogens and HIV-1.9 They have also shown 
activity in GSK3 inhibition in vitro, one of the two kinase implicated in tau 
hyperphosphorylation, the other being CDK-5.10  The decreasing activity against 
M. tuberculosis was in the order from 6-hydroxymanzamine A 50, 8-
hydroyxmanzamine A 49, manzamine A 48, manzamine F 53 to manzamine E 
52. The higher activity in this case maybe due to the position of the OH group at 
R2. The decreasing activity against chloroquine sensitive D6 clone and 
chloroquine resistant W2 clone of P.falciparum was in the order from manzamine 
A 48, 8-hydroxymanzamine A 49, 6-hydroxymanzamine A 50, manzamine F 53 
to manzamine E 52. There is a great difference between the activity of 8-
11 
hydroyxmanzamine A 49 and 6-hydroxymanzamine A 50 that might be due to the 
preference of the OH group to be at R1 for higher activity. The decreasing activity 
against Leishmania donovani was in the order from manzamine A 48, 6-
hydroxymanzamine A 50, manzamine E 52, manzamine F 53 to 8-
hydroyxmanzamine A 49. Generally, the decreasing activity against AIDS 
opportunistic pathogens, namely S. aureus, MRS, C. neoformans and M. 
intracellulare was in the order from manzamine A 48, 8-hydroxymanzamine A 49, 
6-hydroxymanzamine A 50, manzamine F 53 to manzamine E 52 with some 
compounds showing no activity or not tested. The decreasing activity against 
HIV-1 was in the order from 8-hydroyxmanzamine A 49, manzamine A 48, 
manzamine F 53 to manzamine E 52.  The decreasing activity in GSK3 inhibition 
was in the order from 8-hydroyxmanzamine A 49, manzamine A 48, manzamine 
E 52 to manzamine F 53.9 The manzamine alkaloids can be used as a building 
block for the synthesis of more potent and selective GSK-3 inhibitors for the 
control of diabetes and Alzheimer’s disease.10 
 
 
1.3 Reported synthetic approaches to pyrrolo[1,2-a]azepine and pyrido[1,2-
a]azepine systems: selected examples 
 
1.3.1 A short synthesis of racemic (3,10Z)-3-butyllehmizidine 56 and 
(3,10E)-3-butyllehmizidine 14 
 
Jones and co-workers synthesised (3,10Z)-3-butyllehmizidine 56 and (3,10E)-3-
butyllehmizidine 14 in a bid to compare compound 14 to a naturally occurring 
diastereomer 14 found in the ant Myrmicaria melanogaster from Brunei (Scheme 
1).2 {2-[2-(1,3-dioxan-2-yl)ethyl]azepan-1-yl}(phenyl)methanone 55 was prepared 
in a Grignard reaction of 1-benzoylazepan-2-one 54 with a three fold excess of 
the Grignard reagent  prepared from 2-(2-bromoethyl)-1,3-dioxane that was 
stirred overnight at room temperature (a, Scheme 1), followed by addition of 
sodium cyanoborohydride and acetic acid at 0 °C. Th e reaction mixture was 
12 
worked-up and the resulting crude product distilled at 150 – 160 °C to give the 
desired compound 55 at 47% yield that was 81% pure by GC analysis (b, 
Scheme 1). 
 
       
N
Bz
O N
Bz O
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N N+
Scheme 1. (a) Excess Grignard reagent prepared from 2-(2-bromoethyl)-1,3-dioxane,
THF, 0 °C to rt, overnight; ( b) 1.24 NaCNBH3, 8 ml CH3COOH, 0 °C; ( c) 1 g
Ammonium formate, 1g 10% Pd/C, methanol, reflux, overnight; (d) 5ml 10% HCl, 1 drop
70% HClO4 (v/v), THF, rt, 3 days; (e) KCN, excess n-butylmagnesium bromide.2
a, b c, d, e
54 55 56 14
 
 
Compound 55 was deprotected refluxing with ammonium formate and Pd/C in 
THF to yield crude 2-[2-(1,3-dioxan-2-yl)ethyl]azepane in a 70% yield (c, 
Scheme 1). The crude azepane stirred for 3 days with 10% hydrochloric acid and 
one drop of 70% perchloric acid (v/v) in THF, followed by sequential addition of 
potassium cyanide and excess of n-butylmagnesium bromide to yield a 1:1 
mixture of the isomers of 14. Jones and co-workers confirmed the synthetic 
(3,10E)-3-butyllehmizidine 14 to be identical to the naturally occurring compound 
14.2 
 
1.3.2 Mercury-promoted Schmidt reactions 
 
Pearson and co-workers reported the mercury-promoted Schmidt reaction of the 
1-(3-azidopropyl)-2-methylenecyclohexane 57 to be more regioselective 
compared to the proton-promoted Schmidt reaction.11 The lack of regioselectivity 
in the proton-promoted Schmidt reaction is due to carbocation rearrangement 
prior to cyclisation (top path, Scheme 3). The yields for 58/59 were a modest 
40% affected by isolation problems (top path, Scheme 2). A reaction of 
compound 57 with stoichiometric amount of mercuric perchlorate trihydrate or 
13 
mercuric trifluoromethanesulfonate, followed by reduction with sodium 
borohydride gave 58 in 84% and 87% yields, respectively, as determined by GC 
against an internal decane standard, calibrated for relative response. Again, 
isolation difficulties resulted in a 38% yield of 58.11  
 
                   
N3
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N
a) TfOH
CH2Cl2
b)NaBH4
MeOH
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d) NaBH4
15%aq. NaOH
(1 : 1)
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58 59
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+
Hg(ClO4)2 ·3H2O:
84% (38%)
Hg(OTf)2:
87%
Scheme 2. Proton- vs mercury-promoted Schmidt reactions.11
  
 
The proton-promoted Schmidt reaction proceeds as shown (top path, Scheme 
3). Compound 60 results from protonation of the alkene in compound 57, 
followed by migration of the tertiary carbocation. Cyclisation to the 
aminodiazonium ion affords compound 61, in which bonds a or b 
nonregioselectively migrate to form two regioisomeric iminium ions 62. The 
reduction by sodium borohydride affords regioisomers 58/59.11 In the mercury-
promoted Schmidt reaction (bottom path, Scheme 3), a mercuronium ion 63 is 
formed instead of the carbocation when compound 57 is treated with an 
electrophile. Ring-closing by nucleophilic azide attack opens the mercuronium 
ion 63 without rearrangement affording compound 64, in which bond c 
rearranges and the reduction by sodium borohydride gives 58 as the only 
regioisomer.11 
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Scheme 3. Proposed mechanisms for Proton-and mercury-promoted Schmidt 
reactions.11
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Scheme 4. Additional mercury-promoted Schmidt reactions.11
 
 
Compound 58 and (5S)-5-methyl-decahydropyrrolo[1,2-a]azocine 68 were also 
synthesised in a mercury-promoted Schmidt reaction from 6-(3-azidopropyl)-1-
methylcyclohex-1-ene 66 and 1-(3-azidopropyl)-2-methylenecycloheptane 67 
respectively, both in 31% isolated yield.11 
 
15 
1.3.3 Novel synthesis of octahydro-1H-pyrrolo[1,2-a]azepine and 
decahydropyrido[1,2-a]azepine 
 
De Kimpe and co-workers recently reported a short, reliable synthesis of 1-
azabicyclic rings, including examples containing an azepine ring. To achieve 1-
azabicyclo[5.4.0]decane 3 (a,b,c,d, Scheme 5) they reacted 1-bromo-4-
chlorobutane with 2-methyl-1-pyrroline 69, resulting in the stable intermediate 2-
(5-chloropentyl)-1-pyrroline 70 which was isolated. The formation of the iminium 
salt 71 was catalyzed by heat upon distillation of 2-(5-chloropentyl)-1-pyrroline 
70. Iminium salt 71 was then reduced to the desired product 3. To achieve 1-
azabicyclo[5.4.0]undecane 4 (e,f,g,h, Scheme 5) they reacted 1-bromo-4-
chlorobutane with 6-methyl-2,3,4,5-tetrahydropyridine 72 resulting in the stable 
intermediate 6-(5-chloropentyl)-2,3,4,5-tetrahydropyridine 73. The formation of 
the iminium salt 74 was catalysed by heating 6-(5-chloropentyl)-2,3,4,5-
tetrahydropyridine 73 (neat). The iminium salt 70 was then reduced to the 
desired product 4. It was also observed that treatment of 6-(5-chloropentyl)-
2,3,4,5-tetrahydropyridine 73 directly with sodium borohydride resulted in a 
mixture of major 2-(5-chloro-pentyl)piperidine 75 and minor desired 1-
azabicyclo[5.4.0]undecane 4.12 
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69
70 (97%) 71 (85%) 3 (68%)
Cl-
Scheme 5. The synthesis of azabicyclic alkaloids (3)and(4) with larger rings.
(a) 1.1 equiv. LDA, THF, N2, -78 °C, 1 h; ( b) 1.05 equiv. Br(CH2)4Cl, -78 °C, 1 h +
rt, 15 h; (c) 120 °C; ( d) 1 equiv. LiAlH4, Et2O, rt, 45 min; (e) 1.1 equiv. LDA, THF, 
N2, -78 °C, 2 h; ( f) 1.05 equiv. Br(CH2)4Cl, -78 °C - rt, 15 h; ( g) 115 °C; 
(h) 1.5 equiv. LiAlH4, Et2O, heat, 3 h; (i) 2 equiv. NaBH4, MeOH, heat, 3 h.12
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1.3.4 Synthesis of 5/7-, 5/8- and 5/9-bicyclic lactams  
 
Young and co-workers have synthesised 5/7-, 5/8- and 5/9-bicyclic lactam 
templates as constraints for external β-turns, by a route involving ring closing 
metathesis.  The reverse turns occur on the surface of a large functional protein, 
and connect elements of protein secondary structure. They form an important 
design for molecular recognition.  Synthetic β-turns that mimic these turns are 
less liable to proteolysis than natural turns, owing to the ability not to be part of a 
large protein to be constrained in appropriate stable conformations.13,14 
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(2S,5R)-Benzyl 5-allylpyrrolidine-2-carboxylate 76 (common in all of their 
synthetic routes) was synthesised by a route by Scolastico et al. from (S)-2-
benzyl 1-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate over four steps in an overall 
79% yield.13,15 In preparation for 5/7-bicyclic lactam they required (R)-2-(tert-
butoxycarbonyl)but-3-enoic acid 77, which was prepared by the method of 
Rapaport and Afzali-Ardakani from L-vinylglycine prepared from L-methionine.16 
A mixed anhydride made from compound 77 and isobutyl chloroformate was 
condensed and reacted with compound 76 at 0 °C resulting in unwanted (2 S)-2-
benzyl-1-isobutyl-5-allylpyrrolidine-1,2-dicarboxylate 78 and desired (2S)-benzyl 
5-allyl-1-[(S)-2-(tert-butoxycarbonyl)but-3-enoyl]pyrrolidine-2-carboxylate 79 in 
poor yields (a, Scheme 6). A ring closing methatesis by the Grubbs catalyst 
resulted in  (3S,6S,9aR,Z)-benzyl 6-(tert-butoxycarbonyl)-5-oxo-2,3,5,6,9,9a-
hexahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate 80a and (3S,6R,9aR,Z)-
benzyl 6-(tert-butoxycarbonyl)-5-oxo-2,3,5,6,9,9a-hexahydro-1H-pyrrolo[1,2-
a]azepine-3-carboxylate 80b (b, Scheme 6). Compound 80a was hydrolysed to 
the amino acid hydrochloride 81 in a quantitative yield (c, Scheme 6).13 
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Scheme 6. (a) (i) ClCO2iBu, pyridine, THF, 0 °C, 15 min, (ii) 76, THF, rt, 3 h (23% 78, 20% 79); 
(b) ([c-C6H10)3]P)2Cl2Ru=CHPh, CH2Cl2, reflux, 24 h (58% 80a, 9% 80b); (c) 6 N HCl, 60 °C, overnight 
(quant.).13
 
 
(S)-2-(tert-Butoxycarbonyl)pent-4-enoic acid 82 was prepared by the in situ Wittig 
reaction of (S)-tert-butyl 2-(tert-butoxycarbonyl)-4-oxobutanoate with 
18 
methyltriphenylphosphonium ylide, followed by hydrolysis of the alkene using 6 N 
hydrochloric acid and treatment of the resultant amino acid with di-tert-butyl 
dicarbonate under Schotten-Baumann conditions. The mixed anhydride formed 
on reacting compound 82 with isobutyl chloroformate was reacted with 
compound 76 at –78 °C affording unwanted compound 78 and the desired (S)-
benzyl 5-allyl-1-[(S)-2-(tert-butoxycarbonyl)pent-4-enoyl]pyrrolidine-2-carboxylate 
83 in poor yield (a, Scheme 7). Ring closing metathesis gave 5/8-bicyclic lactam 
84 as a single diastereoisomer in good yield (b, Scheme 7).13 
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Scheme 7. (a) (i) ClCO2iBu, pyridine, THF, -78 °C, 15 min, (ii) 76, CH2Cl2, rt, 3 h 
(33% 78, 15% 83); (b) ([c-C6H10)3]P)2Cl2Ru=CHPh, CH2Cl2, reflux, 24 h (65%).13
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In making (S)-2-(tert-butoxycarbonyl)hex-5-enoic acid 85 (S)-tert-butyl 2-(tert-
butoxycarbonyl)-5-[methoxy(methyl)amino]-5-oxopentanoate was reduced to (S)-
tert-butyl 2-(tert-butoxycarbonyl)-5-oxopentanoate (an aldehyde) using tri-tert-
butoxyaluminium hydride followed by Wittig reaction. (S)-tert-Butyl 2-(tert-
butoxycarbonyl)hex-5-enoate was hydrolysed to the corresponding amino acid 
and protected with the Boc group to afford compound 85. Compound 86 was 
accompanied by compound 78 as products in the reaction between the mixed 
anhydride and compound 76 (a, Scheme 8). Ring closing metathesis gave 5/9-
bicyclic lactam 87 as a single diastereoisomer in good yield (b, Scheme 8).13 
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Scheme 8. (a) (i) ClCO2iBu, pyridine, THF, -78 °C, 15 min, (ii) 76, CH2Cl2, rt, 3 h 
(36% 78, 27% 86); (b) ([c-C6H10)3]P)2Cl2Ru=CHPh, CH2Cl2, reflux, 24 h (84%).13
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There are many other literature examples dedicated to the making of 5/7 
azabicyclic alkaloids.17-21  
 
 
1.4 The Wits Background 
 
1.4.1 Introduction to enaminones 
 
An enaminone is a α,β aminoenone in which the lone pair is in conjugation with 
the unsaturated system (see Figure 8). The acyl group stabilises and monitors 
the reactivity of the enamine unit. The electron-withdrawing group (EWG) may 
either influence or overwhelm the reactivity of the enaminone core. The kinds of 
enaminones this group has explored are the vinylogous amides, urethanes, 
cyanamides, ureas, sulfonamides and nitramines (see Figure 8).22 In virtually all 
work from this group, the nitrogen is part of a heterocyclic ring. 
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The cyclic enaminones needed for this project are easily obtained from 
thiolactams. The thiolactams are prepared in a thionation reaction from lactams 
made from primary amine and bifuctional reagents (e.g. 4-chlorobutanoyl 
chloride) or by a Michael addition reaction of secondary thiolactams (e.g. 
pyrrolidine-2-thione) to methyl vinyl ketone-like acceptors (e.g. acrylate esters). 
The alkylidene substituent is either introduced in a Knoevenagel like 
condensation of a relatively acidic component (e.g. nitromethane) with 
methylthioiminium salts or in an Eschenmoser sulfide contraction reaction, with a 
loss of sulfur from the salt that results when thiolactams react with α-
halocarbonyl compounds (Scheme 9).22 
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Enaminones can react as both electrophiles and as nucleophiles. As 
nucleophiles, the enaminone’s expected nucleophilicity at N (I, Figure 9) and C 
(ii, Figure 9) is extended to the carbonyl O group (iii, Figure 9) through 
conjugation. Strong bases can deprotonate the carbon β to N or acid induced 
tautomerism to give further nucleophilicity (iv, Figure 9). As electrophiles, 
enaminones can participate in 1,2-and 1,4-additions (v, vi, Figure 9). We intend 
to explore the ‘enamine’ nucleophilicity at C (ii, Figure 9) to access azabicyclic 
alkaloid scaffolds.22 
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Figure 9. Enaminone rectivity.22
 
 
1.4.2 Alkaloid synthesis via enaminones: Selected Wits examples 
 
Michael and Gravestock have reported the synthesis of alkaloid 167B (±)-95 in 
eight steps with an overall yield of 7.2% based on pyrrolidine-2-thione 89. Their 
synthesis started with the Michael addition of pyrrolidine-2-thione 89 to the 
Michael acceptor 88 to yield ethyl 3-(2-thioxopyrrolidin-1-yl)hexanoate (±)-90 in 
moderate yield, which they could not improve (a, Scheme 10). They then took 3-
(2-thioxopyrrolidin-1-yl)hexanoate (±)-90 through an Eschenmoser reaction with 
ethyl 2-bromoacetate, resulting exclusively in the formation (E)-ethyl 3-[2-(2-
ethoxy-2-oxoethylidene)pyrrolidin-1-yl]hexanoate (±)-91 with excellent yield (b, c. 
Scheme 10). Compound (±)-91 could form the basis the desired acylative 
cyclisation, but they had to convert compound (±)-91 into an anhydride (±)-93 
owing to inefficiency of the saturated ester as an acylating agent. This they did 
through a chemoselective hydrolysis of compound (±)-91 with sodium hydroxide 
refluxing in water. They then followed with the reaction of the resulting salt 
sodium (E)-3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl)hexanoate (±)-92 with 
acetic anhydride in situ at ambient temperature. The enaminone chemistry then 
took centre stage when the temperature was raised to reflux with a spontaneous 
cyclisation of the anhydride, yielding the ethyl 7-oxo-5-propyl-1,2,3,5,6,7-
hexahydroindolizine-8-carboxylate (±)-94 in excellent yield over three steps. The 
23 
synthesis was completed by hydrolysis and decarboxylation of the ester and 
reduction of the remaining functional groups.23 
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Scheme 10. (a) NaOH (cat.), THF, reflux; (b) BrCH2CO2Et, MeCN,
rt; (c) PPh3, NEt3, MeCN, rt; (d) NaOH, H2O, reflux; (e) Ac2O, 
MeCN, rt; (f) MeCN, reflux.23
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Michael and Gravestock extended this work to include an enantioselective 
synthesis of (–)-indolizidine 167B 106.24 They achieved this by using the optically 
pure chiral amine N-benzyl-1-phenylethylamine in the conjugate addition to α,ß-
unsaturated esters, a procedure demonstrated by Davies and Ichihara.25 To 
begin, they had to prepare (E)-tert-butyl hex-2-enoate 98a using the Horner-
Wadsworth-Emmons variation of the Wittig reaction. They treated tert-butyl 2-
bromoacetate 96a with triethyl phosphite at 110 °C achieving tert-butyl 2-
(diethoxyphosphoryl)acetate 97a, which they then treated with butanal in the 
24 
presence of 1,5-diazabicyclo[5.4.0]undec-7-ene and lithium chloride, giving (E)-
tert-butyl hex-2-enoate 98a in 63% yield and 99:1 diastereoselectivity (a, b, 
Scheme 11, Series a). Michael addition of the (R)-N-benzyl-1-phenylethanamine 
anion to (E)-tert-butyl hex-2-enoate 98a gave them the optically active (R)-tert-
butyl 3-{benzyl[(R)-1-phenylethyl]amino}hexanoate 99a in 74% yield (c, Scheme 
11, Series a). Compound 99a was debenzylated in a catalytic reduction reaction 
giving (R)-tert-butyl 3-aminohexanoate 100a in 70% yield (d, Scheme 11, Series 
a). (R)-tert-Butyl 3-(2-oxopyrrolidin-1-yl)hexanoate 101a was made by first 
forming an uncyclised amide intermediate using 4-chlorobutanoyl chloride and 
sodium hydrogen carbonate as proton scavenger,  which was cyclised by 
addition of freshly sublimed potassium tert-butoxide in 56% yield over two steps 
(e, f, Scheme 11, Series a). Compound 101a was thionated using Lawesson’s 
reagent to achieve (R)-tert-butyl 3-(2-thioxopyrrolidin-1-yl)hexanoate 102a in 
85% yield (g, Scheme 11, Series a) . The vinylogous urethane (R,E)-tert-butyl 3-
[2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl]hexanoate 103a was prepared in 
79% yield over two steps, first by S-alkylating compound 102a with ethyl 
bromoacetate followed by the Eschenmoser sulphide contraction (h, i, Scheme 
11, Series a). The tert-butyl ester was not a suitable acylating agent for a ß-
aminoacrylate 103a. (R,E)-3-[2-(2-Ethoxy-2-oxoethylidene)pyrrolidin-1-
yl]hexanoic acid 104 was synthesised using trimethylsilyl iodide to cleave the 
tert-butyl group of compound 103a in variable yields (17%–95%) (j, Scheme 11, 
Series a). This they attributed to extensive decomposition of the labile vinylogous 
urethane under acid hydrolysis conditions. Michael and co-workers managed to 
make indolizidine (R)-ethyl 7-oxo-5-propyl-1,2,3,5,6,7-hexahydroindolizine-8-
carboxylate 105 in 55% yield over two steps from the impure acid 104 in a 
reaction with acetic anhydride (l, Scheme 11, Series a). The unsuccessful 
cyclisation step made them recall that cyclisation under basic conditions gave 
better success.  But using the less hindered ethyl ester would result in far less 
diastereoselectivity as determined by the Davies procedure.25 They then 
replaced the tert-butyl group with a sterically demanding secondary alcohol, (+)-
menthol.24  
25 
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Scheme 11. (a) P(OEt)3, 110°C; ( b) butanal, DBU, LiCl, MeCN, rt; (c) (R)-N-benzyl-1-phenyl-
ethanamine, BuLi, THF, -78°C; ( d) H2 (7 atm), 10 % Pd-C, HOAc, rt; (e) Cl(CH2)3COCl, 
NaHCO3, CHCl, RT; (f) KOBut, ButOH; (g) Lawesson's reagent, toluene, reflux; (h) BrCH2CO2Et,
MeCN, rt (for R = But); (i) Ph3P, Et3N, MeCN, rt; (j) Me3Sil, CCl4, rt (for R = But); (k) KOH, EtOH, 
reflux (for R = menthyl); (l) Ac2O, MeCN, 50 °C. 24
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(1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl 2-bromoacetate 96b was 
quantitatively prepared following a procedure described by Vandewalle and co-
workers from (+)-menthol, sodium hydroxide and bromoacetyl bromide in 
toluene.26 The rest of the synthesis from compound 96b to compound 103b was 
analogous to that described for the tert-butyl series. These compound were 
prepared with the accompanying yields, 97b, 98b (92%), amine 99b (93%), 100b 
(91%), 101b (66%), 102b (83%) and 103b (89%) (a, b, c, d, e, f, g, h, i, Scheme 
11, Series b).  Then they hydrolysed 103b in a reaction with potassium hydroxide 
refluxing in methanol, followed by the cyclisation of the unpurified acid using 
acetic anhydride and potassium carbonate in dry acetonitrile to give compound 
26 
105 in 87% yield over two steps. They achieved the enantioselective synthesis of 
(–)-indolizidine 167B 106 over four steps from compound 105. 24 
 
The previous synthesis illustrated the formation of an azabicyclic system by an 
intramolecular acylation of an enaminone. Michael’s team has also made 
azabicyclic systems by an intramolecular alkylation of an enaminone.25 For 
example; they used six-membered vinylogous urethanes in the synthesis of (±)-
lupinine 115 and (±)-epilupinine 116. This work also showed interesting 
differences in the behavior of 5-and 6-membered vinylogous urethanes. Their 
synthesis began with the Michael addition reaction of thiolactams 89 and 107 to 
tert-butyl acrylate or ethyl acrylate in dry tetrahydrofuran at 40 °C giving N-alkyl-
thiolactams 108a–d in excellent yield (a, Scheme 12). The N-alkyl-thiolactams 
108a–d were converted into vinylogous urethane 109a–d in good yields in a two-
step Eschenmoser sulfide contraction reaction with ethyl bromoacetate in 
acetonitrile at room temperature and followed by triphenylphosphine and 
triethylamine in acetonitrile at room temperature (b, c, Scheme 12).27  
 
Brown’s observation (“Reactions which involve the loss of an exo double bond 
will be favored in the 6-ring as compared to the corresponding 5-ring 
derivative”)28 about the stability and reactivity of double bonds that are exocyclic 
or endocyclic to rings of varying size applied to their vinylogous urethanes.27 The 
loss of the exo double bond in their attempted reduction of the saturated ester of 
the vinylogous urethanes 109c and 109d resulted in compound 112, while their 
reduction of the saturated ester of the vinylogous urethanes 109a and 109b 
resulted in compound 110a (d, Scheme 12) that retained the exo double bond. 
Michael and co-workers took their study further to investigate the lability of 
piperidinylidene vinylogous urethane towards conjugate reduction by using the 
vinylogous cyanamide.  They found that the reduction of vinylogous cyanamides 
113a and 113b gave product 114 in good yields of 74% and 60% respectively, 
with no presence of over reduced product (f, Scheme 12). Compound 109d was 
best reduced with lithium aluminium hydride in a 4:1 ratio combination of solvents 
27 
toluene and diethyl ether at 0 °C, yielding compoun d 110b (62%) and compound 
112 (13%). Michael’s team converted the alcohol into a good leaving group by 
substituting it with iodine in the presence of triphenylphosphine and imidazole, 
making alkyl iodide, which formed in situ and immediately cyclised to give ethyl 
3,4,6,7,8,9-hexahydro-2H-quinolizine-1-carboxylate 111 in 74% yield, when the 
reactants were heated in a 2:1 mixture of toluene and acetonitrile. (±)-Lupinine 
115 was achieved in two more steps and (±)-epilupinine 116 was made in three 
more steps from compound 111 in excellent yields.27 
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120 °C, 80 min; ( f) LiAlH4, THF, rt, 48 h.27
N N
H H
OH OH
115 116
 
 
Michael and co-workers have recently prepared azabicyclo type compound using 
vinylogous sulfonamides instead of the usual vinylogous urethane.29 The 
thiolactams were activated with iodomethane and the resulting thioiminium salt 
was transformed to ß-substituted enamines in the presence of an activated 
28 
methylene system. The thiolactams 117 and 118 were prepared in a thionation 
reaction of corresponding lactams in good yields. 1-[(4-
Methylphenyl)sulfonyl]propan-2-one was also prepared in a reaction of sodium 4-
methylbenzenesulfinate with chloroacetone using procedures in literature in 
excellent yields.30 The thiolactams 117 and 118 were reacted with 1-[(4-
methylphenyl)sulfonyl]propan-2-one resulting in the (E)-3-[2-(2-oxo-1-
tosylpropylidene)pyrrolidin-1-yl]propyl acetate 119 and (E)-ethyl 3-[2-(2-oxo-1-
tosylpropylidene)pyrrolidin-1-yl]propanoate 120 they expected plus the 
vinylogous sulfonamides (E)-3-[2-(tosylmethylene)pyrrolidin-1-yl]propyl acetate 
121 and (E)-ethyl 3-[2-(tosylmethylene)pyrrolidin-1-yl]propanoate 122 (with the 
illustrated (E) geometry) that they did not expect (a, b, Scheme 13). This was as 
a result of spontaneous deacylation of products due to increasing reaction time. 
Compounds 121 and 125 were made by treating 119 and 120 with trifluoroacetic 
acid in acceptable yields (c, Scheme 13). In order to get higher yields, it proved 
to be better to separate the mixture of product first and do the deacylation step 
on compounds 119 and 120 rather than forcing complete deacylation of the 
mixture.24 (E)-3-[2-(Tosylmethylene)pyrrolidin-1-yl]propan-1-ol 123 was prepared 
from compound 121 in a reaction with potassium carbonate (d, Scheme 13) and 
from compound 122 in a reaction with lithium aluminium hydride (e, Scheme 13). 
Compound 123 was ring-closed using triphenylphosphine, imidazole and iodine 
(f, Scheme 13) resulting in 8-tosyl-1,2,3,5,6,7-hexahydroindolizine 124 in good 
yield, while they also achieved 8-tosyl-2,3,5,6-tetrahydroindolizin-7(1H)-one 125 
over two steps in good yield using potassium carbonate and acetic anhydride (g, 
h, Scheme 13).29 This work is now being extended to the synthesis of 3,5-
disubstituted indolizidine alkaloids [S Travis, PhD].  
 
29 
        
N S
R
N
R COMe
SO2-p-Tol
N
R
SO2-p-Tol
H
N
SO2-p-Tol
OAc
N
SO2-p-Tol
CO2Et
N
SO2-p-Tol
OH
N SO2-p-Tol
O
N SO2-p-Tol
+
117 R = (CH2)3OAc
118 R = (CH2)2CO2Et
121 R = (CH2)3OAc
122 R = (CH2)2CO2Et
119 R = (CH2)3OAc
120 R = (CH2)2CO2Et
121
122
123
124
125
a, b c
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Scheme 13. (a) MeI, THF, 0 °C, 1-17 h;  ( b) MeOCCH2SO2-p-Tol, NEt3, CH2Cl2, rt, 
72 h (yields:120 + 122, 5% + 81%; 121 + 123, 5% + 70%); (c) TFA, 80-90 °C, 
30 min (yields: 122, 87%; 123, 92%); (d) K2CO3, MeOH, rt, 1 h (96%); (e) LiAlH4,
THF, rt, 15 h (94%); (f) PPh3, Im, I2, MeCN, reflux, 2 h (80%); (g) KOH, EtOH, reflux, 
30 min, then HCl; (h) K2CO3, AcO, MeCN, 50 °C, 2 h, rt, 21 h (71% over 2 steps ).29
 
 
 
1.5 Aims 
 
This MSc project is a continuation of the Honours projects of Ramsuran and 
Madeley.31,32 Ramsuran attempted the synthesis of azabicyclic systems 3 and 4 
using well established methods within our laboratories for the synthesis of 
azabicyclic systems such as 1 and 2. Owing to time limitation she could not get 
to the all-important ring closing-step that utilizes enaminone chemistry, but 
successfully made (E)-tert-butyl 3-(2-(2-ethoxy-2-oxoethylidene)azepan-1-
yl)propanoate 126. On the other hand Madeley synthesized the scaffold for the 
azabicyclic system 4, namely ethyl 2-oxo-2,3,4,6,7,8,9,10-octahydropyrido[1,2-
a]azepine-1-carboxylate 128. He also attempted to synthesise azabicyclic 
30 
systems in which one of the rings was 13-membered fused to a 6-membered ring 
131, but managed to make compound 127. 
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FIgure 10. Ramsuran's compound 126 and Madeley's compounds 127 and 128
 
 
Before we could extend the methodology for making azabicyclic systems 1 and 2 
to larger rings, we had to make these azabicyclic systems first, to make sure the 
methodology works in my hands.  
 
We aimed to synthesise scaffolds from which we could make the azabicyclic 
systems octahydroindolizine 1, octahydro-1H-quinolizine 2, decahydropyrido[1,2-
a]azepine 4, decahydro-1H-pyrido[1,2-a]azocine 129, dodecahydropyrido[1,2-
a]azonine 130 and 131 (Figure 11).  
 
              
N N N N
1 2 3 4
N N N
129 130 131
Figure 11. Azabicyclic systems with small, medium and large rings
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Thus, the principal aim of my MSc is to make 1-azabicyclic systems in which a 7-
membered or larger ring is fused to a six-membered ring where they share one 
common nitrogen atom. These could then be analogues of the 5,6 (indolizidines) 
and 6,6 (quinolizidines) ring systems, which as shown previously, can easily be 
made by cycloalkalation or cycloacylation of suitable enamine precursors. 
Therefore, in this work, the idea is to start with a large-ring enaminones (132, 
Figure 12), onto which a six-membered ring can be fused by utilizing a variety of 
methods. It is thus necessary to prepare suitable enaminones, which we 
intended would be derived from lactam precursors, as described in Section 1.4.1. 
 
                                              
(CH2)n
N
Z
R
Figure 12. 132  n = 1, 2, 3 and 7
 
 
The synthetic strategy we wish to adopt begins with the Beckmann 
rearrangement reaction (a, Scheme 14) or the Schmidt reaction for making 
lactams from ring ketones that were relatively expensive (b, Scheme 14). The 
Beckmann rearrangement reaction is a two-step reaction starting from cyclic 
ketone, resulting in the formation of a ketoxime in the first step and the second 
step is the rearrangement of the ketoxime to a lactam.  The lactams are 
converted into thiolactams utilising a thionation reaction (c, Scheme 14). The N-
Alkylated thiolactams are formed are a result of a Michael reaction between NH 
thiolactams and tert-butyl acrylate (d, Scheme 14).  
 
The enaminones formed can be achieved by using an Eschenmoser sulfide 
contraction reaction of N-alkylated thiolactams or N-H thiolactams with good 
electron withdrawing groups (e, Scheme 14). For this project, we decided to 
prepare vinylogous urethanes (R = CO2Et) and vinylogous amides (R = COC6H4-
p-NO2 or COPh). This is a two step reaction which starts with S-alkylation of the 
32 
electron withdrawing group which is followed by the extrusion of the sulfur 
substituent.  
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Scheme 14. (a) Beckmann rearrangement reaction; (b) Schmidt reaction; (c) Thionation reaction;
(d) Michael addition reaction; (e) Eschenmoser sulfide contraction reaction; (f) Ring-closing step 1;
(g) Ring-closing step 2.
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The next step was to explore two different methods for building the six-
membered ring onto the enaminone scarffold. In the first, we would use the N-
alkylated products in intramolecular acylation reactions by first hydrolyzing the 
tert-butyl ester to an acid, and then exploiting a previously developed cyclisation 
via a mixed anhydride to give the desired products (f, Scheme 14). In the second 
approach, we planned to investigate an aza-annulation process introduced by 
Stille and co-workers in which secondary enamines are treated with acryloyl 
chloride to give isomeric azabicycles (g, Scheme 14).33 
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CHAPTER 2: RESULTS AND DISCUSSION 
 
 
2.1 Synthesis of azacyclotridecane-2-one by the Beckmann rearrangement 
 
Although commercially available and cheap, azacyclotridecane-2-one 135 was 
initially synthesized by a known Beckmann rearrangement reaction.34 This is a 
two step reaction in which the first step is the formation of ketoxime and the 
second step is the rearrangement of the ketoxime to a lactam. Cyclododecanone 
oxime 134 was prepared in 96% yield from cyclododecanone 133 and 
hydroxylamine hydrochloride (a, Scheme 15). Its melting point of 117 – 118 °C 
was different to that of cyclododecanone 59 – 61 °C .35a  
 
        
O N OH
NH
O
Scheme 15. (a) 2.3 eq. NH2OH.HCl, 2.5 eq. C2H3O2Na.3H2O, MeOH, 90 °C, 3 h; (b) 0.05 eq. Cyanuric chloride, MeCN, relfux, 2.33 h.
a b
133 134 135
 
 
The IR spectrum had a broad peak at νmax = 3413 cm-1 for an OH group, νmax = 
1642 cm-1 for a C=N group and no indication of the carbonyl group at νmax = 1720 
cm-1 from cyclododecanone.  1H NMR spectroscopy indicated the presence of 
the OH group at δ = 7.80 ppm. The 13C NMR spectrum showed the up-field shift 
of the quaternary carbon peak from δ ≈ 200 ppm to δ = 161.2 ppm, indicating the 
disappearance of the carbonyl carbon in cyclododecanone 133 and the 
appearance of the C=N group in cyclododecanone oxime 134. There were no 
competing side reactions; this can be seen by the exceptionally high yield for this 
reaction. The elevated melting point is presumably due to the strong hydrogen 
34 
bonding between the N···HO in cyclododecanone oxime 134 as compared to 
dipole-dipole forces in cyclododecanone.  
 
In the second step of the Beckmann rearrangement reaction a mixture of 
cyclododecanone oxime 134 and cyanuric chloride in acetonitrile was refluxed 
followed by base treatment with sodium hydrogen carbonate. The crude product 
was recrystallised from a mixture of ethyl acetate and hexane, giving the pure 
azacyclotridecane-2-one 135 in 98% yield (b, Scheme 15). Its melting point of 
151 °C was comparable to the literature value 35b of 150 – 153 °C and higher 
than that of cyclododecanone oxime 134.  The IR spectrum had a broad peak at 
νmax = 3307 cm-1 for the NH group and strong peak at νmax = 1639 cm-1 for the 
amide carbonyl group.  1H NMR spectroscopy indicated the presence of the NH 
group at δ = 5.53 ppm, which is an up-field shift of about δ = 2.27 ppm from the 
OH peak of cyclododecanone oxime 134. The 13C NMR spectrum showed the 
down-field shift of the quaternary carbon peak from δ = 161.2 ppm to δ = 173.8 
ppm, indicating an amide type carbonyl group. There were also no competing 
side reactions. This two-step Beckmann reaction was a success with an overall 
yield of 95%. 
 
 
2.2 Synthesis of lactams by the Schmidt reaction 
 
The azocan-2-one 139 and azonan-2-one 140 are also relatively expensive when 
compared to pyrrolidin-2-one, piperidin-2-one and azepan-2-one. Attempted 
synthesis of compounds 139 and 140 from their respective ketooximes in the 
Beckmann rearrangement were unsuccessful, which is in line with the finding of 
Furuya and co-workers, except that they managed to make compound 140.34 
However, the Schmidt reaction, in which the ketone is treated with sodium azide 
under acidic conditions, gave the three lactams in good yield (Scheme 16).36 The 
35 
products were purified by recrystallisation. The mechanism is also shown in the 
Scheme. 
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Scheme 16. The Schmidt reaction and its mechanism.36
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Azocan-2-one 139 was synthesised in 83% yield from cycloheptanone 136. Its 
melting point of 35 – 36 °C was comparable to liter ature value of 35 – 38 °C. 35c 
The IR spectrum had a broad peak at νmax = 3291 cm-1 for an NH group and 
strong peak at νmax = 1659 cm-1 for the amide carbonyl group.  1H NMR 
spectroscopy indicated the presence of NH group at δ = 6.48 ppm. The 13C NMR 
spectrum showed the up-field shift of the quaternary carbon peak from δ ≈ 200 
ppm to δ = 173.4, indicating a change from ketone type quaternary to an amide 
type quaternary. The reaction had no observable side reaction by NMR 
spectroscopy.  
 
Azonan-2-one 140 was synthesised in 96% yield from cyclooctanone 137. Its 
melting point of 75 – 76 °C is clearly different to  that of cyclooctanone 137 32 – 
41 °C and was comparable to the literature value of  74 – 76 °C. 35d The IR 
spectrum had a broad peak at νmax = 3301 cm-1 for an NH group and strong peak 
at νmax = 1651 cm-1 for the amide carbonyl group.  1H NMR spectroscopy 
indicated the presence of NH group at δ = 6.36 ppm.  The 13C NMR spectrum 
showed the up-field shift of the quaternary carbon peak from δ ≈ 200 ppm to δ = 
36 
178.0, indicating a change from ketone type to an amide type carbonyl group. 
The high yield suggests few side reactions. Azacyclotridecan-2-one 135 was 
synthesised in 81% yield from cyclododecanone. The data were comparable to 
those obtained on the product from the Beckmann rearrangement.  
 
We preferred the Schmidt reaction over the Beckmann rearrangement because it 
was employable in the synthesis of all lactams we required. The Schmidt reaction 
was time efficient compared to the two-step Beckmann rearrangement. The 
cyclooximes were also not easy to handle owing to their fluffy nature. 
  
 
2.3 Synthesis of NH thiolactams 
 
The required thiolactams were prepared by the Curphey and Brillon 
procedures.37,38 The products are needed as starting materials for a Michael 
addition reaction or an Eschenmoser sulfide contraction reaction (See sections 
2.4 and 2.5.3).  
 
2.3.1 Synthesis by the Curphey procedure 
 
Curphey’s method makes use of hexamethyldisiloxane (HMDO) with phosphorus 
pentasulfide (P2S5) in the thionation of esters, lactones, 3-oxoesters, amides, 
lactams and ketones.37 This P2S5/HMDO combination has become a popular 
method for effecting thionation, in some cases equaling or exceeding the yields 
produced by Lawesson’s reagent (LR). Reagent-derived byproducts can be 
removed by a simple extractive or chromatographic workup, while the use of LR 
entails the use of large columns, even on small scale owing to LR’s high 
equivalent weight.37 Of relevance to our project Curphey made pyrrolidine-2-
thione 89 and azepane-2-thione 147 in 91% (83% isolated) and 100% (92% 
isolated) yields, respectively. We made five NH thiolactams by this procedure 
37 
and purified them by column chromatography and recrystallisation (Scheme 17 
and Table 2). 
 
         
n(H2C) NH
O
n(H2C) NH
S
0.46 eq. P2S5, 1.5 eq. (CH3)3SiOSi(CH3)3, CH2Cl2, 
3 to 5 days, rt
142 n = 1
143 n = 3
144 n = 4
145 n = 5
135 n = 9
89   n = 1
147 n = 3
148 n = 4
149 n = 5
150 n = 9
Scheme 17. The Curphey procedure
 
 
Table 2. 
Compound Yield 
/ % 
 
m. p. 
/ °C 
Significant 
IR 
signal 
νmax / cm-1 
Significant 
1H NMR 
signal 
δ / ppm 
Significant 
13C NMR 
signal 
δ / ppm 
89 36 103 – 105 (Lit. 103 – 
106)39 
3135 (NH) 8.59 (NH) 206.0 
(C=S) 
147 73 102 – 104  
(Lit. 103 – 104)38  
3423 (NH) 8.84 (NH) 210.7 
(C=S) 
148 71 69 – 72 (Lit. 79 – 82 
°C) 39 
3425 (NH) 8.59 (NH) 209.2 
(C=S) 
149 50 72 – 75 (Lit. 84 – 87 
°C) 39 
3407 (NH) 8.30 (NH) 209.6 
(C=S) 
150 93 104 (Lit. 102 – 104 
°C) 39 
3327 (NH) 7.21 (NH) 205.4 
(C=S) 
 
One example is discussed in detail here. Pyrrolidine-2-thione 89 was synthesised 
from 2-pyrrolidinone 142 in a poor 36% yield as cream crystals. Compound 89 
had a melting point of 103 – 105 °C (Lit. 103 – 106  °C) 39 which is clearly different 
from that of 2-pyrrolidinone 142 (23 – 25 °C). 35e The IR spectrum had a broad 
38 
peak at νmax = 3135 cm-1 for an NH group and no peak for the amide carbonyl 
group at νmax = 1650 cm-1.  1H NMR spectroscopy indicated the presence of an 
NH group at δ = 8.59 ppm. The 13C NMR spectrum showed a quaternary carbon 
peak at δ = 206.0 ppm, indicating a C=S carbonyl group. Compound 142 was not 
recovered after work-up. There may have been competing side reaction owing to 
the low yield of compound 89.  
 
Yields and significant data for the remaining products 147–150 are present in 
Table 2. The isolated yields of compound 89 and azepane-2-thione 147 are low 
compared to those obtained by Curphey for the same compounds. These 
compounds, including azonane-2-thione 149 may have been lost in the 
purification step. The lactams were not recovered in all five reactions, indicating 
either that the reaction went to completion or there were competing side 
reactions. In all cases except 150, a downfield shift of the NH signal from about δ 
≈ 6 ppm to δ ≈ 8 ppm in the 1H NMR spectrum was observed, indicating stronger 
deshielding effects of the sulfur atom. Again, the expected disappearance of the 
amide carbonyl (C=O) at δ ≈ 175 ppm and appearance of the thiolactam carbonyl 
(C=S) at δ ≈ 209 ppm was visible on the 13C NMR spectra in all cases.  
 
The crystal structure of azacyclotridecane-2-thione 150 (Figure 12) carried out by 
Dr C. Perry had its NH group pointing inwards, which may explain its low melting 
point as compared to 150 – 153 °C of azacyclotridec an-2-one 135. Its NH singal 
at δ ≈ 7.21 ppm is also different from the others owing to its conformation. We 
could not compare crystal structures of compounds 135 and 150, because 
attempted recrystallisation of 135 was not successful in all solvents we used. 
Generally, other thiolactams had higher melting points than their respective 
lactams.  
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Figure 12. Azacyclotridecane-2-thione 150 
                                       
 
2.3.2 Synthesis by the Brillon procedure 
 
Brillon’s method makes use of a more electrophilic in situ reagent, sodium 
carbonate/phosphorus pentasulfide A1 (1:1 ratio), in the thionation of amides, 
peptides and lactams.38 This is a modification of a procedure described by 
Scheeren,40 which uses the in situ reagent bicarbonate/phosphorus pentasulfide 
(6:1 ratio). Brillon’s in situ reagent is both soluble in THF and water which made 
for an easy workup procedure. Brillon prepared pyrrolidine-2-thione 89, 
piperidine-2-thione and azepane-2-thione 147 using condition A1 at 25 °C for 2 h 
in yields of 88%, 85% and 84%, respectively (Scheme 18).  
 
                    
n(H2C) NH
O
n(H2C) NH
S
1.05 eq. P2S5, 1.05 eq. NaCO3, THF,
 
4 days, rt
143 n = 3
145 n = 5
147 n = 3
149 n = 5
Scheme 18. The Brillon procedure
P4S10 + Na2CO3                            (P4S10O)2-Na22+
THF
-CO2
A1
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We made two thiolactams by this procedure to compensate for the moderate 
yields from the Curphey procedure. They were also purified by column 
chromatography and recrystallisation. Thiolactams 147 and 149 were 
synthesised from lactams 143 and 145 in good yields of 91% and 84% 
respectively, as colourless crystals. The data were comparable to those obtained 
on the products from the Curphey procedure.  
 
 
2.4 Synthesis of N-alkylated thiolactams 
 
One approach to making our bicyclic systems is to start with a functionalised 3-
carbon chain on nitrogen, and our way of doing this is to attach the chain at the 
thiolactam stage. N-Alkylated thiolactams were synthesised in a Michael reaction 
of NH thiolactam to tert-butyl acrylate as shown in Scheme 19. In this reaction, 
sodium hydroxide is used to deprotonate the nitrogen atom, which then engages 
in a 1,4 addition to tert-butyl acrylate. The electron density travels the conjugated 
system, picking up the acidic proton from the base and resulting in the N-
alkylated thiolactams.27 The products were purified by recrystallisation from ethyl 
acetate:hexane solvent mixture. The following six compounds were synthesised 
by this method (Scheme 19 and Table 3). 
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n(H2C) N
S
n(H2C) N
S
O
O
OH
O
O
H
n(H2C) N
S
O
O
n(H2C) NH
S
NaOH (cat.), 1.20 eq. CH2CHCOOC(CH3)3, 
THF, 40 °C, 17 to 22 h
89   n = 1
107 n = 2
147 n = 3
148 n = 4
149 n = 5
150 n = 9
108b n = 1
108c n = 2
151   n = 3
152   n = 4
153   n = 5
154   n = 9
Scheme 19. Michael addition reaction and proposed mechanism.41
 
 
Table 3 
Com-
pound 
Yield 
/ % 
m. p. 
/ °C 
Significant 
IR 
signal 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
108b 85 48 – 49 1716 
(C=O) 
3.98  
ButCO2CCH2CH2N  
and 3.02  
ButCO2CCH2CH2N 
171.2 (C=O)  
and   
201.9 (C=S) 
 
108c 73 54 – 55 
(Lit. 55 – 
56)27 
1716 
(C=O) 
3.95 
ButCO2CCH2CH2N  
and 2.75 
ButCO2CCH2CH2N 
171.1 (C=O)  
and  
199.9 (C=S) 
 
151 82 60 – 62 1725 
(C=O) 
4.23 
ButCO2CCH2CH2N  
and 3.12 
ButCO2CCH2CH2N 
171.5 (C=O)  
and  
206.8 (C=S) 
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Table 3 (continued) 
Com-
pound 
Yield 
/ % 
m. p. 
/ °C 
Significant 
IR 
signal 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
152 82 66 – 
69 
1727 
(C=O) 
4.13 
ButCO2CCH2CH2N 
and 3.07 
ButCO2CCH2CH2N 
171.3 (C=O)  
and  
205.7 (C=S) 
153 94 64 – 
66 
1726 
(C=O) 
4.12 
ButCO2CCH2CH2N 
and 3.05 
ButCO2CCH2CH2N 
171.7 (C=O)  
and  
206.8 (C=S) 
154 60 86 – 
88 
1727 
(C=O) 
4.10 
ButCO2CCH2CH2N 
and 2.77 
ButCO2CCH2CH2N 
171.6 (C=O)  
and  
205.1 (C=S) 
 
 
One example is discussed in detail here. tert-Butyl 3-(2-thioxopyrrolidin-1-
yl)propanoate 108b was synthesised from 2-pyrrolidine-2-thione 89 in a good 
85% yield as colourless crystals. N-Alkylated thiolactam 108b had a melting point 
of 48 – 49 °C which is clearly different and lower to that pyrrolidine-2-thione 103 
– 105 °C. The IR spectrum had no broad peak above νmax = 3000 cm-1 for an NH 
group and had a peak for the ester carbonyl group at νmax = 1716 cm-1.  1H NMR 
spectroscopy indicated the disappearance of the NH peak at δ = 8.59 ppm. The 
presence of a tert butyl group at δ = 1.46 ppm and two new peaks at δ = 3.98 
ppm and δ = 3.02 ppm for [(CH3)3COOCCH2CH2N] and [(CH3)3COOCCH2CH2N], 
respectively, were evidence for the formation of compound 108b. The 13C NMR 
spectrum showed three quaternary carbon peaks with the first peak at δ = 206.0 
ppm for C=S, the second peak at δ
43 
the third peak at δ = 81.6 ppm for tert butyl group. Pyrrolidine-2-thione 89 was not 
recovered after work-up and the high yield suggests few side reactions.  
 
The data for the remaining products is summarised in Table 3, and the 
spectroscopic details are similar to those for 108b. N-Alkylated thiolactams 108c, 
151, 152 and 153 were also synthesised from their respective unprotected 
thiolactams in good yield as colourless crystals. The reaction went to completion 
as determined by a TLC test. Varying reaction conditions like increasing the 
temperature to 60 °C, longer reaction times and inc reasing the equivalence of the 
acrylate ester did not improve the yield of tert-butyl 3-(2-thioxoazacyclotridecan-
1-yl)propanoate 154.  
 
Azacyclotridecane-2-thione 150 was always recovered after the reaction was 
terminated, owing to the steric hindrance around the nitrogen atom. Looking at 
the crystal structure of 154 (Figure 13) (carried out by Dr C. Perry) we can see 
that the N-alkyl group points away from the ring. Generally, the melting point 
decreased in all N-alkylated thiolactams as compared to their respective 
unprotected thiolactams, owing to the loss of hydrogen bonding present in the 
unprotected thiolactams. The IR spectra had no broad peak for an NH group but 
had a peak for the ester carbonyl group.   
 
Figure 13. tert-butyl 3-(2-thioxoazacyclotridecan-1-yl)propanoate 154 
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2.5 Eschenmoser sulfide contraction 
 
Enaminones are central to the project because they are scaffolds on which we 
are going to build new rings. So, having prepared thiolactams we are now in a 
position to use them in Eschenmoser sulfide contractions to give a variety of 
enaminones. The reaction mechanism is believed to begin when the electron 
density from the nitrogen atom is delocalised onto the sulfur atom, making it 
nucleophilic enough to engage in a substitution reaction replacing the bromine 
atom from the α-position of a compound with a good electron withdrawing group 
(EWG). The thioiminium salt that had been formed is then treated with a base, 
resulting in a compound with a thiirane group. Triphenylphosphine is then 
introduced to scavenge the sulfur atom affording a carbon-carbon double bond 
(Scheme 20).41 This reaction has been reported to be efficient with EWG 
containing compounds such as methyl 2-bromoacetate and methyl 2-bromo-2-
phenylacetate.42,43 
 
                
n(H2C) N
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R
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S
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S
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S
R
EWG
:base
:PPh3
Scheme 20. Eschenmoser sulfide contraction mechanism.41
thioiminium salt
 
 
2.5.1 Synthesis of N-alkyl vinylogous urethanes 
 
Practically, the vinylogous urethanes were prepared by reacting N-alkyl 
thiolactams with ethyl bromoacetate at room temperature, after which S-
45 
alkylation was thought to be complete (followed by the disappearance of starting 
material on a TLC plate), followed by sulfur extrusion using either 
triphenylphosphine or triethyl phosphite with triethylamine acting as the base at 
room temperature.27 The resulting residues were worked-up and purified by 
column chromatography on silica gel. The following five compounds were 
synthesised by this method (Scheme 21 and Table 4). 
 
                
n(H2C) N
S
O
O
108b n = 1
151   n = 3
152   n = 4
153   n = 5
154   n = 9
109b n = 1
155   n = 3
156   n = 4
157   n = 5
158   n = 9
Scheme 21. (a) 1.10 eq. BrCH2COOCH2CH3, MeCN, rt, 42 h; (b) 1.10 eq. PPh3 or 1.10 eq. P(OEt)3, 1.10 eq. Et3N, rt, 25 h.
n(H2C) N O
O
O
O
a, b
 
 
Table 4 
Compo- 
und 
Yield 
/ % 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
109b 88 1725 (sat, C=O), 
1682 (unsat, 
C=O) and 
1588 (alkene) 
4.46 (NC=CH), 
4.03 (OCH2CH3) 
and 
1.21 (OCH2CH3) 
169.0 (NC=C), 
166.4 (CO2Et) and 80.8 
(NC=C) 
155 30 1727 (sat. C=O), 
1683 (unsat. 
C=O) and 
1573 (alkene) 
4.46 (NC=CH), 
4.03 (OCH2CH3) 
and 
1.21 (OCH2CH3) 
169.0 (NC=C), 
166.4 (CO2Et) and 80.8 
(NC=C) 
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Table 4 (continued) 
Compo- 
und 
Yield 
/ % 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
156 21 1728 (sat. C=O), 
1683 (unsat. 
C=O) and 
1567 (alkene) 
4.52 (NC=CH), 
4.08 (OCH2CH3) 
and 
1.25 (OCH2CH3) 
167.5 (NC=C), 
164.6 (CO2Et) and 79.8 
(NC=C) 
157 8 1727 (sat. C=O),  
1683 (unsat. 
C=O) and 
1561 (alkene) 
4.49 (NC=CH), 
4.01 (OCH2CH3) 
and 
1.20 (OCH2CH3) 
168.9 (NC=C), 
167.4 (CO2Et) and 81.3 
(NC=C) 
158 20 1728 (sat. C=O), 
1682 (unsat. 
C=O) and 
1569  alkene) 
4.54 (NC=CH), 
4.07 (OCH2CH3) 
and 
1.31 (OCH2CH3) 
169.0 (NC=C), 
164.8 (CO2Et) and 81.4 
(NC=C) 
 
One example is discussed in detail here. (E)-tert-Butyl 3-(2-(2-ethoxy-2-
oxoethylidene)pyrrolidin-1-yl)propanoate 109b was synthesised from tert-butyl 3-
(2-thioxopyrrolidin-1-yl)propanoate 108b in a good yield of 88% as a red oil. The 
IR spectrum had a stretching band for the saturated ester carbonyl group at νmax 
= 1725 cm-1, a peak for the unsaturated ester carbonyl group at νmax = 1682 cm-1 
and another signal at νmax =1588 for the alkene.  1H NMR spectroscopy indicated 
the presence of a new vinyl proton peak at δ = 4.53 ppm accompanied by two 
new peaks at δ = 4.09 ppm for (OCH2CH3) and δ = 1.25 ppm for the methyl 
group, representative of the ethyl ester. The peak for tert butyl group at δ = 1.45 
ppm and two peaks at δ = 3.42 ppm and δ = 3.13 ppm for ButCO2CCH2CH2N and 
ButCO2CCH2CH2N were still present in compound 109b. The 13C NMR spectrum 
showed four quaternary carbon peaks with the disappearance of a peak at δ = 
206.0 ppm for (C=S) and appearance of a peak at δ = 169.7 ppm for (NC=C), at 
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δ = 171.1 ppm for the tert-butyl ester carbonyl group, at δ = 164.8 ppm for the 
ethyl ester carbonyl group and at δ = 81.4 ppm for tert butyl group. The peak for 
(NC=C) was at δ = 78.6 ppm. Compound 108b was not recovered during 
purification. 
 
The second compound tert-Butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azepan-
1-yl}propanoate 155 was synthesised from tert-butyl 3-(2-thioxoazepan-1-
yl)propanoate 151 in a poor 30% yield as a yellow oil. The thioiminium salt visibly 
formed within 1 h of stirring and was supported by a baseline spot, but spots for 
starting material 151 and triphenylphosphine were present in the reaction mixture 
even when the reaction was left overnight to force complete salt formation. The 
crude product was purified by column chromatography on silica gel and 
appeared to decompose (on the base line of the TLC plate). We found that tert-
butyl 3-(2-oxoazepan-1-yl)propanoate (an N-alkylated lactam) was formed and 
was almost always recovered mixed with tert-butyl 3-(2-thioxoazepan-1-
yl)propanoate 151. This could only happen if moisture was hydrolysing the salt 
before the sulfur extrusion step. We also recovered more unused 
triphenylphosphine than triphenylphosphine sulfide and some triphenylphosphine 
oxides. We suspected that ethyl 2-bromoacetate might have decomposed with 
age, but even after using freshly distilled ethyl bromoacetate yields never 
improved. Many other attempts were taken to make tert-butyl 3-{(2E)-2-
[(ethoxycarbonyl)methylene]azepan-1-yl}propanoate 155, which included salt 
formation without solvent, raising the temperature to 40 °C in the sulfur extrusion 
step and an acid work-up, all of which resulted in either low yield or no product 
recovery. Vinylogous urethane 155 therefore became the main focus in our study 
in order to pave the way for the synthesis of vinylogous urethanes 156, 157 and 
158, their synthesis was met with similar difficulties as for 155. All products were 
obtained as yellow oils. Their spectroscopic data were similar to those of product 
109b, and significant signals are included in Table 4. 
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2.5.2 Synthesis of N-alkyl vinylogous amides 
 
Since we were not able to make vinylogous urethanes in sufficient quantity for 
cyclisation studies, we decided to make a range of vinylogous amides instead, 
for ease of synthesis of vinylogous amides. The vinylogous amides were 
prepared similarly to vinylogous urethanes.27 The resulting residues were 
worked-up and purified by column chromatography on silica gel.  The following 
seven compounds were synthesised by this method (Scheme 22, Table 5). 
 
           
n(H2C) N
S
O
O
108b n = 1
108c n = 2
151   n = 3
152   n = 4
153   n = 5
154   n = 9
159a n = 1
160a n = 2
161a n = 3
161d n = 3
162a n = 4
163a n = 5
164a n = 9
Scheme 22. (a) 1.05 eq. BrCH2CO(C6H4)-p-NO2 a or 1.05 eq. BrCH2CO(C6H5) d, 
MeCN, rt, 22 to 30 h; (b) 1.05 eq. PPh3 or 1.05 eq. P(OEt)3, 1.05 eq. Et3N, rt, 
2 to 24 h.
n(H2C) N O
O
R
a, b
O
O2N
O
a
d
= R
= R
 
 
Table 5 
Com- 
pound 
Yield 
/ % 
m.p. 
/ °C 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
159a 89 128 – 129 1728 
(C=O) 
and 
1678 
(alkene) 
5.73 (NC=CH), 
8.23 and 8.00 
(arom.) 
185.2 (C=O), 
168.6 (NC=C), 
149.0 and 148.0 
(arom.) and 87.0 
(NC=C) 
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160a 32 116 – 117 1722 
(C=O) 
and 
1610 
(alkene) 
5.68 (NC=CH), 
8.22 and 7.96 
(arom.) 
185.0 (C=O), 
166.0 (NC=C), 
149.1 and 148.9 
(arom.) and 90.7 
(NC=C) 
161a 72 oil 1711 
(C=O) 
and 
1622 
(alkene) 
5.62 (NC=CH), 
8.22 and 7.96 
(arom.) 
185.0 (C=O), 
170.8 (NC=C), 
149.1 and 149.0 
(arom.) and 90.6 
(NC=C) 
161d 32 oil 1724 
(C=O) 
and 
1622 
(alkene) 
5.65 (NC=CH), 
7.87, 7.38 and 
7.38 (arom.) 
188.5 (C=O), 
169.2 (NC=C), 
143.3 (arom.) and 
91.9 (NC=C) 
162a 87 71 – 73 1720 
(C=O) 
and 
1616 
(alkene) 
5.71 (NC=CH), 
8.21 and 7.99 
(arom.) 
184.4 (C=O), 
169.7 (NC=C), 
149.2 and 148.9 
(arom.) and 91.0 
(NC=C) 
163a 67 111 – 112 1711 
(C=O) 
and 
1615 
(alkene) 
5.72 (NC=CH), 
8.22 and 8.00 
(arom.) 
184.4 (C=O), 
168.6 (NC=C), 
149.1 and 148.9 
(arom) and 91.7 
(NC=C) 
164a 4 amorphous 
solid 
1725 
(C=O) 
and 
1625 
(alkene) 
5.67 (NC=CH), 
8.23 and 7.97 
(arom.) 
184.8 (C=O), 
170.6 (NC=C), 
149.0 and 148.1 
(arom.) and 91.7 
(NC=C) 
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One example is discussed in detail here. (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-
oxoethylidene]pyrrolidin-1-yl}propanoate 159a was synthesised from tert-butyl 3-
(2-thioxopyrrolidin-1-yl)propanoate 108b in a good 89% yield as orange crystals. 
Compound 159a had a melting point of 128 – 129 °C is clearly dif ferent and 
higher than that of compound 108b of 48 – 49 °C. The IR spectrum had a peak 
for the ester and conjugated ketone group at νmax = 1726 cm-1 and at νmax = 1678 
cm-1, a peak at νmax = 1595 cm-1 for an alkene and N–O aromatic peaks at νmax = 
1514 cm-1 and νmax = 1342 cm-1.  1H NMR spectroscopy indicated the presence 
of a new vinyl proton peak at δ = 5.73 ppm accompanied by two new peaks at δ 
= 8.23 ppm and δ = 8.00 ppm for the aromatic group. The (E) geometry is 
apparent from chemical shieft of CH2 adjacent to C=C (3.40 ppm) which is 
deshielded through space by the C=O group; in (2) analogues this position is 
upfield by 0.5 – 0.8 ppm.27 The 13C NMR spectrum showed six quaternary carbon 
peaks with the disappearance of a peak at δ = 201.9 ppm for (C=S) and 
appearance of a peak at δ = 168.6 ppm for (NC=C), at δ = 185.2 ppm for the 
ketone group, at δ = 170.8 ppm for the tert-butyl ester carbonyl group, at δ = 
149.0 ppm and δ = 148.0 ppm for the aromatic group and at δ = 81.8 ppm for tert 
butyl group. The peak for (NC=C) was at δ = 87.0 ppm. Compound 108b was not 
recovered after purification and the high yield suggest few side products.  
 
Vinylogous amides 161a, 162a and 163a were also synthesised from their 
respective N-alkylthiolactams and the phenacyl bromide in good yield. Generally, 
the salt precipitation occured within 2 h and this was supported by a base line 
spot on a thin layer chromatography test plate. The vinylogous amides were 
afforded with little or no N-alkylthiolactams after purification. However (E)-tert-
Butyl 3-(2-(2-(4-nitrophenyl)-2-oxoethylidene)piperidin-1-yl)propanoate 160a was 
synthesised from tert-butyl 3-(2-thioxopiperidin-1-yl)propanoate 108c in a poor 
32% yield as yellow crystals. Thin layer chromatography showed that the 
thioiminium salt had partially formed after 6 h by a spot on the base line with a 
bright yellow spot at Rf = 0.54 for p-nitrophenacyl bromide. The reaction was 
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stirred for 11 h and a triphenylphosphine and triethylamine solution in acetonitrile 
was added resulting in a dark green colour change. The reaction mixture was 
stirred for an extra 22 h, worked-up and purified by column chromatography on 
silica gel. Compound 108c was recovered together with p-nitrophenacyl bromide 
in significant amounts. We were not able to investigate the cause of failure for 
this reaction owing to time limitations. To our surprise, (E)-tert-butyl 3-(2-(2-oxo-
2-phenylethylidene)azepan-1-yl)propanoate 161d was synthesised from tert-butyl 
3-(2-thioxoazepan-1-yl)propanoate 151 in a poor 32% yield as yellow oil as well. 
The salt had visibly formed after 2 h was supported by a spot on the base line on 
a TLC plate. Compound 151 was the major component recovered after 
purification. (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-
oxoethylidene]azacyclotridecan-1-yl}propanoate 164a was synthesised from tert-
butyl 3-(2-thioxoazacyclotridecan-1-yl)propanoate 154 in a very poor 4% yield as 
yellow amorphous solid. The thin layer chromatography test plate showed that 
the salt had formed after 2 h by a spot on the base line and had precipitated. 
After purification we mainly recovered (Z)-2-(azacyclotridecan-2-ylidene)-1-(4-
nitrophenyl)ethanone 169a (Scheme 23). It seemed that the acrylate ester was 
no longer present and the Eschenmoser sulfide contraction reaction occurred on 
azacyclotridecane-2-thione 150 (Scheme 23). The IR spectra were not so 
different to those of the N-alkylthiolactams except they had stretching band for 
the aromatic ring. The vinyl proton accompanied by two peaks for the aromatic 
group in the 1H NMR spectra were evidence enough that the reaction was 
successful and this was confirmed by the 13C NMR spectra with peaks for all 
quaternary carbons.   
 
2.5.3 Synthesis of NH vinylogous amides 
 
Another approach to making our bicyclic systems is to start with NH vinylogous 
amides in an aza-annulation reaction with acryloyl chloride. These were prepared 
as described in the previous section.27 The resulting residues were worked-up 
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and purified by column chromatography on silica gel.  The following six 
compounds were synthesised by this method (Scheme 27, Table 6). 
 
                         
(CH2)n
H
N R
(CH2)n
H
N
S
89   n = 1
147 n = 3
148 n = 4
149 n = 5
150 n = 9
165a n = 1
166a n = 3
166b n = 3
167a n = 4
168a n = 5
169a n = 9
Scheme 23. (a) 1.05 eq. BrCH2CO(C6H4)pNO2 a 
or 1.05 eq. BrCH2CO(C6H5) b, MeCN, rt, 4 to 
30 h; (b) 1.05 eq. PPh3, 1.05 eq. Et3N, rt, 2 to 24 h.
a, b
O
NO2
O
a
b
R =
R =
 
 
Table 6 
Com- 
pound 
Yield 
/ % 
m.p. 
/ °C 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
165a 79 160 – 
161 
3280 (NH)  
and  
1739 (C=O)  
5.65 (NC=CH), 
11.8 (NH), 
8.23 and 7.99 
(arom.) 
185.4 (C=O), 
173.2 (NC=C), 
149.2 and 146.6 
(arom.) and  
92.1 (NC=C) 
166a 82 124 – 
127 
3280 (NH)  
and  
1739 (C=O)  
5.65 (NC=CH), 
11.8 (NH), 
8.23 and 7.99 
(arom.) 
185.4 (C=O), 
173.2 (NC=C), 
149.2 and 146.6 
(arom.) and  
92.1 (NC=C) 
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Table 6 (continued) 
 
Com- 
pound 
Yield 
/ % 
m.p. 
/ °C 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
1H NMR 
signals 
δ / ppm 
Significant 
13C NMR 
signals 
δ / ppm 
166b 66 64 – 66  3200 – 
3400 (NH)  
and  
1739 (C=O) 
 
5.66 (NC=CH), 
11.5 (NH), 
7.86, 7.37 and 
7.37 (arom.) 
186.7 (C=O), 
170.2 (NC=C), 
139.4 (arom.) and 
89.8 (NC=C) 
167a 76 128 – 
129 
3200 – 
3400 (NH)  
and  
1739 (C=O)  
5.67 (NC=CH), 
11.7 (NH), 
8.24 and 7.99 
(arom.) 
184.5 (C=O), 
172.2 (NC=C), 
148.7 and 146.3 
(arom.) and  
92.4 (NC=C) 
168a 88 128 – 
129 
3200 – 
3400 (NH)  
and  
1739 (C=O)  
5.52 (NC=CH), 
11.6 (NH), 
8.10 and 7.88 
(arom.) 
184.7 (C=O), 
173.3 (NC=C), 
149.3 and 147.0 
(arom.) and  
92.3 (NC=C) 
169a 83 104 – 
105 
3200 – 
3400 (NH)  
and  
1738 (C=O)  
5.65 (NC=CH), 
11.8 (NH), 
8.23 and 7.98 
(arom.) 
184.3 (C=O), 
170.5 (NC=C), 
148.8 and 146.3 
(arom.) and  
92.5 (NC=C) 
 
One example is discussed in detail here. (Z)-1-(4-Nitrophenyl)-2-(pyrrolidin-2-
ylidene)ethanone 165a was synthesised from pyrrolidine-2-thione 89 in a good 
79% yield as yellow crystals. Compound 165a had a melting point of 160 – 161 
°C which is clearly different and higher than that of pyrrolidine-2-thione of 103 – 
105 °C. The IR spectrum had a broad peak at νmax = 3280 cm-1 for an NH group, 
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a peak for the ketone carbonyl group at νmax = 1739 cm-1, a peak at νmax = 1596 
cm-1 for an alkene, a peak at νmax = 1478 cm-1for the aromatic alkene and N–O 
aromatic peaks at νmax = 1534 cm-1 and νmax = 1335 cm-1. 1H NMR spectroscopy 
indicated the presence of NH group at δ = 11.5 ppm and the presence of a new 
vinyl proton peak at δ = 5.66 ppm accompanied by two new peaks at δ = 7.86 
ppm and δ = 7.37 ppm for the aromatic group. The (Z) geometry was apparent 
from chemical shieft of CH2 adjacent to C=C (2.35 – 2.78 ppm); in (E) analogues, 
this position is deshielded through space by the carbonyl group.27 The 13C NMR 
spectrum showed four quaternary carbon peaks with the disappearance of a 
peak at δ = 206.0 ppm for (C=S) and appearance of a peak at δ = 170.6 ppm, δ = 
185.0 ppm, δ = 148.8 ppm and δ = 146.0 ppm for the (NC=C), ketone group and 
aromatic group, respectively. The peak for (NC=C) was at δ = 87.0 ppm. 
Compound 89 was recovered after purification and there were no competing side 
reactions determined by NMR spectroscopy.  
 
The remaining NH vinylogous amides 166a, 166b, 167a, 168a and 169a were 
synthesised from their respective NH thiolactams in good yields as yellow 
crystals. The reaction never went to completion even though the salt completely 
formed (salt precipitated and base line spot on TLC plate), owing to the recovery 
of NH thiolactams in low yield after purification. Specific data are similar to that 
for 165a and significant signals are included in Table 6. 
 
 
2.6 Synthesis of azabicyclic systems by intramolecular cycloacylation 
 
Having prepared the vinylogous urethanes and amides, now we are in a position 
to utilise the enaminone reactivity to achieve azabicyclic models for alkaloids. 
The ring acylative closing mechanism utilises the nucleophilicity at α-carbon to 
the EWG. Trifluoroacetic acid hydrolyses the ester to a carboxylic acid with 2-
methylprop-1-ene as a by-product (a, b Scheme 24). Potassium carbonate 
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deprotonates the carboxylic acid leading to a nucleophilic attack on acetic 
anhydride by the resultant oxygen nucleophile, affording a mixed anhydride 
which is a good leaving group (c, d, Scheme 24). Enaminone chemistry takes 
over from here, with a nucleophilic attack on an electrophile of the mixed 
anhydride, forming a six-membered ring with loss of acetate group (e, Scheme 
24). Potassium carbonate deprotonates the α-hydrogen to EWG affording the 
azabicyclic compounds (f, Scheme 24).32 
 
          
n(H2C) N O
O
EWG
n(H2C) N O C
O
C
CH3
CH3
EWG H
HHH
n(H2C) N OH
O
EWG
HH
H3C CH3
n(H2C) N O
O
EWG O
O
O
n(H2C) N
EWG
O
O
O
H
+
CO32-
K
+
n(H2C) N
EWG
OH
CO32-
n(H2C) N
EWG O
Scheme 24. Acylative ring-closing reaction mechanism.32
H
O
O
a
b
c d
e
f
 
 
Azabicyclic systems were prepared by reacting the tert-butyl-containing 
vinylogous urethanes or amides with trifluoroacetic acid at room temperature 
which resulted in the conversion of the tert-butyl group to the free carboxylic acid 
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group. After removing trifluoroacetic acid in vacuo, the free carboxylic acid was 
converted to an anhydride group in a reaction with potassium carbonate and 
acetic anhydride, which in situ (in acetonitrile at 60 °C) transformed to azabicyc lic 
systems in an acylative ring-closing reaction propagated by the enaminone 
nucleophilicity losing the anhydride as a good leaving group.43 The following 
seven compounds were prepared by this method (Scheme 25, Table 7).  
 
                           
n(H2C) N
R O
109b n = 1
159a n = 1
160a n = 2
161d n = 3
162a n = 4
163a n = 5
164a n = 9
170b n = 1
171a n = 1
172a n = 2
173d n = 3
174a n = 4
175a n = 5
176a n = 9
Scheme 25. (a) 26.9 eq. Trifluoroacetic acid, rt, 4 to 5 h; 
(b) 2.00 eq. K2CO3, 2.00 eq. acetic anhydride, 60 °C, 14 
to 20 h.
n(H2C) N O
O
R
a, b
NO2
O
O
O
O
R = b =
R = a =
R = d =
 
Table 7 
Compound Yield 
/ % 
m.p. 
/ °C 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
13C NMR 
signals 
δ / ppm 
170b 79 149 – 
150 
1726 (C=O) and 
1478 (conj. alkene) 
187.6 (ring, C=O), 173.9 
(NC=C) and 98.9 (NC=C) 
171a 31 230 1739 (C=O) and 
1631 (conj. alkene) 
192.2 (ring, C=O), 174.9 
(NC=C) and 106.8 (NC=C) 
171a 
(isomer?) 
65 230 1739 (C=O) and 
1631 (conj. alkene) 
184.1 (ring, C=O), 170.0 
(NC=C) and 128.0 (NC=C) 
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Table 7 (continued) 
Compound Yield 
/ % 
m.p. 
/ °C 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
13C NMR 
signals 
δ / ppm 
172a 99 116 – 117 1723 (C=O) and 
1645 (conj. alkene) 
194.3 (ring, C=O), 169.3 
(NC=C) and 110.0 (NC=C) 
173d 73 amorphous 
solid 
1738 (C=O) and 
1613 (conj. alkene) 
197.9 (ring, C=O), 170.7 
(NC=C) and 112.2 (NC=C) 
174a 89 175 1738 (C=O) and 
1637 (conj. alkene) 
195.6 (ring, C=O), 172.9 
(NC=C) and 111.0 (NC=C) 
175a 90 131 – 132 1739 (C=O) and 
1631 (conj. alkene) 
195.3 (ring, C=O), 173.1 
(NC=C) and 111.0 (NC=C) 
176a 90 108 – 110 1738 (C=O) and 
1618 (conj. alkene) 
192.9 (ring, C=O), 169.3 
(NC=C) and 109.3 (NC=C) 
 
One example is discussed in detail here. Ethyl 7-oxo-1,2,3,5,6,7-
hexahydroindolizine-8-carboxylate 170b44 was synthesised from (E)-tert-butyl 3-
(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl)propanoate 109b in a good 79% 
yield as colourless crystals. Compound 170b had a melting point of 149 – 150 
°C. The IR spectrum had a peak for the ketone and e ster carbonyl group at νmax 
= 1726 cm-1, two peaks at νmax = 1478 cm-1 for a conjugated alkene and alkene 
peak at νmax = 1432 cm-1. 1H NMR spectroscopy indicated the expected 
disappearance of the tert-butyl group at δ = 1.45 ppm and the vinyl proton at δ = 
4.53 ppm, while the rest of the peaks still remained. The 13C NMR spectrum 
showed four quaternary carbon peaks at δ = 187.6 ppm, δ = 173.9 ppm, δ = 
166.5 ppm, δ = 98.9 ppm for the ketone, (NC=C), ester and (NC=C), respectively. 
(E)-tert-Butyl 3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl)propanoate 109b was 
not recovered after purification. Data were comparable with those reported 
elsewhere.44 
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Attempted synthesis of azabicyclic compounds 128 (Figure 10), 170b (n = 4,5 
and 9) resulted in formation of what seemed to be polymeric material mixed with 
starting material. We tried longer reaction times and longer trifluoroacetic acid 
evaporation times, but all came to nothing. The poor yields of starting materials 
155, 156, 157 and 158 for making compounds similar to compound 170b were 
also a stumbling block in our synthesis. We suspect that failed attempts in 
synthesising azabicyclic scaffolds from 155, 156, 157 and 158 may have been 
due to preferential protonation of the enamine system, giving a charged 
intermediate that is no longer nucleophilic enough for the cyclisation to take 
place. Also, larger rings may have low reactivity owing to constrained 
conformation resulting in highly hindered reactive sites. 
 
Compounds 172a, 176a, 174a, 175a and 173d were synthesised from their 
respective vinylogous amides in good yields as yellow solids. Specific data are 
similar to that for 170b and significant signals are included in Table 7. 
 
8-(4-Nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one 171a was synthesised 
from (E)-tert-butyl 3-(2-(2-(4-nitrophenyl)-2-oxoethylidene)pyrrolidin-1-
yl)propanoate 159a in a poor 31% yield as yellow crystals. The poor yield was 
due to the recovery of what seemed to be a conformational isomer in a 65% yield 
(b, Figure 15). There is a significant difference between the positions of the 
(NC=C) signal in the 13C NMR spectra for 171a and 171a (isomer) at δ = 106.8 
and δ = 128.0, respectively (Table 7 and a, b Figure 15), but the NMR and MS 
(HRMS (EI): found, 286.09385 (C15H14O4N2 requires 286.09536)) data of both 
could fit the desired structure and that is why we suspect conformation isomers.  
We were not able to compare the crystal structures of 171a and its isomer?, 
because of the isomer? could not be recrystallised properly. The crystal structure 
of 8-(4-Nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one 171a (Figure 14) 
(carried out by Dr C. Perry) shows oxygen atoms O1 and O2 far from each other, 
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resulting in a conformation that can also be expected for compound  170b, 172a, 
173d, 174a, 175a and 176a. 
 
Figure 14. 8-(4-Nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one 171a 
 
                                 
Figure 15. (a) 13C NMR spectrum for 171a, (b) 13C NMR spectrum for 171a 
(isomer?). 
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2.7 Synthesis of azabicyclic systems by aza-annulation 
 
Azabicyclic structures were prepared by reacting vinylogous amides with acryloyl 
chloride in dry tetrahydrofuran according to a procedure by Stille.45 The aza-
annulation reaction begins with a 1,2 addition of nitrogen atom to acryloyl 
chloride followed by the elimination of the hydrogen chloride. A Michael type, 1,4 
addition to the acryloyl group by the α-carbon  to the EWG (enaminone 
nucleophilicity) resulted.  The chloride anion then deprotonate α-hydrogen to 
EWG affording the azabicyclic compounds (Scheme 26). 
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Scheme 26. Proposed aza-annulation reaction mechanism.
n(H2C) N
EWG
OCl n(H2C) N
O
EWG
H
+ HCl
n(H2C) N
EWG
O
H
ClH
n(H2C) N
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O
H Cl
n(H2C) N
EWG
O
 
 
The resulting products were purified by recrystallisation from ethyl acetate: 
hexane solvent mixture. The following seven compounds were prepared by this 
method (Scheme 27, Table 8). 
 
             
n(H2C) N
R
O
165a n = 1
177a n = 2
166a n = 3
166b n = 3
167a n = 4
168a n = 5
169a n = 9
178a n = 1
179a n = 2
180a n = 3
180b n = 3
181a n = 4
182a n = 5
183a n = 9
Scheme 27. Aza-annulation reactions.
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Table 8 
Com- 
pound 
Yield 
/ % 
m.p. 
/ °C 
Significant 
IR 
signals 
νmax / cm-1 
Significant 
13C NMR 
signals 
δ / ppm 
178a 100 120 –121 1683 (C=O) and  
1599 (conj. alkene) 
169.6 (amide C=O), 149.3 
(NC=C) and 109.5 (NC=C) 
179a 49 126 – 127 1673 (C=O) and  
1597 (conj. alkene) 
168.7 (amide C=O),  148.1 
(NC=C) and 112.2 (NC=C) 
179a 
(isomer?) 
23 Amorphous 
solid 
1673 (C=O) and  
1597 (conj. alkene) 
168.7 (amide C=O),  150.8 
(NC=C) and 108.4 (NC=C) 
180a 99 130 – 131 1687 (C=O) and  
1597 (conj. alkene) 
170.7 (amide C=O), 150.1 
(NC=C) and 114.7 (NC=C) 
180b 95 103 – 105 1726 (C=O) and  
1677 (conj. alkene) 
168.9 (amide C=O), 136.9 
(NC=C) and 113.7 (NC=C) 
181a 99 59 – 61 1682 (C=O) and  
1573 (conj. alkene) 
169.2 (amide C=O), 148.5 
(NC=C) and 113.3 (NC=C) 
182a 90 110 – 112 1686 (C=O)and  
1582 (conj. alkene) 
169.4 (amide C=O), 148.5 
(NC=C) and 114.4 (NC=C) 
183a 97 107 – 108 1693 (C=O) and  
1567 (conj. alkene) 
169.4 (amide C=O), 148.5 
(NC=C) and 113.3 (NC=C) 
 
One example is discussed in detail here. 8-(4-Nitrobenzoyl)-2,3,6,7-
tetrahydroindolizin-5(1H)-one 178a was synthesised from (Z)-1-(4-nitrophenyl)-2-
(pyrrolidin-2-ylidene)ethanone 165a in a good 100% yield as yellow crystals. 
Compound 178a had a melting point of 120 – 121 °C which is clear ly different 
and lower than that of (Z)-1-(4-nitrophenyl)-2-(pyrrolidin-2-ylidene)ethanone of 
160 – 161 °C. The IR spectrum had a peak for the ke tone carbonyl group at νmax 
= 1683 cm-1, a peaks at νmax = 1599 cm-1 for a conjugated alkene and N–O 
aromatic peaks at νmax = 1516 cm-1 and νmax = 1345 cm-1. 1H NMR spectroscopy 
indicated the expected disappearance of the vinyl proton at δ = 5.73 ppm and of 
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the NH peak at δ = 10.4 ppm and two new peaks at δ = 2.65 ppm for 
(ArCCH2CH2CON and ArCCH2CH2CON). The rest of the peaks still remained. 
The 13C NMR spectrum showed six quaternary carbon peaks at δ = 193.4 ppm, δ 
= 169.6 ppm, δ = 149.3 ppm, (δ = 156.3 ppm and 146.7) and δ = 109.5 ppm for 
the ketone, carbonyl of the amide group, (NC=C), the aromatic group and 
(NC=C), respectively. (Z)-1-(4-Nitrophenyl)-2-(pyrrolidin-2-ylidene)ethanone 178a 
was not recovered after column and there were no competing side reactions.  
 
Compounds 180a, 180b, 181a, 182a and 183d were synthesised from their 
respective NH vinylogous amides in good yields as yellow crystals. Specific data 
is similar to that for 178a and significant signals are included in Table 8. 
 
1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one 179a was synthesised 
from (Z)-1-(4-nitrophenyl)-2-(piperidin-2-ylidene)ethanone 177a in a poor 49% 
yield as yellow crystals. Compound 179a was synthesised with what we 
suspected to be a conformational isomer which had a yield of 23% (Table 8 and 
b, Figure 17). There is a significant difference between signals in the 1H NMR 
spectra for 179a and 179a (isomer) (Table 8 and a, b Figure 17), but the NMR 
and MS (179a, HRMS (EI): found, 300.10836 (C16H16O4N2 requires 300.11101) 
and 179a (isomer), HRMS (EI): found, 300.11080 (C16H16O4N2 requires 
300.11101)) data of both could fit the desired structure and that is why we 
suspect conformation isomers.  We were not able to compare the crystal 
structures of 171a and its isomer?, because of the isomer? was an amorphous 
solid. The crystal structure of 1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-
4-one 179a (Figure 16) (carried out by Dr. C. Perry) has its Ar group in a position 
similar to that of O2 of compound 171a (Figure 14). 
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Figure 16. 1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one 179a 
 
                                          
 
Figure 17. (a) 1H NMR spectrum for 179a, (b) 1H NMR spectrum for 179a 
(isomer?). 
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2.8 Conclusion 
 
Vinylogous urethanes and amides were synthesised by the Eschenmoser sulfide 
contraction reaction. Large ringed vinylogous urethanes 155, 156, 157 and 158 
were obtained in relatively low yields, as compared to small ringed vinylogous 
urethane 109b. This was not the general case in the synthesis of vinylogous 
amides, as they were produced in relatively high yields. A number of attempts to 
improve the yields of large ringed vinylogous urethanes were unsuccessful.  
 
Enaminones 132 (Figure 12) were then subjected to ring-closing conditions. 
Azabicyclic models for alkaloids were synthesised in good yields from vinylogous 
amides under the acylative ring-closing conditions and by the new aza-annulation 
conditions. The key step in the acylative ring-closing conditions is the efficient 
hydrolysis of the tert-butyl ester with trifluoroacetic acid over long periods of time 
followed by cyclisation via a mixed anhydride. The key step in aza-annulation 
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ring-closing conditions is a Michael type, 1,4 addition to the acryloyl group by the 
α-carbon to the EWG utilising enaminone nucleophilicity.  
 
                
n(H2C) N
O
O O
n(H2C) N O
O
O
O
155 n = 1
156 n = 2
157 n = 3
158 n = 7
Scheme 28. Attempted synthesis of azabicyclic scaffolds.
 
 
To our surprise, 1-(4-nitrobenzoyl)-3,4,7,8,9,10-hexahydropyrido[1,2-a]azepin-
2(6H)-one was obtained in a poor yield from 161a. A number of attempts always 
resulted in compound(s) with NMR data that we were not able to interpret. 
Compounds 171a and 179a were obtained in low yields with what appeared to 
be their conformational isomers. Nuclear Overhauser experiments were not 
decisive in giving us the answer to how these isomers differed in structure. We 
were also not able to compare crystal structure as a result of recrystallisation 
difficulties on the isomers. The aza-annulation conditions were more efficient with 
reduced number of synthetic steps to the azabicyclic models for alkaloids and 
generally high yields.  
 
In conclusion, we were able to extend the methodology developed in our 
laboratories for the synthesis of indolizidines and quinolizidines to analogues in 
which at least one of the rings was seven-, eight-, nine- and thirteen-membered.  
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2.9 Future work 
Our synthetic strategy needs to be improved for the Michael reaction of 
azacyclotridecane-2-thione 150 with tert-butyl acrylate. Compound 150 behaves 
differently in solution compared to solid state. Maybe doing the reaction at low 
temperatures might restrict compound 150 to a steady conformation, increasing 
the probability for reaction sites to find each other. The Eschenmoser sulfide 
contraction reaction needs a separate study, to investigate the contributions of 
different types of electron withdrawing in the reaction.  
 
The azabicyclic systems 1, 2, 4, 129, 130 and 131 can be achieved by the 
proposed synthetic strategies in Scheme 29 and Scheme 30. First, we would 
have to oxidise the ketone carbonyl to an ester group in a Baeyer-Villager 
oxidation reaction (a, Scheme 29 and 30). This substituent can then be removed 
by hydrolysis and decarboxylation reaction using potassium hydroxide at 100 °C 
(b, Scheme 29 and 30).24 A reduction with lithium aluminium hydride has been 
found to be selective for the exo-double bond to the ring containing nitrogen for 
azabicyclic scaffold where n = 1 or 2.27 This can be tried for the reduction for the 
reduction of larger rings as well (c, Scheme 29), although there is a tendency for 
decreased reactivity of the exo-double bond in larger ringed systems.27 We would 
hope that the same reduction method reduces both the alkene and amide 
carbonyl groups, to afford the desired products (c, Scheme 30).24  The ketone 
group can be removed by protecting the compound without the exo-double bond 
with propane-1,3-dithiol and later removing the whole group using Raney nickel 
(d, e, Scheme 29),24 to achieve azabicyclic systems such as 1, 2, 4, 129, 130 
and 131 (Figure11). 
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Scheme 29. Proposed synthetic strategy to azabicyclic systems 1, 
2, 4, 129, 130 and 131. (a) Baeyer-Villager oxidation, (b) Hydrolysis
and decarboxylation, (c) Alkene reduction, (d) and (e) Ketone reduction
n = 1-5, 9 n = 1-5, 9n = 1-5, 9
n = 1-5, 9
a b
c
de
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Scheme 30. Proposed synthetic strategy to azabicyclic systems 1, 
2, 4, 129, 130 and 131
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Another approach to the azabicyclic scaffolds is to build a seven-membered ring 
instead of the six-membered ring. The seven-membered ring can be accessed 
from the N-alkylation of thiolactams with ethyl 4-bromobutanoate and ring-closing 
under basic conditions (a, c, Scheme 31).29 
 
   
n(H2C)
N S
n(H2C)
N S
n(H2C)
N
R n(H2C)
N
R
OH
n = 1-5, 9 n = 1-5, 9
a
Scheme 31. (a) N-Alkylation reaction; (b) Eschenmoser sulfide contraction reaction and 
(c) Ring-closing step
n = 1-5, 9
R = CO2Et
    = COPh
    = COC6H4 -p-NO2
n = 1-5, 9
R = CO2Et
    = COPh
    = COC6H4 -p-NO2
CO2Et CO2Et
b c
 
 
In applying the Wits approach to naturally occurring compounds, we would 
attempt a racemic synthesis of 3-pentyl-octahydro-1H-pyrrolo[1,2-a]azepine (n = 
3) and its analogues (n = 1-5, 9, Scheme 32). This method uses the 
intramolecular aza-Wittig reaction to vinylogous urethanes and amides instead of 
the Eschenmoser sulfide contraction reaction.46 Organoazides (n = 1-5,7) could 
be synthesised in two steps in a γ-monoalkylation of the dianions with  an α,ω-
dihaloalkane followed by a nucleophilic displacement of X by NaN3 (a, b, 
Scheme 32).  
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Scheme 32. Proposed synthetic route to racemic 3-pentyl-octahydro-1H-pyrrolo[1,2-a]
azepine (n = 3) and its analogous. (a) gamma-Monoalkylation of the dianions with  an  
alpha, omega-dihaloalkane, (b) Substitution, (c) Organoazide reaction, (d) N-Alkylation 
reaction.
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The vinylogous urethanes could be accessed by treating the organoazides with 1 
equivalent of triphenylphosphine in ether of benzene (c, Scheme 32).46 N-
Alkylation of vinylogues urethanes with tert-butyl 2-bromoheptanoate would result 
in racemic (E)-tert-butyl 2-(2-(2-ethoxy-2-oxoethylidene)azepan-1-yl)heptanoate 
and its analogous (d, Scheme 32),47 which would the be subjected to acidic ring-
closing conditions to give ethyl racemic 2-oxo-4-pentyl-2,3,4,6,7,8,9,10-
octahydropyrido[1,2-a]azepine-1-carboxylate and its analogues. The reaction to 
follow then would be similar to those mentioned (Scheme 29) to afford desired 
racemic products. 
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CHAPTER 3 
 
3.1 General experimental methods 
 
Glassware was pre-dried by an open flame or in an oven at 150 °C. All reactions 
except the Schmidt reaction were done under nitrogen atmosphere. All solvents 
used in reactions except methanol were distilled prior to use. Tetrahydrofuran 
was pre-dried over calcium chloride and distilled under nitrogen from 
benzophenone and sodium. Dichloromethane and acetonitrile were distilled 
under nitrogen from calcium hydride and sodium, respectively. The organic 
extracts from an aqueous phase were either dried over magnesium sulfate or 
sodium sulfate. Solvents and volatiles were removed (in vacuo) using a rotary 
evaporator, followed by an oil vacuum pump at pressures below 1.0 mmHg.  
 
Products were purified by either recrystallisation or column chromatography. 
Solids were recrystallised in an ethyl acetate:hexane solvent mixture while 
column chromatography was carried out using silica gel (Merck, 60-230). Melting 
points were measured on a Reichert hot-stage microscope apparatus, and are 
uncorrected. The solvents used in column chromatography were distilled for 
better purity. Thin layer chromatography was performed on aluminium-backed 
Alugram Sil G/UV254 plates pre-coated with 0.25 mm silica gel 60 and separation 
patterns were visualised using ultraviolet light, potassium permanganate 
developing reagent or iodine vapour.   
 
Nuclear magnetic resonance (NMR) spectra were recorded using the Brucker 
WM-300 at 300 MHz for proton (1H) NMR and at 75 MHz for carbon (13C) NMR 
spectra. Deuteriated chloroform (CDCl3) was used as a solvent and 
tetramethylsilane (TMS) as internal standard. Chemical shifts (δ) are reported in 
parts per million (ppm) relative to TMS. The multiplicity is abbreviated as follows: 
s = singlet, d = doublet, t = triplet, q = quartet and m = multiplet. Infrared (IR) 
spectra were recorded using thin film or product pellets on a Varian Vector 800 
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FTIR spectrometer. MS spectroscopy conditions: EIMS data were obtained on a 
VG70SEQ or a Thermo DSF spectrometer at 70 eV. 
 
3.2 General procedure for synthesizing lactams using the Beckmann 
rearrangement method 
 
3.2.1 Synthesis of Cyclododecanone oxime (134) 
N OH*
Cyclododecanone 133 (5.042 g, 27.66 mmol), hydroxyamine 
hydrochloride (4.431 g, 63.76 mmol, 2.3 equiv) and sodium acetate trihydrate 
(9.411 g, 69.14 mmol, 2.5 equiv) were reacted in methanol (100 ml) in the 
manner which has been described by a general procedure in the reference.34 A 
solution of sodium acetate trihydrate in distilled water was added to a solution of 
ketone and hydroxylamine hydrochloride in methanol at room temperature. A 
white precipitate was formed. The reaction mixture was reflux heated for 3 h. The 
reaction mixture was then neutralised with saturated aqueous sodium hydrogen 
carbonate solution.  The neutralised reaction mixture was extracted with diethyl 
ether. The organic layer was washed with a saturated sodium chloride solution 
and dried over anhydrous magnesium sulphate. The solvent was removed in 
vacuo. The product which solidified on cooling was purified by recrystallisation 
from an ethyl acetate: hexane solvent mixture to give cyclododecanone oxime 
134 (5.211 g, 96%) as a white solid, m.p. 117 – 118 °C;  νmax (NaCl; Thin 
Film)/cm-1 3413 (s, br, OH); δH (300 MHz; CDCl3; Me4Si) 7.80 (1H, s, br, OH), 
2.42 (2H, m, CH2C=NOH), 2.26 (2H, m, CH2C=NOH), 1.62 (4H, m, 
CH2CH2C=NOH) and 1.33 (14H, m, CH2CH2CH2); δC (75 MHz; CDCl3) 161.2 
(C=NOH), 30.7 (C*H2C=NOH), 26.5 (CH2C=NOH), 25.9, 25.4, 25.2, 24.4, 23.9, 
23.7, 23.6, 23.6 and 23.1 (remaining CH2). 
 
 
73 
3.2.2 Synthesis of Azacyclotridecane-2-one (135) 
NH
O
 Cyclododecanone oxime 134 (397 mg, 2.01 mmol) and cyanuric 
chloride (25.2 mg, 0.14 mmol, 0.07 equiv) were reacted in acetonitrile (6.50 ml) in 
the manner which has been described by a procedure in the reference.34 A 
mixture of ketoxime and cyanuric chloride in dry acetonitrile was refluxed under 
nitrogen atmosphere for 2.5 h. The reaction mixture was quenched with 
saturated aqueous sodium hydrogen carbonate solution. Ethyl acetate was 
added to the neutralised reaction mixture in the separator funnel to extract the 
organic content. The organic layer was dried over anhydrous magnesium 
sulphate and evaporated in vacuo. The product which solidified was purified by 
recrystallisation from an ethyl acetate: hexane solvent mixture to give 
azacyclotridecane-2-one 135 (388 mg, 98%) as colourless crystals, m.p. 151 °C, 
Lit.35b m.p. 150 – 153 °C; νmax (NaCl; Thin Film)/cm-1 3307 (s, br, N-H), 2934 (s, 
C-H) and 1639 (s, C=O); δH (300 MHz; CDCl3; Me4Si) 5.53 (1H, s, br, NH), 3.30 
(2H, m, CH2N), 2.20 (2H, m, CH2C=O), 1.67 (2H, m, CH2CH2N), 1.50 (2H, m, 
CH2CH2C=O) and 1.33 (7×2H, m CH2CH2CH2); δC (75 MHz; CDCl3) 173.8 
(C=O), 39.5 (CH2N), 37.4 (CH2C=O), 28.7, 27.2, 26.8, 26.6, 26.1, 25.6, 25.3, 
25.1 and 24.3 (remaining CH2). 
 
 
3.3 General procedure: The Schmidt reaction 
 
The lactams were prepared by a procedure in the reference.36 Sodium azide was 
added (as rapidly as the evolution of nitrogen would permit) into a mixture of 
concentrated hydrochloric acid and ketone in an ice-bath. The reaction mixture 
was stirred for 4 h. Sodium carbonate was added until the mixture was slightly 
alkaline. Distilled water was added to dissolve the inorganic salts, and the oil 
which had separated was extracted with dichloromethane. The organic extracts 
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were dried over anhydrous magnesium sulphate and the solvent was removed in 
vacuo. The crystals which were formed on cooling were purified by re-
crystallisation in an ethyl acetate: hexane solvent mixture. The following three 
compounds were prepared by this method 
 
(a) Azocan-2-one (139) 
NH
O
A mixture of cycloheptanone 136 (10.000 g, 89.13 mmol) and 
concentrated hydrochloric acid (20.00 ml) was treated with sodium azide (8.924 
g, 137.27 mmol, 1.54 equiv) as described above to give azocan-2-one 139 
(9.452 g, 83%) as colourless crystals, m.p. 35 – 36 °C, Lit. 35c m.p. 35 – 38 °C; 
νmax (NaCl; Thin Film)/cm-1 3291 (s, br, N-H), 2928 (s, C-H) and 1659 (s, C=O); 
δH (300 MHz; CDCl3; Me4Si) 6.84 (1H, s, br, NH), 3.32 (2H, t, J 6.0, CH2N), 2.42 
(2H, t, J 5.4, CH2C=O), 1.81 (2H, m, CH2CH2N) and 1.58 (3×2H, m, 
CH2CH2CH2); δC (75 MHz; CDCl3) 173.4 (C=O), 46.0 (CH2N), 32.5 (CH2C=O), 
32.3, 28.3, 26.1 and 25.2 (remaining CH2’s) 
 
(b) Azonan-2-one (140) 
NH
O
A mixture of cyclooctanone 137 (2.250 g, 17.84 mmol) and 
concentrated hydrochloric acid (10.00 ml) was treated with sodium azide (1.781 
g, 27.40 mmol, 1.54 equiv) as described above to give azonan-2-one 140 (2.520 
g, 96%) as colourless crystals, m.p. 75 – 76 °C, Li t.35d m.p. 74 – 76 °C; νmax 
(NaCl; Thin Film)/cm-1 3301 (s, br, N-H), 2930 (s, C-H) and 1651 (s, C=O); δH 
(300 MHz; CDCl3; Me4Si) 6.36 (1H, s, br, NH), 3.36 (2H, m , CH2N), 2.43 (2H, t, J 
6.35, CH2C=O), 1.81 (2H, m, CH2CH2N) and 1.62 – 1.40 (4×2H, m CH2CH2CH2); 
δC (75 MHz; CDCl3) 178.0 (C=O), 43.3 (CH2N), 33.0 (CH2C=O), 30.0, 27.8, 25.4, 
24.5 and 23.1 (remaining CH2’s) 
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(c) Azacyclotridecan-2one (141) 
NH
O
A mixture of cyclotridecanone 133 (10.000 g, 54.84 mmol) and 
concentrated hydrochloric acid (20.00 ml) was treated with sodium azide (5.491 
g, 84.46 mmol, 1.54 equiv) in the manner which has been described above to 
give azacyclotridecane-2-one 135 (8.750 g, 81%) as colourless crystals. The 
data is the same as reported above. 
 
 
3.4 Thionation of lactams 
 
3.4.1 The Curphey procedure 
 
The thiolactams were prepared by a procedure in the reference.37 A mixture of 
lactam, phosphorus pentasulfide and hexamethyldisiloxane in dry 
dichloromethane was stirred at room temperature under nitrogen atmosphere for 
3 to 5 days. Saturated aqueous potassium carbonate was carefully added to the 
reaction mixture which was stirred for another 5 min before being transferred to a 
separator funnel. The organic layer was extracted repeatedly with 
dichloromethane. The organic extracts were dried over anhydrous magnesium 
sulphate and the solvent was evaporated in vacuo. The crude products which 
were formed were either purified by recrystallisation in an ethyl acetate: hexane 
solvent mixture or purified by column chromatography on silica gel using EtOAc: 
Hexane {(0.5:9.5), (1:9), (2:8) and (3:7)} solvent mixture as eluent. 
 
3.4.2 The Brillon procedure 
 
The thiolactams were prepared by a procedure in the reference.38 Sodium 
carbonate was added portion-wise over 5 min to a vigorously stirred suspension 
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of phosphorus pentasulfide in dry tetrahydrofuran and left to stir at room 
temperature for 15 min. The lactam was added to the clear yellow solution and 
the reaction was left stirring at room temperature for 4 days. The reaction was 
quenched by the cautious addition of aqueous sodium carbonate solution. After 
stirring for 5 min, the mixture was extracted repeatedly with dichloromethane and 
the combined organic extracts were dried over anhydrous magnesium sulphate, 
evaporated in vacuo and purified by recrystallisation from ethyl acetate: hexane 
solvent mixture. 
 
(a) Pyrrolidine-2-thione (89) 
NH
S
A mixture of pyrrolidin-2-one 142 (5.600 g, 85.10 mmol), phosphorus 
pentasulfide (6.728 g, 30.27 mmol, 0.46 equiv) and hexamethyldisiloxane 
(16.027 g, 98.70 mmol, 1.5 equiv) in dry dichloromethane (150.00 ml,  1.77 ml 
per mmol) were reacted according to general procedure 1 to give  pyrrolidine-2-
thione 89 (2.420 g, 36%) as cream crystals, m.p. 103 – 105 °C , Lit39 m.p. 103 – 
106 °C; R f  0.40 (EtOAc: Hex, 6:4); νmax (NaCl; Thin Film)/cm-1 3135 (w, br, N-H),  
2947 (vw, C-H); δH (300 MHz; CDCl3; Me4Si)  8.59 (1H, s, br, NH), 3.67 (2H, t, J 
7.2, CH2N), 3.92 (2H, t, J 7.9, CH2C=S) and 2.23 (2H, m CH2CH2CH2N); δC (75 
MHz; CDCl3) 206.0 (C=S), 49.7 (CH2N), 43.3 (CH2C=S) and 23.0 (CH2CH2N); 
HRMS (EI): found, 101.02938 (C4H7NS requires 101.02992). 
 
(b) Azepane-2-thione (147) 
NH
S
(i) A mixture of azepan-2-one 143 (10.000 g, 88.36 mmol), phosphorus 
pentasulphide (9.034 g, 40.64 mmol, 0.46 equiv) and hexamethyldisiloxane 
(21.521 g, 135.533 mmol, 1.5 equiv) in dry dichloromethane (154.62 ml, 1.75 ml 
per mmol) were reacted according to general procedure 1 to give azepane-2-
thione 147 (8.306 g, 73%) as colourless crystals, m.p. 102 – 104 °C, Lit. 38 m.p. 
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103 – 104 °C; R f  0.25 (EtOAc:Hex, 3:7); νmax (NaCl; Thin Film)/cm-1 3423 (m, br, 
N-H), 2936 (vw, C-H); δH (300MHz; CDCl3; Me4Si) 8.84 (1H, s, br, NH), 3.38 (2H, 
dd, J 5.6 and 9.7, CH2N), 2.99 (2H, m, CH2C=S) and 1.81 – 1.71 (3×2H, m 
CH2CH2CH2); δC (300MHz; CDCl3) 210.7 (C=S), 47.4 (CH2N), 45.2 (CH2C=S), 
30.6, 28.4 and 24.8 (remaining CH2’s); HRMS (EI): found, 129.06067 (C6H11NS 
requires 129.06122). 
 
(ii) A mixture of azepan-2-one 143 (5.008 g, 44.25 mmol), phosphorus 
pentasulphide (10.320 g, 46.42 mmol, 1.05 equiv) and sodium carbonate (6.152 
g, 58.02 mmol, 1.3 equiv) in dry tetrahydrofuran (150 ml, 3.39 ml per mmol) were 
reacted according to general procedure 2 to give azepane-2-thione 147 (5.207 g, 
91%) as colourless crystals. The data is the same as reported above. 
 
(c) Azocane-2-thione (148) 
NH
S
A mixture of azocan-2-one 144 (9.453 g, 74.30 mmol), phosphorus 
pentasulphide (7.597 g, 34.18 mmol, 0.46 equiv) and hexamethyldisiloxane 
(18.097 g, 111.45 mmol, 1.5 equiv) in dry dichloromethane (130 ml, 1.75 ml per 
mmol) were reacted according to general procedure 1 to give azocane-2-thione 
148 (7.513 g, 71%) as colourless crystals, m.p. 69 – 72 °C, Lit. 39 m.p. 79 – 82 °C; 
Rf 0.69  (EtOAc:Hex, 4:1); νmax (NaCl; Thin Film)/cm-1 3425 (m, br, N-H), 2927 
(vw, C-H); δH (300 MHz; CDCl3; Me4Si) 8.59 (1H, s, br, NH), 3.46 (2H, m, CH2N), 
2.92 (2H, t, J 6.3, CH2C=S), 1.93 (2H, m, CH2CH2N) 1.68 (2H, m, CH2CH2C=S) 
and 1.57 (2×2H, m CH2CH2CH2); δC (75 MHz; CDCl3) 209.2 (C=S), 45.7 (CH2N), 
39.6 (CH2C=S), 32.1, 30.7, 25.3 and 25.0 (remaining CH2’s); HRMS (EI): found, 
143.07631 (C7H13NS requires 143.07687). 
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(d) Azonane-2-thione (149) 
NH
S
(i) A mixture of azonan-2-one 145 (2.520 g, 17.84 mmol), phosphorus 
pentasulphide (1.825 g, 8.21 mmol, 0.46 equiv) and hexamethyldisiloxane (4.345 
g, 26.76 mmol, 1.5 equiv) in dry dichloromethane (32 ml, 1.79 ml per mmol) were 
reacted according to general procedure 1 to give azonane-2-thione 149 (1.260 g, 
50%) as colourless crystals, m.p. 72 – 75 °C, Lit. 39 m.p. 84 – 87 °C;  R f  0.77  
(EtOAc:Hex, 4:1); νmax (NaCl; Thin Film)/cm-1 3407 (m, br, N-H); δH (300 MHz; 
CDCl3; Me4Si) 8.30 (1H, s, br, NH), 3.51 (2H, m, CH2N), 2.92 (2H, m, CH2C=S), 
1.95 (2H, m, CH2CH2N), 1.68 (2H, m, CH2CH2C=S) and 1.57 (3×2H, m, 
CH2CH2CH2); δC (75 MHz; CDCl3) 209.6 (C=S), 48.0 (CH2N), 41.4 (CH2C=S), 
29.2, 28.4, 27.7, 24.7 and 24.1 (remaining CH2’s); HRMS (EI): found, 157.09199 
(C8H15NS requires 157.09252). 
 
(ii) a mixture of azonan-2-one 145 (2.692 g, 19.06 mmol), phosphorus 
pentasulphide (4.498 g, 20.01 mmol, 1.05 equiv) and sodium carbonate (2.626 g, 
24.78 mmol, 1.3 equiv) in dry tetrahydrofuran (150 ml, 8.31 ml per mmol) were 
reacted according to general procedure 2 to give azonane-2-thione 149 (2.998 g, 
84%) as colourless crystals. The data is the same as reported above. 
 
(e) Azacyclotridecane-2-thione (150) 
NH
S
A mixture of azacyclotridecan-2-one 135 (5.000 g, 25.33 mmol), 
phosphorus pentasulphide (2.604 g, 11.72 mmol, 0.46 equiv) and 
hexamethyldisiloxane (16.170 g, 38.00 mmol, 1.5 equiv) in dry dichloromethane 
(22.76 ml, 0.90 ml per mmol) were reacted according to general procedure 1 to 
give azacyclotridecane-2-thione 150 (5.050 g, 93 %) as colourless crystals, m.p. 
104 °C, Lit. 39 m.p. 102 – 104 °C; R f 0.53 (EtOAc:Hex, 3:7); νmax (NaCl; Thin 
79 
Film)/cm-1 3327 (m, br, N-H); δH (300 MHz; CDCl3; Me4Si) 7.21 (1H, s, br, NH), 
3.77 (2H, m, CH2N), 2.73 (2H, m, CH2C=S), 1.81 (2H, m, CH2CH2N), 1.68 (2H, 
m, CH2CH2C=S) and 1.43 – 1.33 (7×2H, m CH2CH2CH2); δC (75 MHz; CDCl3) 
205.4 (C=S), 46.8 (CH2N), 45.3 (CH2C=S), 27.5, 26.6, 26.4, 25.9, 25.5, 25.2, 
24.5, 24.2 and 23.9 (remaining CH2’s); HRMS (EI): found, 213.15460 (C12H23NS 
requires 213.15512). 
 
 
3.5 General procedure for the N-alkylation of thiolactams with acrylate 
esters 
 
The N-alkylthiolactams were prepared by a procedure in the reference.27 To a 
stirred solution of the thiolactam in dry tetrahydrofuran was added a catalytic 
amount of sodium hydroxide, followed by the dropwise addition of tert-butyl 
acrylate. The mixture was stirred at 40 oC for 17 - 22 h, before evaporating the 
solvent in vacuo. The residue was dissolved in dichloromethane, and the 
resulting solution was washed with distilled water and saturated sodium chloride 
solution. The organic layer was dried over anhydrous magnesium sulphate, 
filtered and evaporated in vacuo to yield oil which solidified on cooling at room 
temperature. The product was purified by recrystallisation from ethyl acetate: 
hexane solvent mixture. The following compounds were prepared by this method. 
 
(a) tert-Butyl 3-(2-thioxopyrrolidin-1-yl)propanoate (108b) 
N
S
O
O
 Pyrrolidine-2-thione 89 (626 mg, 5.73 mmol), tert-butyl 
acrylate (882 mg, 6.88 mmol, 1.20 equiv) and a catalytic amount of sodium 
hydroxide in dry tetrahydrofuran (50.00 ml) were reacted as described above to 
give tert-butyl 3-(2-thioxopyrrolidin-1-yl)propanoate 108b (1.125 g, 85%) as 
colourless crystals, m.p. 48 – 49 °C; R f  0.34 (EtOAc:Hex, 3:7); νmax (NaCl; Thin 
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Film)/cm-1 2981 (m, C-H), 1716 (s, C=O) and 1151 (s, C-O); δH (300 MHz; CDCl3; 
Me4Si) 3.98 (2H, t, J 6.7, (CH3)3COOCCH2CH2N), 3.79 (2H, t, J 7.3, 
CH2CH2CH2N), 3.02 (2H, t, J 7.9, CH2C=S), 2.67 (2H, t, J 6.7, 
(CH3)3COOCCH2CH2N), 2.05 (2H, m, CH2CH2CH2) and 1.46 (3×3H, s, (CH3)3C); 
δC (75 MHz; CDCl3) 201.9 (C=S), 171.2 (C=O), 81.6 ((CH3)3C), 56.2 
(CH2CH2CH2N), 45.4 ((CH3)3COOCCH2CH2N), 44.3 (CH2CH2CH2C=S), 32.8 
((CH3)3COOCCH2CH2N), 28.5 ((CH3)3C) and 20.3 (CH2CH2C=S); HRMS (EI): 
found, 229.11310 (C11H19O2NS requires 229.11365). 
 
(b) tert-butyl 3-(2-thioxopiperidin-1-yl)propanoate (108c) 
 
27
 
N
S
O
O Piperidine-2-thione 107 (376 mg, 3.26 mmol), tert-butyl 
acrylate (501 mg, 3.91 mmol, 1.20 equiv) and a catalytic amount of sodium 
hydroxide in dry tetrahydrofuran (5.70 ml) were reacted as described above to 
give tert-butyl 3-(2-thioxopiperidin-1-yl)propanoate 108c (0.579 g, 73%) as 
colourless crystals, m.p. 54 – 55 °C, Lit m.p. 55 –  56 °C; 22 Rf  0.45 (EtOAc:Hex, 
3:7); νmax (NaCl; Thin Film)/cm-1 ; δH (300 MHz; CDCl3; Me4Si) 3.95 (2H, t, J 6.9, 
(CH3)3COOCCH2CH2N), 3.34 (2H, t, J 5.7, CH2CH2CH2N), 2.75 (2H, t, J 6.2, 
CH2C=S), 2.55 (2H, t, J 6.9, (CH3)3COOCCH2CH2N), 1.68 (2H, m, 
CH2CH2CH2N), 1.52 (2H, m, CH2CH2CH2N) and 1.45 (3×3H, s, (CH3)3C); δC (75 
MHz; CDCl3) 199.9 (C=S), 171.1 (C=O), 81.0 ((CH3)3C), 52.0 (CH2CH2CH2N), 
51.1 ((CH3)3COOCCH2CH2N), 42.1 (CH2CH2CH2C=S), 32.1 
((CH3)3COOCCH2CH2N), 23.2 (CH2CH2CH2N), 28.3 ((CH3)3C) and 20.7 
(CH2CH2C=S). 
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(c) tert-Butyl 3-(2-thioxoazepan-1-yl)propanoate (151) 
N
S
O
O Azepane-2-thione 147 (2.000 g, 15.47 mmol), tert-butyl 
acrylate (2.379 g, 18.56 mmol, 1.20 equiv) and a catalytic amount of sodium 
hydroxide in dry tetrahydrofuran (27.00 ml) were reacted as described above to 
give tert-butyl 3-(2-thioxoazepan-1-yl)propanoate 151 (3.267 g, 82%) as 
colourless crystals, m.p. 60 – 62 °C; R f  0.57 (EtOAc:Hex, 3:7); νmax (NaCl; Thin 
Film)/cm-1 2932 (m, C-H), 1725 (s, C=O) and 1156 (s, C-O); δH (300 MHz; CDCl3; 
Me4Si) 4.23 (2H, t, J 6.9, (CH3)3COOCCH2CH2N), 3.74 (2H, m, CH2CH2CH2N), 
3.12 (2H, m, CH2C=S), 2.72 (2H, t, J 6.9, (CH3)3COOCCH2CH2N), 1.73 – 1.65 
(3×2H, m, CH2CH2CH2) and 1.45 (3×3H, s, (CH3)3C); δC (75 MHz; CDCl3) 206.8 
(C=S), 171.5 (C=O), 81.4 ((CH3)3C), 55.4 (CH2CH2CH2N), 53.3 
((CH3)3COOCCH2CH2N), 47.6 (CH2CH2CH2C=S), 33.0 ((CH3)3COOCCH2CH2N), 
28.5 ((CH3)3C), 29.6, 27.6 and 25.0 (remaining CH2’s); HRMS (EI): found, 
257.14705 (C13H23O2NS requires 257.144954). 
 
(d) tert-Butyl 3-(2-thioxoazocan-1-yl)propanoate (152) 
N
S
O
O Azocane-2-thione 148 (2.000 g, 13.96 mmol), tert-butyl 
acrylate (2.147 g, 16.75 mmol, 1.20 equiv) and a catalytic amount of sodium 
hydroxide in dry tetrahydrofuran (24.00 ml) were reacted as described above to 
give tert-butyl 3-(2-thioxoazocan-1-yl)propanoate 152 (3.541 g, 93%) as crystals, 
m.p. 66 – 69 °C; R f 0.64 (EtOAc:Hex, 3:7); νmax (NaCl; Thin Film)/cm-1 2929 (m, 
C-H), 1727 (s, C=O) and 1154 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 4.13 (2H, t, 
J 6.9, (CH3)3COOCCH2CH2N), 3.81 (2H, m, CH2CH2CH2N), 3.07 (2H, m, 
CH2C=S), 2.81 (2H, t, J 7.0, (CH3)3COOCCH2CH2N), 1.94 (2H, m, 
CH2CH2CH2N), 1.75 (2H, m, CH2CH2CH2C=S), 1.45 (3×3H, s, (CH3)3C) and 1.58 
– 1.48 (2×2H, m, CH2CH2CH2); δC (75 MHz; CDCl3) 205.7 (C=S), 171.3 (C=O), 
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81.0 ((CH3)3C), 52.2 (CH2CH2CH2N), 49.5 ((CH3)3COOCCH2CH2N), 32.2 
(CH2CH2CH2C=S), 44.9 ((CH3)3COOCCH2CH2N), 28.1 ((CH3)3C), 31.4, 25.9, 
29.6 and 24.7 (remaining CH2’s); HRMS (EI): found, 271.15878 (C14H25O2NS 
requires 271.1606). 
 
(e) tert-Butyl 3-(2-thioxoazonan-1-yl)propanoate  (153) 
N
S
O
O Azonane-2-thione 149 (0.799 g, 5.08 mmol), tert-butyl 
acrylate (0.782 g, 6.10 mmol, 1.20 equiv) and a catalytic amount of sodium 
hydroxide in dry tetrahydrofuran (9.00 ml) were reacted as described above to 
give tert-butyl 3-(2-thioxoazonan-1-yl)propanoate  153 (1.367 g, 94%) as 
colourless crystals, m.p. 64 – 66 °C; R f 0.62  (EtOAc:Hex, 3:7); νmax (NaCl; Thin 
Film)/cm-1 2927 (m, C-H), 1726 (s, C=O) and 1155 (s, C-O); δH (300 MHz; CDCl3; 
Me4Si) 4.12 (2H, m, (CH3)3COOCCH2CH2N), 3.81 (2H, m, CH2CH2CH2N), 3.05 
(2H, m, CH2C=S), 2.82 (2H, t, J 7.0, (CH3)3COOCCH2CH2N), 1.95 (2H, m, 
CH2CH2CH2N), 1.77 (2H, m, CH2CH2CH2C=S), 1.45 (3×3H, s, (CH3)3C) and 1.57 
– 1.51 (3×2H, m, CH2CH2CH2); δC (75 MHz; CDCl3) 206.8 (C=S), 171.7 (C=O), 
81.4 ((CH3)3C), 54.2 (CH2CH2CH2N), 49.4 ((CH3)3COOCCH2CH2N), 45.4 
(CH2CH2CH2C=S), 32.3 ((CH3)3COOCCH2CH2N), 28.5 ((CH3)3C), 29.1, 27.1, 
28.1, 25.1 and 22.8 (remaining CH2’s); HRMS (EI): found, 285.17625 
(C15H27O2NS requires 285.17625). 
 
(f) tert-Butyl 3-(2-thioxoazacyclotridecan-1-yl)propanoate (154) 
N
S
O
O Azacyclotridecane-2-thione 150 (1.013 g, 4.75 mmol), 
tert-butyl acrylate (0.731 g, 5.70 mmol, 1.20 equiv) and a catalytic amount of 
sodium hydroxide in dry tetrahydrofuran (8.00 ml) were reacted as described 
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above to give tert-butyl 3-(2-thioxoazacyclotridecan-1-yl)propanoate 154 (0.978 
g, 60%) as colourless crystals, m.p. 86 – 88 °C; R f 0.72  (EtOAc:Hex, 3:7); νmax 
(NaCl; Thin Film)/cm-1 2931 (m, C-H), 1727 (s, C=O) and 1155 (s, C-O); δH (300 
MHz; CDCl3; Me4Si) 4.10 (2H, m, (CH3)3COOCCH2CH2N), 3.49 (2H, m, 
CH2CH2CH2N), 2.77 (2x2H, m, (CH3)3COOCCH2CH2N and CH2C=S), 1.81 
(2×2H, m, CH2CH2CH2N and CH2CH2CH2C=S), 1.45 (3×3H, s, (CH3)3C) and 
1.60 – 1.26 (7×2H, m, CH2CH2CH2); δC (75 MHz; CDCl3) 205.1 (C=S), 171.6 
(C=O), 81.4 ((CH3)3C), 51.8 (CH2CH2CH2N), 50.0 ((CH3)3COOCCH2CH2N), 42.8 
(CH2CH2CH2C=S), 32.6 ((CH3)3COOCCH2CH2N), 28.5 ((CH3)3C), 26.8, 26.7, 
26.3, 24.6, 24.5, 24.3, 24.3, 23.5 and 23.2  (remaining CH2’s); HRMS (EI): found, 
341.23908 (C19H35O2NS requires 341.23885). 
 
 
3.6 General procedure for the preparation of N-alkyl vinylogous urethanes 
from N-alkylthiolactams 
 
The vinylogous urethanes were prepared by a procedure in the reference.27 Ethyl 
bromoacetate was added dropwise to a stirred solution of N-alkylthiolactams in 
dry acetonitrile. The resulting solution was stirred at room temperature for 42 h, 
after which the S-alkylation was complete. The volatiles were removed in vacuo. 
The salt was then re-dissolved in dry acetonitrile, after which triphenylphosphine 
or triethylphosphite and triethylamine were added to induce sulphur extrusion. 
The resulting solution was left to stir at ambient temperature for 25 h. Distilled 
water was added and the resulting solution was extracted with dichloromethane. 
The organic extracts were dried over anhydrous magnesium sulphate, filtered 
and evaporated in vacuo. The crude product was purified by column 
chromatography on silica gel using ethyl acetate: hexane (0.5:9.5) solvent 
mixture as eluent. The following compounds were prepared by this method. 
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(a) (E)-tert-Butyl 3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl)propanoate 
(109b) 
N O
O
O
O
 tert-Butyl 3-(2-thioxopyrrolidin-1-yl)propanoate 108b (236 
mg, 1.03 mmol) and ethyl bromoacetate (252 mg, 1.31 mmol, 1.30 equiv) in dry 
MeCN (10.00 ml) were reacted as described above, followed by the addition of 
P(OEt)3 (199 mg, 1.20 mmol, 1.20 equiv) and Et3N (221 mg, 2.18 mmol, 2.10 
equiv) in dry MeCN (10.00 ml) (Specific reaction conditions: Scheme 21. (a) rt, 8 
h, (b) rt, 1.5 h) to give (E)-tert-butyl 3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-
yl)propanoate 109b (257 mg, 88%) as a red oil. Rf 0.36  (EtOAc: Hexane, 3:7); 
νmax (NaCl; Thin Film)/cm-1  2974 (vw, =C-H), 1725 (m, sat, C=O), 1682 (m, 
unsat, C=O),  1588 (s, C=C) and 1125 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 
4.53 (1H, s, C=CHCOOEt), 4.09 (2H, q, J 7.1, COOCH2CH3), 3.42 (2×2H, m, 
(CH3)3COOCCH2CH2N and CH2CH2CH2N), 3.13 (2H, t, J 7.8, CH2C=C), 2.49 
(2H, t, J 7.0, (CH3)3COOCCH2CH2N), 1.92 (2H, p, J 7.4, CH2CH2CH2), 1.45 
(3×3H, s, (CH3)3C) and 1.25 (3H, t, J 7.1, CH2CH3) ; δC (75 MHz; CDCl3) 171.1 
((CH3)3COOCCH2CH2N), 169.7 (NC=C), 164.8 (CH3CH2OOC), 81.4 ((CH3)3C), 
78.6 (NC=C), 58.6 (CH3CH2),  53.1 (CH2CH2CH2N), 42.4 
((CH3)3COOCCH2CH2N), 32.9 (CH2CH2CH2C=C), 32.6 ((CH3)3COOCCH2CH2N), 
28.4 ((CH3)3C), 21.5 (CH2CH2CH2) and 15.1 (CH2CH3); HRMS (EI): found, 
283.17781 (C15H25O4N requires 283.17836).  
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 (b) tert-Butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azepan-1-yl}propanoate 
(155) 
N O
O
O
O
 tert-Butyl 3-(2-thioxoazepan-1-yl)propanoate 151 (1.274 g, 
4.95 mmol) and ethyl bromoacetate (0.910 g, 5.45 mmol, 1.10 equiv) in dry 
MeCN (8.60 ml) were reacted as described above, followed by the addition of 
PPh3 (0.551 g, 5.45 mmol, 1.10 equiv) and Et3N (1.429 g, 5.45 mmol, 1.10 equiv) 
in dry MeCN (8.60 ml) (Specific reaction conditions: Scheme 21. (a) rt, 23.5 h, 
(b) rt, 1 h) to give tert-butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azepan-1-
yl}propanoate 155 (0.290 g, 19%) as a yellow oil. Rf 0.52  (EtOAc: Hexane, 3:7); 
νmax (NaCl; Thin Film)/cm-1 2931 (vw, =C-H), 1727 (m, sat, C=O), 1683 (m, unsat, 
C=O), 1573 (s, C=C) and 1136 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 4.46 (1H, s, 
C=CHCOOEt), 4.03 (2H, q, J 7.1, COOCH2CH3), 3.48 (2H, t, J 7.0, 
(CH3)3COOCCH2CH2N), 3.40 (2H, m, CH2CH2CH2N), 3.20 (2H, m, CH2C=C), 
2.50 (2H, t, J 7.0, (CH3)3COOCCH2CH2N), 1.60 (2×2H, m, CH2CH2CH2), 1.52 
(2H, m, CH2CH2CH2), 1.42 (3×3H, s, (CH3)3C) and 1.21 (3H, t, J 7.1, CH2CH3) ; 
δC (75 MHz; CDCl3) 170.8 ((CH3)3COOCCH2CH2N), 169.0 (NC=C), 166.4 
(CH3CH2OOC), 82.7 ((CH3)3C), 80.8 (NC=C), 58.1 (CH3CH2),  52.9 
(CH2CH2CH2N), 48.5 ((CH3)3COOCCH2CH2N), 29.2 (CH2CH2CH2C=C), 32.8 
((CH3)3COOCCH2CH2N), 27.9 ((CH3)3C), 28.7, 27.0, 25.9 (remaining CH2’s) and 
14.6 (CH2CH3); HRMS (EI): found, 311.20906 (C17H29O4N requires 311.20966). 
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(c) tert-Butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azocan-1-yl}propanoate 
(156) 
N O
O
OO
  tert-Butyl 3-(2-thioxoazocan-1-yl)propanoate 152(3.472 g, 
12.71 mmol) and ethyl bromoacetate (2.350 g, 14.07 mmol, 1.10 equiv) in dry 
acetonitrile (22.40 ml) were reacted as described above, followed by the addition 
of PPh3 (3.690 g, 14.07 mmol, 1.10 equiv) and Et3N (1.424 g, 14.07 mmol, 1.10 
equiv) in dry MeCN (22.40 ml) (Specific reaction conditions: Scheme 21. (a) rt, 
23 h, (b) rt, 22 h) to give tert-butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azocan-
1-yl}propanoate 156 (1.178 g, 21%) as a yellow oil. Rf 0.61  (EtOAc: Hexane, 
3:7); νmax (NaCl; Thin Film)/cm-1 2929 (vw, =C-H), 1728 (m, sat, C=O), 1683 (m, 
unsat, C=O), 1567 (s, conj, C=C) and 1133 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 
4.52 (1H, s, C=CHCOOEt), 4.08 (2H, q, J 7.1, COOCH2CH3), 3.46 (2H, m, 
(CH3)3COOCCH2CH2N), 3.46 (2H, m, CH2CH2CH2N), 3.07 (2H, m, CH2C=C), 
2.57 (2H, t, J 7.1, (CH3)3COOCCH2CH2N), 1.78 (2H, m, CH2CH2N), 1.60 (2H, m, 
CH2CH2C=C),  1.58 (2×2H, m, CH2CH2CH2), 1.58 (3×3H, s, (CH3)3C) and 1.25 
(3H, t, J 7.1, CH2CH3) ; δC (75 MHz; CDCl3) 169.9 ((CH3)3COOCCH2CH2N), 
167.5 (NC=C), 164.6 (CH3CH2OOC), 81.1 ((CH3)3C), 79.8 (NC=C), 57.0 
(CH3CH2),  44.7 (CH2CH2CH2N), 47.7 ((CH3)3COOCCH2CH2N), 28.5 
(CH2CH2CH2C=C), 31.3 ((CH3)3COOCCH2CH2N), 26.9 ((CH3)3C), 29.2, 25.3, 
24.9, 23.5 (remaining CH2’s) and 13.5 (CH2CH3); HRMS (EI): found, 325.22465 
(C18H31O4N requires 325.22531). 
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(d) tert-Butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azonan-1-yl}propanoate 
(157) 
N O
O
OO
 tert-Butyl 3-(2-thioxoazonan-1-yl)propanoate 153 (1.326 g, 
4.64 mmol) and ethyl bromoacetate (0.852 g, 5.10 mmol, 1.10 equiv) in dry 
MeCN (8.10 ml) were reacted as described above, followed by the addition of 
PPh3 (1.337 g, 5.10 mmol, 1.10 equiv) and Et3N (0.516 g, 5.10 mmol, 1.10 equiv) 
in dry MeCN (8.10 ml) (Specific reaction conditions: Scheme 21. (a) rt, 23 h, (b) 
rt, 22 h) to give tert-butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azonan-1-
yl}propanoate 157 (0.175 g, 8%) as an yellow oil. Rf 0.62  (EtOAc: Hexane, 3:7); 
νmax (NaCl; Thin Film)/cm-1 2932 (vw, =C-H), 1727 (m, sat, C=O), 1683 (m, unsat, 
C=O), 1561 (s, C=C) and 1136 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 4.49 (1H, s, 
C=CHCOOEt), 4.01 (2H, q, J 7.1, COOCH2CH3) 3.42 (2H, m, 
(CH3)3COOCCH2CH2N), 3.35 (2H, t, J 7.0, CH2CH2CH2N), 3.05 – 2.79 (2H, m, 
CH2C=C), 2.51 (2H, t, J 7.0, (CH3)3COOCCH2CH2N), 1.74 (2H, m, CH2CH2N), 
1.38 (3×3H, s, (CH3)3C), 1.20 (3H, t, J 3.6, CH2CH3) and 1.59 – 1.16 (4×2H, m, 
CH2CH2CH2); δC (75 MHz; CDCl3) 171.6 ((CH3)3COOCCH2CH2N), 168.9 (NC=C), 
167.4 (CH3CH2OOC), 84.2 ((CH3)3C), 81.3 (NC=C), 58.6 (CH3CH2),  50.6 
(CH2CH2CH2N), 45.3 ((CH3)3COOCCH2CH2N), 30.0 (CH2CH2CH2C=C), 32.5 
((CH3)3COOCCH2CH2N), 28.5 ((CH3)3C), 15.1 (CH2CH3), 28.2, 27.6, 26.2, 27.1 
and 21.6 (remaining CH2’s); HRMS (EI): found, 339.24046 (C19H33O4N requires 
339.24096). 
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(e) tert-Butyl 3-{(2E)-2-[(ethoxycarbonyl)methylene]azacyclotridecan-1-
yl}propanoate (158) 
N O
O
OO
 tert-Butyl 3-(2-thioxoazacyclotridecan-1-yl)propanoate 
158 (0.978 g, 2.86 mmol) and ethyl bromoacetate (0.526 g, 3.15 mmol, 1.10 
equiv) in dry MeCN (10.00 ml) were reacted as described above, followed by the 
addition of PPh3 (0.826 g, 3.15 mmol, 1.10 equiv) and Et3N (0.319 g, 3.15 mmol, 
1.10 equiv) in dry MeCN (10.00 ml) (Specific reaction conditions: Scheme 21. (a) 
rt, 23 h, (b) rt, 22 h) to give tert-butyl 3-{(2E)-2-
[(ethoxycarbonyl)methylene]azacyclotridecan-1-yl}propanoate 154 (249 mg, 
20%) as a yellow oil. Rf 0.72 (EtOAc: Hexane, ); νmax (NaCl; Thin Film)/cm-1 2932 
(vw, =C-H), 1728 (m, sat, C=O), 1682 (m, unsat, C=O), 1569 (s, C=C) and 1152 
(s, C-O); δH (300 MHz; CDCl3; Me4Si) 4.54 (1H, s, C=CHCOOEt), 4.07 (2H, q, J 
6.1, COOCH2CH3), 3.46 (2H, t, J 7.4, (CH3)3COOCCH2CH2N), 3.25 (2H, m, 
CH2CH2CH2N), 2.76 (2H, t, J 7.2, CH2C=C), 2.50 (2H, t, J 7.4, 
(CH3)3COOCCH2CH2N), 1.81 (2H, m, CH2CH2N), 1.46 (3×3H, s, (CH3)3C) 1.31 
(3H, t, J 3.6, CH2CH3) and 1.65 – 1.22 (8×2H, m, CH2CH2CH2); δC (75 MHz; 
CDCl3) 171.4 ((CH3)3COOCCH2CH2N), 169.0 (NC=C), 164.8 (CH3CH2OOC), 
84.2 ((CH3)3C), 81.4 (NC=C), 58.6 (CH3CH2),  51.8 (CH2CH2CH2N), 50.0 
((CH3)3COOCCH2CH2N), 46.2 (CH2CH2CH2C=C), 49.0 ((CH3)3COOCCH2CH2N), 
28.5 ((CH3)3C), 15.1 (CH2CH3), 33.1, 32.6, 26.8, 26.7, 25.2, 24.8, 24.5, 24.3 and 
23.2  (remaining CH2’s); HRMS (EI): found, 395.30302 (C23H41O4N requires 
395.30356). 
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3.7 General procedure for the preparation of N-alkyl vinylogous amides 
from N-alkylthiolactams 
 
The vinylogous amides were prepared by a procedure in reference.27 p-
Nitrophenacyl bromide or phenacyl bromide was added to a stirred solution of N-
alkylthiolactams in dry acetonitrile. The resulting solution was stirred at room 
temperature for 22 – 30 h, after which the S-alkylation was complete shown by 
formation of the thioiminium salt. This was then followed by the addition of 
triphenylphosphine and triethylamine to induce sulphur extrusion. The resulting 
solution was left to stir at ambient temperature for 2 – 24 h. Distilled water was 
added and the resulting solution was extracted with dichloromethane. The 
organic extracts were dried over anhydrous sodium sulphate, filtered and 
evaporated in vacuo. The crude product was purified by column chromatography 
on silica gel using ethyl acetate: hexane (0.5:9.5) solvent mixture as eluent. The 
following compounds were prepared by this procedure. 
 
(a) (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]pyrrolidin-1-
yl}propanoate (159a) 
N O
O
O
O2N
 tert-Butyl 3-(2-thioxopyrrolidin-1-yl)propanoate 
108b (504 mg, 2.20 mmol) and p-nitrophenacyl bromide (564 mg, 2.31 mmol, 
1.05 equiv) in dry MeCN (45.00 ml) were reacted as described above, followed 
by the addition of PPh3 (606 mg, 2.31 mmol, 1.05 equiv) and Et3N (234 mg, 2.31 
mmol, 1.05 equiv) (Specific reaction conditions: Scheme 22. (a) rt, 22 h, (b) rt, 2 
h) to give (E)-tert-butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]pyrrolidin-1-
yl}propanoate 159a (758 mg, 89%) as orange crystals, m.p. 128 – 129 °C ; Rf 
0.076  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1  2987 (vw, =C-H), 1726 
(m, C=O), 1678 (m, conj, C=C), 1595 (s, C=C), 1514 (m, aromatic, N-O), 1342 
(m, aromatic, N-O) and 1148 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 8.23 (2×1H, 
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d, J 8.7, CHCNO2), 8.00 (2×1H, d, J 8.7, CHCHCNO2) 5.73 (1H, s, C=CHCOAr), 
3.67 (2H, t, J 6.8 (CH3)3COOCCH2CH2N), 3.57 (2H, t, J 7.3, CH2CH2CH2N), 3.40 
(2H, t, J 7.8, CH2C=C), 2.61 (2H, t, J 6.8, (CH3)3COOCCH2CH2N), 2.05 (2H, p, J 
7.6, CH2CH2CH2) and 1.45 (3×3H, s, (CH3)3C); δC (75 MHz; CDCl3) 185.2 
(CHCOAr), 170.8 ((CH3)3COOCCH2CH2N), 168.6 (NC=C), 149.0 (CHCNO2), 
148.0 (CCHCHCNO2), 128.5 (CHCHCNO2), 123.7 (CHCNO2), 81.8 ((CH3)3C), 
87.0 (NC=C),  53.6 (CH2CH2CH2N), 42.8 ((CH3)3COOCCH2CH2N), 34.5 
(CH2CH2CH2C=C), 33.0 ((CH3)3COOCCH2CH2N), 28.4 ((CH3)3C) and 21.2 
(CH2CH2CH2); HRMS (EI): found, 360.16797 (C19H24O5N2 requires 360.16852).  
 
(b) (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]piperidin-1-
yl}propanoate (160a) 
N O
O
O
O2N
tert-Butyl 3-(2-thioxopiperidin-1-yl)propanoate 108c 
(297 mg, 1.22 mmol) and p-nitrophenacyl bromide (312 mg, 1.28 mmol, 1.05 
equiv) in dry MeCN (15.00 ml) were reacted as described above, followed by the 
addition of PPh3 (336 mg, 1.28 mmol, 1.05 equiv) and Et3N (130 mg, 1.28 mmol, 
1.05 equiv) (Specific reaction conditions: Scheme 22. (a) rt, 11 h, (b) rt, 22 h) to 
give (E)-tert-butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]piperidin-1-
yl}propanoate 160a (146 mg, 32%) as yellow crystals, m.p. 116 – 117 °C ; Rf 0.13  
(EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 2970 (vw, =C-H), 2360 (w, R3-
N+ ions), 1722 (m, C=O), 1610 (m, conj, C=C), 1588 (s, C=C), 1514 (m, aromatic, 
N-O), 1346 (m, aromatic, N-O) and 1142 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 
8.22 (2×1H, d, J 8.5, CHCNO2), 7.96 (2×1H, d, J 8.5, CHCHCNO2) 5.68 (1H, s, 
C=CHCOAr), 3.67 (2H, t, J 6.9 (CH3)3COOCCH2CH2N), 3.44 (2H, t, J 5.8, 
CH2CH2CH2N), 3.34 (2H, t, J 6.3, CH2C=C), 2.65 (2H, t, J 6.9, 
(CH3)3COOCCH2CH2N), 1.84 (2H, m, CH2CH2CH2), 1.72 (2H, m, CH2CH2CH2) 
and 1.45 (3×3H, s, (CH3)3C); δC (75 MHz; CDCl3) 185.0 (CHCOAr), 170.9 
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((CH3)3COOCCH2CH2N), 166.0 (NC=C), 149.1 (CHCNO2), 148.9 
(CCHCHCNO2), 128.4 (CHCHCNO2), 123.7 (CHCNO2), 81.9 ((CH3)3C), 90.7 
(NC=C),  51.3 (CH2CH2CH2N), 48.7 ((CH3)3COOCCH2CH2N), 32.6 
(CH2CH2CH2C=C), 28.9 ((CH3)3COOCCH2CH2N), 28.4 ((CH3)3C) 23.2 
(CH2CH2CH2) and 19.3 (CH2CH2CH2); HRMS (EI): found, 374.18361 
(C20H26O5N2 requires 374.18417). 
 
(c) (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azepan-1-
yl}propanoate (161a) 
N O
O
O
O2N
 tert-Butyl 3-(2-thioxoazepan-1-yl)propanoate 151 
(746 mg, 2.90 mmol) and p-nitrophenacyl bromide (744 mg, 3.05 mmol, 1.05 
equiv) in dry MeCN (40.00 ml) were reacted as described above, followed by the 
addition of PPh3 (800 mg, 3.05 mmol, 1.05 equiv) and Et3N (309 mg, 3.05 mmol, 
1.05 equiv) (Specific reaction conditions: Scheme 22. (a) rt, 23 h, (b) rt, 4 h) to 
give (E)-tert-butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azepan-1-yl}propanoate 
161a (812 mg, 72%) as yellow oil. Rf 0.23  (EtOAc: Hexane, 3:7); νmax (NaCl; 
Thin Film)/cm-1  2981 (vw, =C-H), 2360 (w, R3-N+ ions), 1711 (m, C=O), 1622 (m, 
conj, C=C), 1591 (s, C=C), 1514 (m, aromatic, N-O), 1341 (m, aromatic, N-O) 
and 1152 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 8.22 (2×1H, d, J 8.7, CHCNO2), 
7.96 (2×1H, d, J 8.7, CHCHCNO2), 5.62 (1H, s, C=CHCOAr), 3.72 (2H, t, J 6.9 
(CH3)3COOCCH2CH2N), 3.61 (2H, m, CH2CH2CH2N), 3.51 (2H, m, CH2C=C), 
2.64 (2H, t, J 6.9, (CH3)3COOCCH2CH2N), 1.74 (2×2H, m, CH2CH2CH2), 1.67 
(2H, m, CH2CH2CH2) and 1.46 (3×3H, s, (CH3)3C); δC (75 MHz; CDCl3) 185.6 
(CHCOAr), 170.8 ((CH3)3COOCCH2CH2N), 170.8 (NC=C), 149.1 (CHCNO2), 
149.0 (CCHCHCNO2), 128.5 (CHCHCNO2), 123.6 (CHCNO2), 81.8 ((CH3)3C), 
91.6 (NC=C),  53.9 (CH2CH2CH2N), 49.5 ((CH3)3COOCCH2CH2N), 33.5 
(CH2CH2CH2C=C), 29.7 ((CH3)3COOCCH2CH2N), 28.4 ((CH3)3C), 28.5, 28.4 and 
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25.5 (remaining CH2’s); HRMS (EI): found, 388.19928 (C21H28O5N2 requires 
388.19982). 
 
(d) (E)-tert-Butyl 3-[2-(2-oxo-2-phenylethylidene)azepan-1-yl]propanoate 
(161d) 
N O
O
O
 tert-Butyl 3-(2-thioxoazepan-1-yl)propanoate 151 (509 
mg, 1.97 mmol) and phenacyl bromide (412 mg, 2.07 mmol, 1.05 equiv) in dry 
MeCN (15.00 ml) were reacted as described above, followed by the addition of 
PPh3 (535 mg, 2.07 mmol, 1.05 equiv) and Et3N (206 mg, 2.07 mmol, 1.05 equiv) 
(Specific reaction conditions: Scheme 22. (a) rt, 20 h, (b) rt, 4 h) to give (E)-tert-
butyl 3-[2-(2-oxo-2-phenylethylidene)azepan-1-yl]propanoate 161d (216 mg, 
32%) as yellow oil. Rf 0.25  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 
2911 (vw, =C-H), 2360 (w, R3-N+ ions), 1724 (m, C=O), 1622 (m, conj, C=C), 
1574 (s, C=C), 1529 (s, aromatic, C=C), 1450 (m, aromatic, C=C) and 1151 (s, 
C-O); δH (300 MHz; CDCl3; Me4Si) 7.87 (2×1H, dd, J 1.8, J 7.4, COCCHCH), 
7.38 (2×1H, m, COCCHCH), 7.38 (1H, m, COCCHCHCH), 5.65 (1H, s, 
C=CHCOAr), 3.67 (2H, t, J 7.0, (CH3)3COOCCH2CH2N), 3.54 (2H, m, 
CH2CH2CH2N), 3.48 (2H, m, CH2C=C), 2.61 (2H, t, J 7.0, 
(CH3)3COOCCH2CH2N), 1.71 (2×2H, m, CH2CH2CH2), 1.62 (2H, m, CH2CH2CH2) 
and 1.46 (3×3H, s, (CH3)3C); δC (75 MHz; CDCl3) 188.5 (CHCOAr), 171.1 
((CH3)3COOCCH2CH2N), 169.2 (NC=C), 143.3 (COCCHCHCH), 130.7 
(COCCHCHCH), 128.4 (COCCHCHCH), 127.7 (COCCHCHCH), 81.7 ((CH3)3C), 
91.9 (NC=C),  53.7 (CH2CH2CH2N), 49.5 ((CH3)3COOCCH2CH2N), 33.5 
(CH2CH2CH2C=C), 29.9 ((CH3)3COOCCH2CH2N), 28.5 ((CH3)3C), 28.8, 28.3 and 
25.9 (remaining CH2’s); HRMS (EI): found, 343.21421 (C21H28O3N requires 
343.21474). 
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(e) (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azocan-1-
yl}propanoate (162a) 
N
O
O
O
O2N
 tert-Butyl 3-(2-thioxoazocan-1-yl)propanoate 152 
(582 mg, 2.14 mmol) and p-nitrophenacyl bromide (549 mg, 2.25 mmol, 1.05 
equiv) in dry MeCN (40.00 ml) were reacted as described above, followed by the 
addition of PPh3 (591 mg, 2.25 mmol, 1.05 equiv) and Et3N (228 mg, 2.25 mmol, 
1.05 equiv) (Specific reaction conditions: Scheme 22. (a) rt, 23 h, (b) rt, 4 h) to 
give (E)-tert-butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azocan-1-yl}propanoate 
162a (750 mg, 87%) as yellow crystals, m.p. 71 – 73 °C; Rf 0.30  (EtOAc: 
Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 2921 (vw, =C-H), 2360 (w, R3-N+ ions), 
1720 (m, C=O), 1616 (m, conj, C=C), 1586 (s, C=C), 1513 (s, aromatic, N-O), 
1462 (m, aromatic, C=C), 1336 (s, aromatic, N-O) and 1159 (s, C-O); δH (300 
MHz; CDCl3; Me4Si) 8.21 (2×1H, d, J 8.7, CHCNO2), 7.99 (2×1H, d, J 8.7, 
CHCHCNO2) 5.71 (1H, s, C=CHCOAr), 3.69 (2H, m, (CH3)3COOCCH2CH2N), 
3.69 (2H, m, CH2CH2CH2N), 3.30 (2H, m, CH2C=C), 2.69 (2H, t, J 7.1, 
(CH3)3COOCCH2CH2N), 1.92 (2H, m, CH2CH2CH2N), 1.71 (2H, m, 
CH2CH2CH2C=C), 1.50 (2×2H, m, CH2CH2CH2CH2C=C) and 1.47 (3×3H, s, 
(CH3)3C); δC (75 MHz; CDCl3) 184.4 (CHCOAr), 170.8 ((CH3)3COOCCH2CH2N), 
169.7 (NC=C), 149.2 (CHCNO2), 148.9 (CCHCHCNO2), 128.5 (CHCHCNO2), 
123.6 (CHCNO2), 81.9 ((CH3)3C), 91.0 (NC=C),  50.0 (CH2CH2CH2N), 47.1 
((CH3)3COOCCH2CH2N), 38.1 (CH2CH2CH2C=C), 33.1 ((CH3)3COOCCH2CH2N), 
28.4 ((CH3)3C), 30.2, 29.9, 26.6  and 25.2 (remaining CH2’s); HRMS (EI): found, 
402.21493 (C22H30O5N2 requires 402.21547). 
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(f) (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azonan-1-
yl}propanoate (163a) 
N
O
O
O
O2N
 tert-Butyl 3-(2-thioxoazonan-1-yl)propanoate 153 
(601 mg, 2.11 mmol) and p-nitrophenacyl bromide (542 mg, 2.22 mmol, 1.05 
equiv) in dry MeCN (40.00 ml) were reacted as described above, followed by the 
addition of PPh3 (582 mg, 2.22 mmol, 1.05 equiv) and Et3N (225 mg, 2.22 mmol, 
1.05 equiv) (Specific reaction conditions: Scheme 22. (a) rt, 23 h, (b) rt, 4 h) to 
give (E)-tert-butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azonan-1-yl}propanoate 
163a (620 mg, 67%) as yellow crystals, m.p. 111 – 112 °C ; Rf 0.30  (EtOAc: 
Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1  2931 (vw, =C-H), 1711 (m, C=O), 1615 
(w, conj, C=C), 1587 (m, C=C), 1513 (s, aromatic, N-O), 1466 (m, aromatic, 
C=C), 1338 (s, aromatic, N-O) and 1153 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 
8.22 (2×1H, d, J 8.8, CHCNO2), 8.00 (2×1H, d, J 8.8, CHCHCNO2) 5.72 (1H, s, 
C=CHCOAr), 3.67 (2H, m, (CH3)3COOCCH2CH2N), 3.67 (2H, m, CH2CH2CH2N), 
3.24 (2H, m, CH2C=C), 2.70 (2H, t, J 7.0, (CH3)3COOCCH2CH2N), 1.94 (2H, m, 
CH2CH2CH2N), 1.75 (2H, m, CH2CH2CH2C=C), 1.60 (2H, m, CH2CH2CH2CH2N), 
1.51 (2H, m, CH2CH2CH2CH2C=C) and 1.47 (3×3H, s, (CH3)3C); δC (75 MHz; 
CDCl3) 184.4 (CHCOAr), 170.8 ((CH3)3COOCCH2CH2N), 170.6 (NC=C), 149.1 
(CHCNO2), 148.9 (CCHCHCNO2), 128.5 (CHCHCNO2), 123.6 (CHCNO2), 81.8 
((CH3)3C), 91.7 (NC=C),  51.4 (CH2CH2CH2N), 46.2 ((CH3)3COOCCH2CH2N), 
32.7 (CH2CH2CH2C=C), 30.8 ((CH3)3COOCCH2CH2N), 28.4 ((CH3)3C), 29.6, 
27.6, 26.7, 25.9 and 21.8 (remaining CH2’s ); HRMS (EI): found, 416.23060 
(C23H32O5N2 requires 416.23112). 
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(g) (E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azacyclotridecan-1-
yl}propanoate (164a) 
N
O
O
O
O2N
 tert-Butyl 3-(2-thioxoazacyclotridecan-1-
yl)propanoate 154 (581 mg, 1.70 mmol) and p-nitrophenacyl bromide (437 mg, 
1.79 mmol, 1.05 equiv) in dry MeCN (40.00 ml) were reacted as described, 
followed by the addition of PPh3 (469 mg, 1.79 mmol, 1.05 equiv) and Et3N (181 
mg, 1.79 mmol, 1.05 equiv) (Specific reaction conditions: Scheme 22. (a) rt, 24 
h, (b) rt, 5 h) to give (E)-tert-butyl 3-{2-[2-(4-nitrophenyl)-2-
oxoethylidene]azacyclotridecan-1-yl}propanoate 164a (30 mg, 4%) as yellow 
amorphous solid. Rf 0.60  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 2929 
(vw, =C-H), 2360 (w, R3N+ ions), 1725 (m, C=O), 1625 (w, conj, C=C), 1594 (m, 
C=C), 1523 (s, aromatic, N-O), 1467 (m, aromatic, C=C), 1342 (s, aromatic, N-O) 
and 1150 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 8.23 (2×1H, d, J 8.6, CHCNO2), 
7.97 (2×1H, d, J 8.5, CHCHCNO2), 5.67 (1H, s, C=CHCOAr), 3.64 (2H, m, 
(CH3)3COOCCH2CH2N), 3.34 (2H, m, CH2CH2CH2N), 2.97 (2H, m, CH2C=C), 
2.61 (2H, t, J 6.0, (CH3)3COOCCH2CH2N), 1.89 – 1.26 (9×2H, m, CH2CH2CH2) 
and 1.46 (3×3H, s, (CH3)3C); δC (75 MHz; CDCl3) 184.8 (CHCOAr), 170.9 
((CH3)3COOCCH2CH2N), 168.6 (NC=C), 149.0 (CHCNO2), 128.1 
(CCHCHCNO2), 128.5 (CHCHCNO2), 123.8 (CHCNO2), 82.0 ((CH3)3C), 91.7 
(NC=C),  49.6 (CH2CH2CH2N), 46.9 ((CH3)3COOCCH2CH2N), 33.2 
(CH2CH2CH2C=C), 28.0 ((CH3)3COOCCH2CH2N), 28.5 ((CH3)3C), 27.2, 27.1, 
25.2, 24.9, 24.7, 24.1, 24.1, 23.0 and 22.9 (remaining CH2’s); HRMS (EI): found, 
472.29318 (C27H40O5N2 requires 472.29372). Compound 164a was recovered 
with (Z)-2-(azacyclotridecan-2-ylidene)-1-(4-nitrophenyl)ethanone 169a (108 mg, 
13%) as yellow crystals. Data is to follow on page 99. 
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3.8 General procedure for the preparation of NH vinylogous amides from 
thiolactams 
 
The vinylogous amides were prepared by a procedure in reference.27 p-
Nitrophenacyl bromide or phenacyl bromide was added to a stirred solution of 
thiolactams in dry acetonitrile. The resulting solution was stirred at room 
temperature for 4 – 30 h, after which the S-alkylation was complete shown by 
formation of the thioiminium salt. This was then followed by the addition of 
triphenylphosphine and triethylamine to induce sulphur extrusion. The resulting 
solution was left to stir at ambient temperature for 2 – 24 h. Distilled water was 
added and the resulting solution was extracted with dichloromethane. The 
organic extracts were dried over anhydrous sodium sulphate, filtered and 
evaporated in vacuo. The crude product was purified by column chromatography 
on silica gel using ethyl acetate: hexane (0.5:9.5) solvent mixture as eluent. The 
following compounds were prepared by this method. 
 
(a) (Z)-1-(4-Nitrophenyl)-2-(pyrrolidin-2-ylidene)ethanone (165a) 
H
N
O
NO2
Pyrrolidine-2-thione 89 (653 mg, 6.45 mmol) and p-
nitrophenacyl bromide (1.65 g, 6.77 mmol, 1.05 equiv) in dry MeCN (60.00 ml) 
were reacted as described above, followed by the addition of PPh3 (1.78 g, 6.77 
mmol, 1.05 equiv) and Et3N (685 mg, 6.77 mmol, 1.05 equiv) (Specific reaction 
conditions: Scheme 23. (a) rt, 4 h, (b) rt, 3 h) to give (Z)-1-(4-nitrophenyl)-2-
(pyrrolidin-2-ylidene)ethanone 165a (1.176 g, 79%) as yellow crystals, m.p. 160 – 
161 °C; R f 0.15  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 3280 (m, N-
H), 2891 (vw, =C-H), 1739 (w, C=O), 1596 (m, C=C), 1534 (s, aromatic, N-O), 
1478 (m, aromatic, C=C) and 1335 (s, aromatic, N-O); δH (300 MHz; CDCl3; 
Me4Si) 10.44 (NH), 8.23 (2×1H, dd, J 8.8 and J 1.05, CHCNO2), 7.99 (2×1H, dd, 
J 8.8, CHCHCNO2), 5.80 (1H, s, C=CHCOAr), 3.71 (2H, t, J 7.1, CH2CH2CH2N), 
2.78 (2H, t, J 7.9, CH2C=C) and 2.10 (2H, m, CH2CH2CH2N); δC (75 MHz; CDCl3) 
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185.0 (CHCOAr), 170.6 (NC=C), 148.8 (CHCNO2), 146.0 (CCHCHCNO2), 127.9 
(CHCHCNO2), 123.5 (CHCNO2), 87.0 (NC=C),  48.1 (CH2CH2CH2N), 33.1 
(CH2CH2CH2C=C) and 21.3 (CH2CH2CH2N); HRMS (EI): found, 232.08524 
(C12H12O3N2 requires 232.08479). Compound 165a was recovered with 
pyrrolidine-2-thione 89 (0.283 g, 19%) as cream crystals. Data is above on page 
76. 
 
(b) (Z)-2-(Azepan-2-ylidene)-1-(4-nitrophenyl)ethanone (166a) 
NH
O
NO2
 Azepane-2-thione 147 (502 mg, 3.88 mmol) and p-
nitrophenacyl bromide (995 mg, 4.08 mmol, 1.05 equiv) in dry MeCN (30.00 ml) 
were reacted as described above, followed by the addition of PPh3 (1.069 g, 4.08 
mmol, 1.05 equiv) and Et3N (413 mg, 4.08 mmol, 1.05 equiv) (Specific reaction 
conditions: Scheme 23. (a) rt, 19 h, (b) rt, 2 h) to give (Z)-2-(azepan-2-ylidene)-1-
(4-nitrophenyl)ethanone 166a (829 mg, 82%) as yellow crystals, m.p. 125 – 127 
°C; R f 0.16  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 3280 (m, N-H), 
2919 (vw, =C-H), 1739 (w, C=O), 1587 (m, C=C), 1505 (s, aromatic, N-O), 1450 
(m, aromatic, C=C) and 1317 (s, aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 
11.7 (NH), 8.23 (2×1H, d, J 8.8, CHCNO2), 7.99 (2×1H, m, CHCHCNO2), 5.67 
(1H, s, C=CHCOAr), 3.47 (2H, dd, J 9.9 and J 5.8, CH2CH2CH2N), 2.54 – 2.43 
(2H, m, CH2C=C) and 1.80 – 1.65 (3×2H, m, CH2CH2CH2CH2N); δC (75 MHz; 
CDCl3) 185.4 (CHCOAr), 173.2 (NC=C), 149.2 (CHCNO2), 146.6 
(CCHCHCNO2), 128.1 (CHCHCNO2), 123.8 (CHCNO2), 92.1 (NC=C),  45.0 
(CH2CH2CH2N), 35.8 (CH2CH2CH2C=C), 31.0, 29.3 and 25.9 (remaining CH2’s); 
HRMS (EI): found, 260.11554 (C14H16O3N2 requires 260.11609). 
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(c) (Z)-2-(Azepan-2-ylidene)-1-phenylethanone (166b) 
NH
O
Azepane-2-thione 147 (700 mg, 5.42 mmol) and phenacyl 
bromide (1.133 g, 5.69 mmol, 1.05 equiv) in dry MeCN (40.00 ml) were reacted 
as described above, followed by the addition of PPh3 (1.492 g, 5.69 mmol, 1.05 
equiv) and Et3N (576 mg, 5.69 mmol, 1.05 equiv) (Specific reaction conditions: 
Scheme 23. (a) rt, 30 h, (b) rt, 24 h) to give (Z)-2-(azepan-2-ylidene)-1-
phenylethanone 166b (770 mg, 66%) as yellow crystals, m.p. 64 – 66 °C; Rf 0.40  
(EtOAc: Hexane, 3:7) νmax (NaCl; Thin Film)/cm-1  3200 – 3400 (v br, N-H), 2924 
(m, =C-H), 1739 (w, C=O), 1585 (m, C=C), 1548 (s, aromatic, C=C), and 1434 
(m, aromatic, C=C); δH (300 MHz; CDCl3; Me4Si) 11.5 (NH), 7.86 (2×1H, m, 
COCCHCH), 7.37 (3×1H, m, COCCHCHCH), 5.66 (1H, s, C=CHCOAr), 3.36 
(2H, m, CH2CH2CH2N), 2.40 (2H, m, CH2C=C) and 1.68 – 1.60 (3×2H, m, 
CH2CH2CH2CH2N); δC (75 MHz; CDCl3) 186.7 (CHCOAr), 170.2 (NC=C), 139.4 
(COCCHCH), 129.1 (COCCHCHCH), 126.9 (COCCHCHCH), 125.6 
(COCCHCHCH), 89.8 (NC=C),  43.1 (CH2CH2CH2N), 34.1 (CH2CH2CH2C=C), 
29.3, 28.1 and 24.6 (remaining CH2’s); HRMS (EI): found, 215.13095 (C14H17ON 
requires 215.13101). 
 
(d) (Z)-2-(Azocan-2-ylidene)-1-(4-nitrophenyl)ethanone (167a) 
NH
O
NO2
 Azocane-2-thione 148 (501 mg, 3.50 mmol) and p-
nitrophenacyl bromide (898 mg, 3.68 mmol, 1.05 equiv) in dry MeCN (40.00 ml) 
were reacted as described above, followed by the addition of PPh3 (965 mg, 3.68 
mmol, 1.05 equiv) and Et3N (372 mg, 3.68 mmol, 1.05 equiv) (Specific reaction 
conditions: Scheme 23. (a) rt, 20 h, (b) rt, 2.5 h) to give (Z)-2-(azocan-2-ylidene)-
1-(4-nitrophenyl)ethanone 167a (726 mg, 76%) as yellow crystals, m.p. 128 – 
129 °C; R f 0.33  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1   3200 – 3400 
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(v br, N-H), 2928 (m, =C-H), 1739 (w, C=O), 1586 (m, C=C), 1548 (s, aromatic, 
N-O), 1472 (m, aromatic, C=C) and 1338 (s, aromatic, N-O); δH (300 MHz; 
CDCl3; Me4Si) 11.8 (NH), 8.24 (2×1H, d, J 8.8, CHCNO2), 7.99 (2×1H, d, J 8.8, 
CHCHCNO2), 5.65 (1H, s, C=CHCOAr), 3.52 (2H, dd, J 7.2 and J 11.6, 
CH2CH2CH2N), 2.47 (2H, m, CH2C=C), 1.86 – 1.79 (2H, m, CH2CH2CH2CH2N), 
1.75 – 1.68 (2H, m, CH2CH2CH2CH2C=C) and 1.62 – 1.51 (2×2H, m, 
CH2CH2CH2CH2N); δC (75 MHz; CDCl3) 184.5 (CHCOAr), 172.2 (NC=C), 148.7 
(CHCNO2), 146.3 (CCHCHCNO2), 127.7 (CHCHCNO2), 123.4 (CHCNO2), 91.4 
(NC=C),  41.7 (CH2CH2CH2N), 32.2 (CH2CH2CH2C=C), 31.0, 30.9, 25.5 and 24.6 
(remaining CH2’s); HRMS (EI): found, 274.13120 (C15H18O3N2 requires 
274.13174). 
 
(e) (Z)-2-(Azonan-2-ylidene)-1-(4-nitrophenyl)ethanone (168a) 
NH
O
NO2
 Azonane-2-thione 149 (530 mg, 3.37 mmol) and p-
nitrophenacyl bromide (864 mg, 3.54 mmol, 1.05 equiv) in dry MeCN (40.00 ml) 
were reacted as described above, followed by the addition of PPh3 (929 mg, 3.54 
mmol, 1.05 equiv) and Et3N (358 mg, 3.54 mmol, 1.05 equiv) (Specific reaction 
conditions: Scheme 23. (a) rt, 20 h, (b) rt, 2.5 h) to give (Z)-2-(azonan-2-ylidene)-
1-(4-nitrophenyl)ethanone 168a (860 mg, 88%) as yellow crystals, m.p. 128 – 
129 °C; R f 0.41  (EtOAc: Hexane, 3:7); νmax (NaCl; Thin Film)/cm-1 3200 – 3400 
(v br, N-H), 2927 (m, methane, =C-H), 1739 (w, C=O), 1586 (m, C=C), 1555 (s, 
aromatic, N-O), 1474 (m, aromatic, C=C) and 1338 (s, aromatic, N-O); δH (300 
MHz; CDCl3; Me4Si) 11.8 (NH), 8.10 (2×1H, d, J 8.7, CHCNO2), 7.88 (2×1H, d, J 
8.7, CHCHCNO2), 5.52 (1H, s, C=CHCOAr), 3.42 (2H, dd, J 6.9 and J 11.5, 
CH2CH2CH2N), 2.35 (2H, m, CH2C=C), 1.70 (2H, m, CH2CH2CH2CH2N), 1.61 
(2H, m, CH2CH2CH2CH2C=C) and 1.50 – 1.41 (3×2H, m, CH2CH2CH2CH2CH2N); 
δC (75 MHz; CDCl3) 184.7 (CHCOAr), 173.3 (NC=C), 149.3 (CHCNO2), 147.0 
(CCHCHCNO2), 128.4 (CHCHCNO2), 124.0 (CHCNO2), 92.3 (NC=C),  44.7 
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(CH2CH2CH2N), 33.4 (CH2CH2CH2C=C), 30.6, 29.0, 27.7, 25.9 and 23.2 
(remaining CH2’s); HRMS (EI): found, 288.14685 (C16H20O3N2 requires 
288.14739). 
 
(f) (Z)-2-(Azacyclotridecan-2-ylidene)-1-(4-nitrophenyl)ethanone (169a) 
NH
O
NO2
 Azacyclotridecane-2-thione 150 (614 mg, 2.88 
mmol) and p-nitrophenacyl bromide (737 mg, 3.02 mmol, 1.05 equiv) in dry 
MeCN (50.00 ml) were reacted as described above, followed by the addition of 
PPh3 (792 mg, 3.02 mmol, 1.05 equiv) and Et3N (306 mg, 3.02 mmol, 1.05 equiv) 
(Specific reaction conditions: Scheme 23. (a) rt, 16 h, (b) rt, 2 h) to give (Z)-2-
(azacyclotridecan-2-ylidene)-1-(4-nitrophenyl)ethanone 169a (991 mg, 83%) as 
yellow crystals, m.p. 104 – 105 °C; R f 0.54  (EtOAc: Hexane, 3:7); νmax (NaCl; 
Thin Film)/cm-1 3200 – 3400 (v br, N-H), 2930 (m, =C-H), 1738 (w, C=O), 1589 
(m, C=C), 1552 (s, aromatic, N-O), 1464 (m, aromatic, C=C) and 1338 (s, 
aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 11.6 (NH), 8.23 (2×1H, d, J 8.9, 
CHCNO2), 7.98 (2×1H, d, J 8.9, CHCHCNO2), 5.65 (1H, s, C=CHCOAr), 3.42 
(2H, dd, J 7.0 and J 13.8, CH2CH2CH2N), 2.39 (2H, m, CH2C=C), 1.78 – 1.68 
(2×2H, m, CH2CH2CH2CH2N and CH2CH2CH2CH2C=C) and 1.56 – 1.32 (7×2H, 
m, CH2CH2CH2); δC (75 MHz; CDCl3) 184.3 (CHCOAr), 170.5 (NC=C), 148.8 
(CHCNO2), 146.3 (CCHCHCNO2), 127.7 (CHCHCNO2), 123.4 (CHCNO2), 92.5 
(NC=C),  41.4 (CH2CH2CH2N), 31.6 (CH2CH2CH2C=C), 28.3, 25.7, 25.5, 25.4, 
25.3, 24.8, 24.4, 24.3 and 23.2 (remaining CH2’s); HRMS (EI): found, 344.20943 
(C20H28O3N2 requires 344.20999). 
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3.9 Synthesis of azabicyclic systems by intramolecular cycloacylation 
 
The ring closed compounds were prepared by a procedure in reference.44 A 
mixture of vinylogous urethanes or amides and trifluoroacetic acids at room 
temperature, was stirred for 4 – 5 h. Trifluoroacetic acid was removed under high 
vacuum for a period of about 2 – 24 h. The resulting carboxylic acid was 
dissolved in acetonitrile, followed by the addition of potassium carbonate and 
acetic anhydride. The resulting solution was stirred at 60 °C for 14 – 20 h. The 
solvent was removed in vacuo. Water was added and the resulting solution was 
extracted with dicloromethane. The organic extracts were dried over anhydrous 
sodium sulphate, filtered and evaporated in vacuo. The crude product was 
purified by column chromatography on silica gel using methanol: ethyl acetate 
(2:8) solvent mixture as eluent. The following compounds were prepared by this 
method. 
 
(a) Ethyl 7-oxo-1,2,3,5,6,7-hexahydroindolizine-8-carboxylate (170b) 
 
39,48 
N
O
O
O
 (E)-tert-Butyl 3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-
yl)propanoate 109b (240 mg, 0.847 mmol) and trifluoroacetic acid (2.597 g, 22.8 
mmol, 26.9 equiv) were reacted as described above, followed by the addition of 
potassium carbonate (104 mg, 1.02 mmol, 1.20 equiv) and acetic anhydride (234 
mg, 1.69 mmol, 2.00 equiv) in acetonitrile (2.82 ml) (Specific reaction conditions: 
Scheme 25. (a) rt, 4 h, (b) 60 °C, 20 h) to give ethyl 7-oxo-1,2,3,5,6,7-
hexahydroindolizine-8-carboxylate 170b 39,48 (177 mg, 79%) as colourless 
crystals, m.p. 73 – 75 °C (Lit. m.p. 74.5 – 75.5 °C ); Rf 0.24  (MeOH: EtOAc, 2:8); 
νmax (NaCl; Thin Film)/cm-1 3055 (w, methylene, C-H), 1726 (m, C=O), 1478 (m, 
conj, C=C), 1432 (s, C=C) and 1098 (s, C-O); δH (300 MHz; CDCl3; Me4Si) 4.22 
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(2H, q, J 7.1, COOCH2CH3), 3.57 (2×2H, m, (COCCH2CH2N and CH2CH2CH2N), 
3.28 (2H, t, J 7.8, (COCCH2CH2N), 2.58 (2H, t, J 7.7, CH2C=C), 2.14 (2H, m, 
CH2CH2CH2) and 1.32 (3H, t, J 7.1, CH2CH3); δC (75 MHz; CDCl3) 187.6 
(CH3CH2OOCC(=C)OCCH2CH2N), 173.9 (NC=C), 166.5 (CH3CH2OOC), 98.9 
(NC=C), 59.9 (CH3CH2),  55.0 (CH2CH2CH2N), 44.4 (C(=C)OCCH2CH2N), 36.1 
(C(=C)OCCH2CH2N), 35.3 (CH2CH2CH2), 21.5 (CH2CH2CH2C=C) and 14.9 
(CH2CH3); HRMS (EI): found, 209.10467  (C11H15O3N requires 209.10519). 
 
(b) 8-(4-Nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one (171a) 
N
O
O2N
O
 (i) (E)-tert-Butyl 3-(2-(2-(4-nitrophenyl)-2-
oxoethylidene)pyrrolidin-1-yl)propanoate 159a (307 mg, 0.852 mmol) and 
trifluoroacetic acid (2.611 g, 22.9 mmol, 26.9 equiv) were reacted as described 
above, followed by the addition of potassium carbonate (104 mg, 1.02 mmol, 
1.20 equiv) and acetic anhydride (236 mg, 1.70 mmol, 2.00 equiv) in acetonitrile 
(40.00 ml) (Specific reaction conditions: Scheme 25. (a) rt, 4 h, (b) 60 °C, 19.5 h) 
to give 8-(4-nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one 170a (75 mg, 
31%) as yellow crystals, m.p. 230 °C; R f 0.39  (MeOH: EtOAc, 2:8); νmax (NaCl; 
Thin Film)/cm-1 2970 (w, methylene, C-H), 2360 (w, R3N+ ions), 1739 (m, C=O), 
1631 (w, conj, C=C), 1595 (m, C=C), 1512 (s, aromatic, N-O), 1462 (m, aromatic, 
C=C) and 1342 (s, aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.19 (2×1H, d, J 
8.8, CHCNO2), 7.62 (2×1H, d, J 8.8, CHCHCNO2), 3.69 (2×2H, m, 
(COCCH2CH2N and CH2CH2CH2N)), 3.39 (2H, t, J 7.8, (COCCH2CH2N), 2.62 
(2H, t, J 7.7, CH2C=C) and 2.22 (2H, m, CH2CH2CH2); δC (75 MHz; CDCl3) 192.2 
(ArC(=C)OCCH2CH2N), 188.4 (COCCHCHCNO2), 174.9 (NC=C), 148.9 
(COCCHCHCNO2), 148.5 (COCCHCHCNO2), 129.0 (COCCHCHCNO2), 123.4 
(COCCHCHCNO2), 106.8 (NC=C), 55.1 (CH2CH2CH2N), 44.7 
(C(=C)OCCH2CH2N), 35.4 (C(=C)OCCH2CH2N), 34.8 (CH2CH2CH2C=C) and 
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21.5 (CH2CH2CH2); HRMS (EI): found, 286.09385 (C15H14O4N2 requires 
286.09536). 
(ii) 8-(4-Nitrobenzoyl)-2,3,5,6-tetrahydroindolizin-7(1H)-one isomer (160 mg, 
65%) was synthesised as yellow crystals, m.p. 230 °C; Rf 0.16  (MeOH: EtOAc, 
2:8); νmax (NaCl; Thin Film)/cm-1 2970 (w, methylene, C-H), 2360 (w, R3N+ ions), 
1739 (m, C=O), 1631 (w, conj, C=C), 1595 (m, C=C), 1512 (s, aromatic, N-O), 
1462 (m, aromatic, C=C) and 1342 (s, aromatic, N-O); δH (300 MHz; CDCl3; 
Me4Si) 8.25 (2×1H, d, J 8.8, CHCNO2), 8.04 (2×1H, d, J 8.8, CHCHCNO2), 3.69 
(2×2H, m, (COCCH2CH2N and CH2CH2CH2N)), 3.39 (2H, t, J 7.9, 
(COCCH2CH2N), 2.53 (2H, t, J 7.4, CH2C=C) and 2.08 (2H, m, CH2CH2CH2); δC 
(75 MHz; CDCl3) 184.1 (ArC(=C)OCCH2CH2N), 177.9 (COCCHCHCNO2), 170.0 
(NC=C), 146.9 (COCCHCHCNO2), 145.9 (COCCHCHCNO2), 126.4 
(COCCHCHCNO2), 122.0 (COCCHCHCNO2), 128.0 (NC=C), 52.1 
(CH2CH2CH2N), 42.5 (C(=C)OCCH2CH2N), 33.1 (C(=C)OCCH2CH2N), 32.8 
(CH2CH2CH2C=C) and 18.3 (CH2CH2CH2); HRMS (EI): found, 286.09385 
(C15H14O4N2 requires 286.09536). 
 
(c) 1-(4-Nitrobenzoyl)-3,4,6,7,8,9-hexahydroquinolizin-2-one (172a) 
N
O
O2N O
 (E)-tert-Butyl 3-(2-(2-(4-nitrophenyl)-2-
oxoethylidene)piperidin-1-yl)propanoate 160a (116 mg, 0.320 mmol) and 
trifluoroacetic acid (982 mg, 8.61 mmol, 26.9 equiv) were reacted as described 
above, followed by the addition of potassium carbonate (65 mg, 0.640 mmol, 
2.00 equiv) and acetic anhydride (88 mg, 0.640 mmol, 2.00 equiv) in acetonitrile 
(14.00 ml) (Specific reaction conditions: Scheme 25. (a) rt, 4 h, (b) 60 °C, 20 h) 
to give 1-(4-nitrobenzoyl)-3,4,6,7,8,9-hexahydroquinolizin-2-one 172a(95 mg, 
99%) as yellow crystals, m.p. 138 – 139 °C; R f 0.41  (MeOH: EtOAc, 2:8); νmax 
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(NaCl; Thin Film)/cm-1 2930 (w, methylene, C-H), 2360 (w, R3N+ ions), 1723 (vw, 
C=O), 1645 (w, conj, C=C), 1607 (m, C=C), 1552 (s, aromatic, N-O), 1508 (m, 
aromatic, C=C) and 1343 (s, aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.19 
(2×1H, d, J 8.6, CHCNO2), 7.74 (2×1H, d, J 8.6, CHCHCNO2), 3.65 (2H, t, J 7.3, 
(COCCH2CH2N), 3.52 (2H, t, J 6.0, CH2CH2CH2N), 2.95 (2H, t, J 6.1, 
(COCCH2CH2N), 2.54 (2H, t, J 7.5, CH2C=C) 1.96 (2H, m, CH2CH2CH2N) and 
1.74 (2H, m, CH2CH2CH2C=C); δC (75 MHz; CDCl3) 194.3 
(ArC(=C)OCCH2CH2N), 188.8 (COCCHCHCNO2), 169.3 (NC=C), 149.1 
(COCCHCHCNO2), 147.9 (COCCHCHCNO2), 129.3 (COCCHCHCNO2), 123.6 
(COCCHCHCNO2), 110.0 (NC=C), 52.0 (CH2CH2CH2N), 50.9 
(C(=C)OCCH2CH2N), 35.2 (C(=C)OCCH2CH2N), 28.6 (CH2CH2CH2C=C), 22.6 
(CH2CH2CH2N) and 18.8 (CH2CH2CH2C=C); HRMS (EI): found, 300.10710 
(C16H16O4N2 requires 300.11101). 
 
(d) 1-Benzoyl-3,4,7,8,9,10-hexahydropyrido[1,2-a]azepin-2(6H)-one (173d) 
N
O
O
(E)-tert-Butyl 3-(2-(2-oxo-2-phenylethylidene)azepan-1-
yl)propanoate 161d (110 mg, 0.321 mmol) and trifluoroacetic acid (952 mg, 8.35 
mmol, 26.9 equiv) were reacted as described above, followed by the addition of 
potassium carbonate (65.5 mg, 0.642 mmol, 2.00 equiv) and acetic anhydride 
(88,7 mg, 0.642 mmol, 2.00 equiv) in acetonitrile (20.00 ml) (Specific reaction 
conditions: Scheme 25. (a) rt, 4 h, (b) 60 °C, 20 h) to give 1-benzoyl-
3,4,7,8,9,10-hexahydropyrido[1,2-a]azepin-2(6H)-one 173d (63 mg, 73%) as 
yellow amorphous solid. Rf 0.47  (MeOH: EtOAc, 2:8); νmax (NaCl; Thin Film)/cm-1  
2922 (w, methylene, C-H), 2360 (vw, R3N+ ions), 1738 (m, C=O), 1613 (w, conj, 
C=C), 1538 (m, C=C), 1467 (s, aromatic, C=C) and 1387 (m, aromatic, C=C); δH 
(300 MHz; CDCl3; Me4Si) 7.77 (2×1H, m, COCCHCHCH), 7.45 – 7.38 (3×1H, m, 
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COCCHCHCH), 3.70 – 3.61 (2×2H, m, (CH3)3COOCCH2CH2N and 
CH2CH2CH2N), 2.56 (2×2H, m, (CH3)3COOCCH2CH2N and CH2C=C) and 1.71 
(3×2H, m, CH2CH2CH2N and CH2CH2CH2C=C); δC (75 MHz; CDCl3) 197.9 
(ArC(=C)OCCH2CH2N), 189.5 (COC6H5), 170.7 (NC=C), 140.5 (COCCHCHCH), 
132.5 (COCCHCHCH), 129.4 (COCCHCHCH), 128.5 (COCCHCHCH), 112.2 
(NC=C), 55.6 (CH2CH2CH2N), 52.1 (C(=C)OCCH2CH2N), 36.3 
(C(=C)OCCH2CH2N), 31.5 (CH2CH2CH2C=C), 29.3, 27.4 and 25.6 (remaining 
CH2’s); HRMS (EI): found, 269.13829 (C17H19O2N requires 269.14158). 
 
(e) 1-(4-Nitrobenzoyl)-3,4,6,7,8,9,10,11-octahydropyrido[1,2-a]azocin-2-one 
(174a) 
N
O
O2N O
 (E)-tert-Butyl 3-(2-(2-(4-nitrophenyl)-2-
oxoethylidene)azocan-1-yl)propanoate 162a (549 mg, 1.36 mmol) and 
trifluoroacetic acid (4.173 g, 36.6 mmol, 26.9 equiv) were reacted as described 
given, followed by the addition of potassium carbonate (208 mg, 2.04 mmol, 1.50 
equiv) and acetic anhydride (376 mg, 2.72 mmol, 2.00 equiv) in acetonitrile 
(20.00 ml, 14.71 ml per  mmol) (Specific reaction conditions: Scheme 25. (a) rt, 
4.5 h, (b) 60 °C, 20 h) to give 1-(4-nitrobenzoyl)-3,4,6,7,8,9,10,11-
octahydropyrido[1,2-a]azocin-2-one 174a (398 mg, 89%) as yellow crystals, m.p. 
175 °C; R f 0.083  (EtOAc: Hex, 7:3); νmax (NaCl; Thin Film)/cm-1 2919 (w, 
methylene, C-H), 2360 (vw, R3N+ ions), 1738 (m, C=O), 1637 (w, conj, C=C), 
1602 (m, C=C), 1549 (s, aromatic, N-O), 1514 (m, aromatic, C=C) and 1338 (s, 
aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.20 (2×1H, d, J 8.1, CHCNO2), 
7.78 (2×1H, d, J 8.1, CHCHCNO2), 3.70 (2×2H, m, COCCH2CH2N and 
CH2CH2CH2N), 2.82 (2H, m, COCCH2CH2N), 2.52 (2H, m, CH2C=C), 1.96 – 1.81 
(2×2H, m, CH2CH2CH2N and CH2CH2CH2C=C) and 1.57 (2×2H, m, 
CH2CH2CH2N and CH2CH2CH2C=C); δC (75 MHz; CDCl3) 195.6 
106 
(ArC(=C)OCCH2CH2N), 190.1 (COCCHCHCNO2), 172.9 (NC=C), 149.7 
(COCCHCHCNO2), 148.1 (COCCHCHCNO2), 129.7 (COCCHCHCNO2), 124.1 
(COCCHCHCNO2), 111.0 (NC=C), 52.1 (CH2CH2CH2N), 49.8 
(C(=C)OCCH2CH2N), 36.0 (C(=C)OCCH2CH2N), 31.8 (CH2CH2CH2C=C), 29.6, 
29.6, 26.7 and 25.4 (remaining CH2’s); HRMS (EI): found, 328.14479 
(C18H20O4N2 requires 328.14231). 
 
(f) 1-(4-Nitrobenzoyl)-3,4,7,8,9,10,11,12-octahydropyrido[1,2-a]azonin-2(6H)-
one (175a) 
N
O
O2N O
 (E)-tert-Butyl 3-(2-(2-(4-nitrophenyl)-2-
oxoethylidene)azonan-1-yl)propanoate 163a (310 mg, 0.744 mmol) and 
trifluoroacetic acid (2.280 g, 20.0 mmol, 26.9 equiv) were reacted as described 
above, followed by the addition of potassium carbonate (114 mg, 1.12 mmol, 
1.50 equiv) and acetic anhydride (206 mg, 1.49 mmol, 2.00 equiv) in acetonitrile 
(20.00 ml) (Specific reaction conditions: Scheme 25. (a) rt, 4.5 h, (b) 60 °C, 20 h) 
to give 1-(4-nitrobenzoyl)-3,4,7,8,9,10,11,12-octahydropyrido[1,2-a]azonin-2(6H)-
one 175a (256 mg, 90%) as yellow crystals, m.p. 131 – 132 °C ; Rf 0.083  (EtOAc: 
Hex, 7:3); νmax (NaCl; Thin Film)/cm-1 2919 (w, methylene, C-H), 2360 (w, R3N+ 
ions), 1739 (m, C=O), 1631 (w, conj, C=C), 1595 (m, C=C), 1512 (s, aromatic, N-
O), 1462 (m, aromatic, C=C) and 1342 (s, aromatic, N-O); δH (300 MHz; CDCl3; 
Me4Si) 8.21 (2×1H, d, J 8.4, CHCNO2), 7.76 (2×1H, d, J 8.6, CHCHCNO2), 3.76 
(2H, m, COCCH2CH2N), 3.67 (2H, m,  CH2CH2CH2N), 2.81 (2H, m, 
(COCCH2CH2N), 2.53 (2H, m, CH2C=C), 1.86 – 1.84 (2×2H, m, CH2CH2CH2N 
and CH2CH2CH2C=C), 1.68 (2H, m, CH2CH2CH2N ) and 1.56 (2×2H, m, 
CH2CH2CH2C=C and CH2CH2CH2CH2N); δC (75 MHz; CDCl3) 195.3 
(ArC(=C)OCCH2CH2N), 189.7 (COCCHCHCNO2), 173.1 (NC=C), 149.3 
(COCCHCHCNO2), 147.6 (COCCHCHCNO2), 129.3 (COCCHCHCNO2), 123.8 
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(COCCHCHCNO2), 111.0 (NC=C), 53.2 (CH2CH2CH2N), 48.7 
(C(=C)OCCH2CH2N), 35.4 (C(=C)OCCH2CH2N), 31.5 (CH2CH2CH2C=C), 29.0, 
27.3, 26.8, 26.4 and 21.2 (remaining CH2’s); HRMS (EI): found, 342.15385 
(C19H22O4N2 requires 342.15796). 
 
(g) 1-(4-Nitrobenzoyl)-3,4,7,8,9,10,11,12,13,14,17,16-dodecahydropyrido[1,2-
a]azacyclotridecin-2(6H)-one (176a) 
N
O
O
NO2
 (E)-tert-Butyl 3-(2-(2-(4-nitrophenyl)-2-
oxoethylidene)azacyclotridecan-1-yl)propanoate 164a (20 mg, 0.0423 mmol) and 
trifluoroacetic acid (130 mg, 1.14 mmol, 26.9 equiv) were reacted as described 
above, followed by the addition of potassium carbonate (8.64 mg, 0.0846 mmol, 
2.00 equiv) and acetic anhydride (11.7 mg, 0.0846 mmol, 2.00 equiv) in 
acetonitrile (20.00 ml) (Specific reaction conditions: Scheme 25. (a) rt, 4 h, (b) 60 
°C, 20 h) to give 1-(4-nitrobenzoyl)-3,4,7,8,9,10,11,12,13,14,17,16-
dodecahydropyrido[1,2-a]azacyclotridecin-2(6H)-one 176a (6 mg, 36%) as yellow 
crystals, m.p. 108 – 110 °C; R f 0.78  (MeOH: EtOAc, 2:8); νmax (NaCl; Thin 
Film)/cm-1 2925 (m, methylene, C-H), 2360 (w, R3N+ ions), 1738 (m, C=O), 1618 
(w, conj, C=C), 1618 (m, C=C), 1536 (s, aromatic, N-O), 1445 (m, aromatic, 
C=C) and 1343 (s, aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.21 (2×1H, d, J 
8.7, CHCNO2), 7.74 (2×1H, d, J 8.7, CHCHCNO2), 3.68 (2H, m, COCCH2CH2N), 
3.48 (2H, m,  CH2CH2CH2N), 2.58 – 2.48 (2×2H, m, COCCH2CH2N and 
CH2C=C), 1.86 – 1.81 (2×2H, m, CH2CH2CH2N and CH2CH2CH2C=C), 1.60 – 
1.55 (2×2H, m, CH2CH2CH2N and  CH2CH2CH2C=C) and 1.34 (7×2H, m, 
CH2CH2CH2); δC (75 MHz; CDCl3) 192.9 (ArC(=C)OCCH2CH2N), 187.4 
(COCCHCHCNO2), 169.3 (NC=C), 147.2 (COCCHCHCNO2), 145.6 
(COCCHCHCNO2), 127.2 (COCCHCHCNO2), 121.6 (COCCHCHCNO2), 109.3 
(NC=C), 49.3 (CH2CH2CH2N), 47.2 (C(=C)OCCH2CH2N), 33.7 
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(C(=C)OCCH2CH2N), 28.0 (CH2CH2CH2C=C), 27.2, 24.7, 23.0, 22.5, 22.3, 22.1, 
21.7, 21.1 and 20.7 (remaining CH2’s); HRMS (EI): found, 398.21860 
(C23H30O4N2 requires 398.22056). 
 
 
3.10 Reactions of N-H vinylogous amides with acryloyl chloride 
 
The ring closed compounds were prepared by a procedure in reference.45 
Acryloyl chloride was added dropwise to a solution of vinylogous amide in 
tetrahydrofuran. The resulting solution was left stirring at 45 °C for 17 – 24 h. 
Saturated sodium hydrogen carbonate was added the reaction mixture, followed 
by the addition distilled water. The resulting solution was extracted with 
dichloromethane. The organic extracts were dried over Na2SO4 and evaporated 
in vacuo. The crude product was purified by column recrystallisation. The 
following compounds were prepared by this procedure. 
 
(a) 8-(4-Nitrobenzoyl)-2,3,6,7-tetrahydroindolizin-5(1H)-one (178a) 
N
O
O2N
O
 (Z)-1-(4-Nitrophenyl)-2-(pyrrolidin-2-ylidene)ethanone 
165a (826 mg, 3.56 mmol) and acryloyl chloride (370 mg, 4.09 mmol, 1.15 equiv) 
were reacted in tetrahydrofuran (50.00 ml) as described above to give 8-(4-
nitrobenzoyl)-2,3,6,7-tetrahydroindolizin-5(1H)-one 178a (1.019 g, 100%) as 
yellow crystals, m.p. 120 – 121 °C; R f 0.04  (EtOAc: Hex, 3:7); νmax (NaCl; Thin 
Film)/cm-1  2880 (m, methylene, C-H), 2854 (w, methine, C-H), 1683 (m, aromatic 
ketones, C=O), 1599 (s, conj, C=C), 1516 (s, aromatic, N-O) and 1345 (s, 
aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.18 (2×1H, d, J 8.6, CHCNO2), 
7.63 (2×1H, d, J 8.6, CHCHCNO2), 3.66 (2H, t, J 7.2, CH2CH2CH2N), 2.65 (2×2H, 
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m, ArCCH2CH2CON and ArCCH2CH2CON), 2.50 (2H, t, J 7.3, CH2C=C) and 1.89 
(2H, p, J 7.4, CH2CH2CH2); δC (75 MHz; CDCl3) 193.4 (COCCHCHCNO2), 169.6 
(ArCCH2CH2CON), 156.3 (COCCHCHCNO2), 149.3 (NC=C), 146.7 
(COCCHCHCNO2), 128.9 (COCCHCHCNO2), 124.0 (COCCHCHCNO2), 109.5 
(NC=C), 46.3 (CH2CH2CH2N), 33.2 (CH2CH2CH2N), 31.6 
(C(=C)OCCH2CH2CON), 23.4 (CH2CH2CH2C=C) and 22.0 
(C(=C)OCCH2CH2CON); HRMS (EI): found, 286.09379 (C15H14O4N2 requires 
286.09536). 
 
(b) 1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one (179a) 
N
O
O2N
O
 (i) (Z)-1-(4-Nitrophenyl)-2-(piperidin-2-ylidene)ethanone 
177a (533 mg, 2.16 mmol) and acryloyl chloride (224 mg, 2.48 mmol, 1.15 equiv) 
were reacted in tetrahydrofuran (40.00 ml) as described above to give 1-(4-
nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one 179a (319 mg, 49%) as 
yellow crystals, m.p. 126 – 127 °C; R f 0.59  (EtOAc: Hex, 7:3); νmax (NaCl; Thin 
Film)/cm-1  2947 (w, methylene, C-H), 1673 (m, aromatic ketones, C=O), 1597 (s, 
conj, C=C), 1520 (s, aromatic, N-O) and 1346 (s, aromatic, N-O); δH (300 MHz; 
CDCl3; Me4Si) 8.30 (2×1H, d, J 8.6, CHCNO2), 7.86 (2×1H, d, J 8.6, 
CHCHCNO2), 3.82 (2H, t, J 6.1, CH2CH2CH2N), 2.68 (2H, t, J 6.5, 
ArCCH2CH2CON), 2.58 (2×2H, m, ArCCH2CH2CON and CH2C=C), 1.82 (2H, m, 
CH2CH2CH2N) and 1.68 (2H, m, CH2CH2CH2C=C); δC (75 MHz; CDCl3) 192.9 
(COCCHCHCNO2), 168.7 (ArCCH2CH2CON), 150.8 (NC=C), 140.8 
(COCCHCHCNO2), 134.2 (COCCHCHCNO2), 130.0 (COCCHCHCNO2), 124.4 
(COCCHCHCNO2), 108.4 (NC=C), 47.2 (CH2CH2CH2N), 40.8 
(C(=C)OCCH2CH2CON), 30.2 (CH2CH2CH2C=C), 23.0 (CH2CH2CH2C=C), 22.9 
110 
(CH2CH2CH2N), and 21.8 (C(=C)OCCH2CH2CON); HRMS (EI): found, 
300.10836 (C16H16O4N2 requires 300.11101). 
(ii) 1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one isomer ? (150 mg, 
23%) was synthesised as an amorphous solid; Rf 0.36  (EtOAc: Hex, 7:3); νmax 
(NaCl; Thin Film)/cm-1  2947 (w, methylene, C-H), 1673 (m, aromatic ketones, 
C=O), 1597 (s, conj, C=C), 1520 (s, aromatic, N-O) and 1346 (s, aromatic, N-O); 
δH (300 MHz; CDCl3; Me4Si) 8.35 (2×1H, d, J 8.8, CHCNO2), 8.14 (2×1H, d, J 
8.8, CHCHCNO2), 4.71 (1H, t, J 3.9, CH2CH2CH2N), 4.36 (1H, t, J 5.2, 
CH2CH2CH2N), 3.94 (1H, m, ArCCH2CH2CON), 3.66 (1H, m, ArCCH2CH2CON) 
2.57 (2H, m, ArCCH2CH2CON), 2.18 (2H, m, CH2C=C), 2.09 (2H, m, 
CH2CH2CH2N) and 1.82 (2H, m, CH2CH2CH2C=C); δC (75 MHz; CDCl3) 198.2 
(COCCHCHCNO2), 167.4 (ArCCH2CH2CON), 149.1 (COCCHCHCNO2), 148.1 
(NC=C), 143.7 (COCCHCHCNO2), 127.8 (COCCHCHCNO2), 122.4 
(COCCHCHCNO2), 112.2 (NC=C), 38.8 (CH2CH2CH2N), 30.0 
(C(=C)OCCH2CH2CON), 25.6 (CH2CH2CH2C=C), 22.1 (CH2CH2CH2C=C), 20.6 
(CH2CH2CH2N), and 18.4 (C(=C)OCCH2CH2CON); HRMS (EI): found, 
300.11080 (C16H16O4N2 requires 300.11101). 
 
 (c) 1-(4-Nitrobenzoyl)-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-4(6H)-one 
(180a) 
N
O
O2N
O
 (Z)-2-(Azepan-2-ylidene)-1-(4-nitrophenyl)ethanone 166a 
(473 mg, 1.82 mmol) and acryloyl chloride (189 mg, 2.09 mmol, 1.15 equiv) were 
reacted in tetrahydrofuran (11.62 ml) as described above to give 1-(4-
nitrobenzoyl)-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-4(6H)-one  180a (563 
mg, 99%) as yellow crystals, m.p. 130 – 131 °C; R f 0.20  (EtOAc: Hex, 3:7); νmax 
(NaCl; Thin Film)/cm-1 2896 (w, methine, C-H), 1687 (m, aromatic ketones, 
111 
C=O), 1597 (s, conj, C=C), 1516 (s, aromatic, N-O) and 1344 (s, aromatic, N-O) ; 
δH (300 MHz; CDCl3; Me4Si) 8.22 (2×1H, d, J 8.7, CHCNO2), 7.80 (2×1H, d, J 
8.7, CHCHCNO2), 3.85 (2H, m, CH2CH2CH2N), 2.56 (2H, m, ArCCH2CH2CON), 
2.52 – 2.41 (2×2H, m, ArCCH2CH2CON and CH2C=C), 1.57 (3×2H, m, 
CH2CH2CH2N, CH2CH2CH2C=C) and CH2CH2CH2N); δC (75 MHz; CDCl3) 195.5 
(COCCHCHCNO2), 170.7 (ArCCH2CH2CON), 152.7 (COCCHCHCNO2), 150.1 
(NC=C), 144.9 (COCCHCHCNO2), 129.8 (COCCHCHCNO2), 124.8 
(COCCHCHCNO2), 114.7 (NC=C), 42.8 (CH2CH2CH2N), 32.0 
(C(=C)OCCH2CH2CON), 30.4 (CH2CH2CH2C=C), 29.2, 29.0, 27.6 (remaining 
CH2’s) and 24.0 (C(=C)OCCH2CH2CON); HRMS (EI): found, 314.12329 
(C17H18O4N2 requires 314.12666). 
 
(d) 1-Benzoyl-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-4(6H)-one (180b) 
N
O
O
 (Z)-2-(Azepan-2-ylidene)-1-phenylethanone 166b (607 mg, 2.82 
mmol) and acryloyl chloride (293 mg, 3.24 mmol, 1.15 equiv) were reacted in 
tetrahydrofuran (40.00 ml) as described above to give 1-benzoyl-2,3,7,8,9,10-
hexahydropyrido[1,2-a]azepin-4(6H)-one 180b (722 mg, 95%) as yellow crystals, 
m.p. 103 – 105 °C; R f 0.23  (EtOAc: Hex, 3:7); νmax (NaCl; Thin Film)/cm-1  2930 
(m, methylene, C-H), 2850 (w, methine, C-H), 1726 (w, C=O), 1677 (m, aromatic 
ketones, C=O) and 1605 (s, conj, C=C); δH (300 MHz; CDCl3; Me4Si) 7.78 (2×1H, 
t, J 7.7, COCCHCHCH), 7.55 (1H, t, J 7.7, COCCHCHCH), 7.46 (2×1H, t, J 7.4, 
COCCHCHCH), 3.89 (2H, m, CH2CH2CH2N), 2.58 (3×2H, m, ArCCH2CH2CON, 
ArCCH2CH2CON and CH2C=C), 1.65 (3×2H, m, CH2CH2CH2N, CH2CH2CH2C=C) 
and CH2CH2CH2N); δC (75 MHz; CDCl3) 195.8 (COCCHCHCH), 168.9 
(ArCCH2CH2CON), 146.8 (COCCHCHCH), 136.9 (NC=C), 130.9 
(COCCHCHCH), 127.1 (COCCHCHCH), 126.8 (COCCHCHCH), 113.7 (NC=C), 
40.5 (CH2CH2CH2N), 29.9 (C(=C)OCCH2CH2CON), 28.2 (CH2CH2CH2C=C), 
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27.2, 27.1, 25.6 (remaining CH2’s) and 21.9 (C(=C)OCCH2CH2CON); HRMS (EI): 
found, 269.13866 (C17H19O2N requires 269.14158). 
 
(e) 1-(4-Nitrobenzoyl)-2,3,6,7,8,9,10,11-octahydropyrido[1,2-a]azocin-4-one 
(181a) 
N
O
O2N
O
 (Z)-2-(Azonan-2-ylidene)-1-(4-nitrophenyl)ethanone 167a 
(482 mg, 1.76 mmol) and acryloyl chloride (183 mg, 2.02 mmol, 1.15 equiv) were 
reacted in tetrahydrofuran (20.00 ml) as described above to give 1-(4-
nitrobenzoyl)-2,3,6,7,8,9,10,11-octahydropyrido[1,2-a]azocin-4-one 181a (578 
mg, 99%) as yellow crystals, m.p. 59 – 61 °C; R f 0.24  (EtOAc: Hex, 3:7); νmax 
(NaCl; Thin Film)/cm-1 2920 (m, methylene, C-H), 2855 (w, methine, C-H), 1682 
(m, aromatic ketones, C=O), 1573 (s, conj, C=C), 1516 (s, aromatic, N-O) and 
1348 (s, aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.19 (2×1H, d, J 8.5, 
CHCNO2), 7.73 (2×1H, d, J 8.5, CHCHCNO2), 3.86 (2H, m, CH2CH2CH2N), 2.72 
(2H, m, ArCCH2CH2CON), 2.44 – 2.39 (2×2H, m, ArCCH2CH2CON and 
CH2C=C), 1.74 (2H, m, CH2CH2CH2N), 1.64 (2H, m, CH2CH2CH2C=C) 1.46 
(2×2H, m, CH2CH2CH2N and CH2CH2CH2C=C); δC (75 MHz; CDCl3) 193.4 
(COCCHCHCNO2), 169.2 (ArCCH2CH2CON), 152.8 (COCCHCHCNO2), 148.5 
(NC=C), 143.6 (COCCHCHCNO2), 128.2 (COCCHCHCNO2), 122.7 
(COCCHCHCNO2), 113.3 (NC=C), 40.8 (CH2CH2CH2N), 30.9 
(C(=C)OCCH2CH2CON), 30.1 (CH2CH2CH2C=C), 27.8, 26.2, 24.4, 24.1 
(remaining CH2’s) and 23.0 (C(=C)OCCH2CH2CON); HRMS (EI): found, 
328.14505 (C18H20O4N2 requires 328.14231). 
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(f) 1-(4-Nitrobenzoyl)-2,3,7,8,9,10,11,12-octahydropyrido[1,2-a]azonin-4(6H)-
one (182a) 
N
O
O2N
O
 (Z)-2-(Azonan-2-ylidene)-1-(4-nitrophenyl)ethanone 168a 
(401 mg, 1.39 mmol) and acryloyl chloride (145 mg, 1.60 mmol, 1.15 equiv) were 
reacted in tetrahydrofuran (20.00 ml) as described above to give 1-(4-
nitrobenzoyl)-2,3,7,8,9,10,11,12-octahydropyrido[1,2-a]azonin-4(6H)-one 182a 
(476 mg, 90%) as yellow crystals, m.p. 110 – 112 °C ; Rf 0.26  (EtOAc: Hex, 3:7); 
νmax (NaCl; Thin Film)/cm-1 2929 (m, methylene, C-H), 2851 (w, methine, C-H), 
1686 (m, aromatic ketones, C=O), 1582 (s, conj, C=C), 1517 (s, aromatic, N-O) 
and 1347 (s, aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.22 (2×1H, d, J 8.7, 
CHCNO2), 7.72 (2×1H, d, J 8.7, CHCHCNO2), 3.79 (2H, m, CH2CH2CH2N), 2.72 
(2H, m, ArCCH2CH2CON), 2.44 – 2.45 (2H, m, ArCCH2CH2CON) 2.39 – 2.35 
(2H, m, CH2C=C), 1.82 – 1.71 (2×2H, m, CH2CH2CH2N and CH2CH2CH2C=C) 
1.55 – 1.46  (3×2H, m, CH2CH2CH2N, CH2CH2CH2C=C and CH2CH2CH2CH2N); 
δC (75 MHz; CDCl3) 193.2 (COCCHCHCNO2), 169.4 (ArCCH2CH2CON), 153.9 
(COCCHCHCNO2), 148.5 (NC=C), 143.8 (COCCHCHCNO2), 128.0 
(COCCHCHCNO2), 122.8 (COCCHCHCNO2), 114.4 (NC=C), 43.3 
(CH2CH2CH2N), 31.3 (C(=C)OCCH2CH2CON), 28.7 (CH2CH2CH2C=C), 28.6, 
28.1, 26.8, 23.1, 23.0 (remaining CH2’s) and 22.7 (C(=C)OCCH2CH2CON); 
HRMS (EI): found, 342.15738 (C19H22O4N2 requires 342.15796). 
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(g) 1-(4-Nitrobenzoyl)-2,6,7,8,9,10,11,12,13,14,15,16-dodecahydropyrido[1,2-
a]azacyclotridecin-4(3H)-one (183a) 
N
O
NO2
O
 (Z)-2-(Azacyclotridecan-2-ylidene)-1-(4-
nitrophenyl)ethanone 169a (489 mg, 1.42 mmol) and acryloyl chloride (148 mg, 
1.63 mmol, 1.15 equiv) were reacted in tetrahydrofuran (40.00 ml) as described 
above to give 1-(4-nitrobenzoyl)-2,6,7,8,9,10,11,12,13,14,15,16-
dodecahydropyrido[1,2-a]azacyclotridecin-4(3H)-one 183a (563 mg, 97%) as 
yellow crystals, m.p. 107 – 108 °C; R f 0.40  (EtOAc: Hex, 3:7); νmax (NaCl; Thin 
Film)/cm-1 2923 (m, methylene, C-H), 2850 (w, methine, C-H), 1693 (m, aromatic 
ketones, C=O), 1567 (s, conj, C=C), 1520 (s, aromatic, N-O) and 1350 (s, 
aromatic, N-O); δH (300 MHz; CDCl3; Me4Si) 8.20 (2×1H, d, J 8.5, CHCNO2), 
7.72 (2×1H, d, J 8.4, CHCHCNO2), 3.60 (2H, m, CH2CH2CH2N), 2.55 – 2.49 (2H, 
m, ArCCH2CH2CON), 2.46 – 2.43 (2H, m, ArCCH2CH2CON) 2.38 – 2.35 (2H, m, 
CH2C=C), 1.69 – 1.56 (2×2H, m, CH2CH2CH2N and CH2CH2CH2C=C) 1.49 (2H, 
m, CH2CH2CH2N), 1.40 (2H, m, CH2CH2CH2C=C) and 1.24 (5×2H, m, 
CH2CH2CH2); δC (75 MHz; CDCl3) 193.6 (COCCHCHCNO2), 169.4 
(ArCCH2CH2CON), 152.4 (COCCHCHCNO2), 148.5 (NC=C), 143.9 
(COCCHCHCNO2), 128.0 (COCCHCHCNO2), 122.8 (COCCHCHCNO2), 113.3 
(NC=C), 40.4 (CH2CH2CH2N), 30.8 (C(=C)OCCH2CH2CON), 26.4 
(CH2CH2CH2C=C), 25.7, 25.6, 25.1, 23.7, 23.5, 23.1, 22.6, 22.4, 21.6 (remaining 
CH2’s) and 21.6 (C(=C)OCCH2CH2CON); HRMS (EI): found, 398.22000 
(C23H30O4N2 requires 398.22056). 
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120 
Azepane-2-thione (147) 
 
 
 
121 
Azepane-2-thione (147) 
122 
tert-Butyl 3-(2-thioxopyrrolidin-1-yl)propanoate (108b) 
 
 
 
123 
tert-Butyl 3-(2-thioxopyrrolidin-1-yl)propanoate (108b) 
 
 
 
124 
tert-Butyl 3-(2-thioxoazepan-1-yl)propanoate (151) 
 
 
 
125 
tert-Butyl 3-(2-thioxoazepan-1-yl)propanoate (151) 
 
 
 
126 
(E)-tert-Butyl 3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl)propanoate 
(109b) 
 
 
127 
(E)-tert-Butyl 3-(2-(2-ethoxy-2-oxoethylidene)pyrrolidin-1-yl)propanoate 
(109b) 
 
 
128 
(E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]pyrrolidin-1-
yl}propanoate (159a) 
 
 
129 
(E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]pyrrolidin-1-
yl}propanoate (159a) 
 
 
130 
(E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]piperidin-1-
yl}propanoate (160a) 
 
 
131 
(E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]piperidin-1-
yl}propanoate (160a) 
 
 
132 
(E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azepan-1-
yl}propanoate (161a) 
 
133 
(E)-tert-Butyl 3-{2-[2-(4-nitrophenyl)-2-oxoethylidene]azepan-1-
yl}propanoate (161a) 
 
 
134 
 
(E)-tert-Butyl 3-[2-(2-oxo-2-phenylethylidene)azepan-1-yl]propanoate (161d) 
 
 
135 
 
(E)-tert-Butyl 3-[2-(2-oxo-2-phenylethylidene)azepan-1-yl]propanoate (161d) 
 
 
136 
(Z)-1-(4-Nitrophenyl)-2-(pyrrolidin-2-ylidene)ethanone (165a) 
 
 
 
137 
(Z)-1-(4-Nitrophenyl)-2-(pyrrolidin-2-ylidene)ethanone (165a) 
 
 
 
138 
(Z)-2-(Azepan-2-ylidene)-1-phenylethanone (166b) 
 
 
 
139 
(Z)-2-(Azepan-2-ylidene)-1-phenylethanone (166b) 
 
 
 
140 
(Z)-2-(Azocan-2-ylidene)-1-(4-nitrophenyl)ethanone (167a) 
 
 
 
141 
(Z)-2-(Azocan-2-ylidene)-1-(4-nitrophenyl)ethanone (167a) 
 
 
 
142 
(Z)-2-(Azonan-2-ylidene)-1-(4-nitrophenyl)ethanone (168a) 
 
 
 
143 
(Z)-2-(Azonan-2-ylidene)-1-(4-nitrophenyl)ethanone (168a) 
 
 
 
144 
(Z)-2-(Azacyclotridecan-2-ylidene)-1-(4-nitrophenyl)ethanone (169a) 
 
 
 
145 
(Z)-2-(Azacyclotridecan-2-ylidene)-1-(4-nitrophenyl)ethanone (169a) 
 
 
 
146 
8-(4-Nitrobenzoyl)-2,3,6,7-tetrahydroindolizin-5(1H)-one (178a) 
 
 
 
147 
8-(4-Nitrobenzoyl)-2,3,6,7-tetrahydroindolizin-5(1H)-one (178a) 
 
 
 
148 
1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one (179a) 
 
 
 
149 
1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one (179a) 
 
 
 
150 
1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one (179a) (isomer?) 
 
 
 
151 
1-(4-Nitrobenzoyl)-2,3,6,7,8,9-hexahydroquinolizin-4-one (179a) (isomer?) 
 
 
 
152 
1-Benzoyl-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-4(6H)-one (180b) 
 
 
 
153 
1-Benzoyl-2,3,7,8,9,10-hexahydropyrido[1,2-a]azepin-4(6H)-one (180b) 
 
